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ABSTRACT
CALCIUM/DIACYLGLYCEROL-de pe n d e n t pr o t e i n p h o s p h o r y l a t i o n 
IN THE NERVOUS SYSTEM
Katherine Ann Albert 
Yale University- 
1988
Calcium/diacylglycerol-dependent protein kinase, most often 
referred to as protein kinase C, is of interest to research groups 
across many scientific disciplines for two major reasons. First, 
protein kinase C is of general importance in signal transduction because 
its second messenger activator, diacylglycerol, is generated by 
phosphoinositide metabolism in response to a host of biologically active 
molecules. Second, protein kinase C has been identified as the cellular 
receptor for tumor-promoting phorbol esters. Protein kinase C is of 
particular interest to neuroscientists because its highest activity is 
in the nervous system. The studies described in this dissertation were 
undertaken to analyze the role of protein kinase C in the nervous 
system. Three different approaches were employed. First, a major 
endogenous substrate for protein kinase C, the 87-kDa protein, was 
identified in brain, was purified, and was characterized with respect to 
its physicochemical properties and its distribution. Second, the effect 
of phosphorylation by protein kinase C was examined with a nervous 
system substrate of known function, namely tyrosine hydroxylase. Third,
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the regulation of protein kinase C by calcium-binding proteins was 
examined.
The 87-kDa protein was identified in bovine brain and was purified
from bovine forebrain supernatant with the use of conventional
chromatographic methods. The physicochemical properties of the 87-kDa
protein indicated that the molecular weight was 68 kDa, and that the
protein was an extremely elongated monomer. The 87-kDa protein was
32phosphorylated by protein kinase C to a stoichiometry of 2.2 mol P per 
mol protein, exclusively on serine residues.
The 87-kDa protein was characterized with respect to its species, 
tissue, and subcellular distribution. A similar protein was present in 
monkey, human, rat, mouse, and bovine brain, in Torpedo californica 
electric organ, and in a variety of non-neuronal rat and bovine tissues. 
The rat protein was of M 4,000-7,000 lower, and was slightly more 
acidic, than the bovine protein. The distribution of the 87-kDa protein 
was found to be similar to the distribution of protein kinase C.
Protein kinase C was found to phosphorylate and activate tyrosine 
hydroxylase. The results suggest that protein kinase C and cAMP- 
dependent protein kinase phosphorylate the same site(s) on tyrosine 
hydroxylase, and activate tyrosine hydroxylase by the same mechanism.
Calmodulin was found previously to inhibit the 
calcium/phospholipid-dependent phosphorylation of the 87-kDa protein, in 
a crude extract prepared from rat brain synaptosomal cytosol. In the 
present work, rabbit brain calmodulin and some other calcium-binding 
proteins were found to inhibit the phosphorylation of the 87-kDa protein
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by protein kinase C, in the purified system. These results suggest that 
protein kinase C may be regulated by calcium-binding proteins.
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Chapter 1. GENERAL INTRODUCTION
PROTEIN PHOSPHORYLATION
A major interest of biological science at present is the 
elucidation of the mechanisms involved in the transduction of 
extracellular signals into biological responses. Protein phosphoryla­
tion has been recognized as one powerful common pathway through which 
target cells respond to extracellular signals. Important early advances 
in this research were the first description of a protein kinase (Burnett 
and Kennedy, 1954), the demonstration that epinephrine stimulates 
glycogenolysis in the liver by increasing the synthesis of cyclic AMP 
(cAMP) (Rail et al.. 1957), the first purification of a protein kinase, 
namely phosphorylase b kinase (Krebs et al.. 1964), and the discovery of 
cAMP-dependent protein kinase and its activation as a step in the 
sequence of events by which epinephrine regulates glycogen metabolism 
(Walsh et al.. 1968).
Cyclic AMP-dependent protein kinase was found to be present in a 
wide variety of tissue and phyla of the animal kingdom (Kuo and 
Greengard, 1969). A role for cAMP-dependent protein phosphorylation in 
the nervous system was suggested by the presence of a high activity of 
the kinase in brain (Miyamoto et al.. 1969).
These and subsequent findings led to the suggestion that 
activation of cAMP-dependent protein kinase is both a necessary and
1
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2sufficient step through which cAMP, and those regulatory agents that act 
by altering cAMP levels, produce both metabolic and physiological 
responses (Kuo and Greengard, 1969; Greengard et al.. 1971; for reviews 
see Nestler and Greengard, 1984; Krebs and Beavo, 1979). Because of the 
discovery of additional second messengers and their corresponding 
protein kinases, the original hypothesis has been expanded to state that 
a wide variety of extracellular signals produce many of their metabolic 
and physiological responses through the regulation of specific protein 
kinases (Greengard, 1978, 1987).
The presence of a number of phosphorylation systems in high 
concentration in the brain provides evidence for their importance in 
nervous tissue (Nestler and Greengard, 1984; Nairn et al.. 1985b). A 
scheme of intracellular protein phosphorylation pathways in the nervous 
system is illustrated in Figure 1. A variety of extracellular signals, 
or first messengers, such as neurotransmitters, hormones, or the nerve 
impulse itself, produce a variety of biological responses by one or 
another of the pathways shown in this scheme. There are four known 
second messengers, namely, cAMP, cyclic GMP (cGMP), calcium, and 
diacylglycerol, which achieve many of their effects through activation 
of their specific protein kinase(s), namely cAMP-dependent protein 
kinase, cGMP-dependent protein kinase, calcium/calmodulin-dependent 
protein kinases, and calcium/diacylglycerol-dependent protein kinase 
(protein kinase C). All of these kinases phosphorylate serine and 
threonine residues on their substrate proteins. There are also protein 
kinases which phosphorylate tyrosine residues on their substrate 
proteins, and for which no activators have yet been identified.
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3Figure 1. Protein phosphorylation in the nervous system. Extracellular 
signals (first messengers) produce specific biological responses in target 
neurons via a series of intracellular signals (second, third, and other 
messengers). Second messengers in the brain include cyclic AMP, cyclic GMP, 
calcium, and diacylglycerol. Cyclic AMP and cyclic GMP produce many of 
their second messenger actions through the activation of virtually one type 
of cyclic AMP-dependent protein kinase and one type of cyclic GMP-dependent 
protein kinase, respectively. The former enzyme exhibits a broad substrate 
specificity and the latter a more restricted specificty. Calcium exerts 
certain of its second messenger actions through the activation of 
calcium/calmodulin-dependent protein kinases. Most calcium/calmodulin- 
dependent protein kinases exhibit restricted substrate specificities.
Calcium exerts other actions through a variety of physiological effectors 
other than protein kinases. Diacylglycerol with calcium, in the presence of 
phosphatidylserine, produces its second messenger action through the 
activation of one type of protein kinase, called protein kinase C. These 
various cyclic nucleotide-dependent and calcium-dependent protein kinases 
phosphorylate proteins specifically at serine and threonine residues. There 
is also a class of protein kinases that phosphorylate proteins specifically 
at tyrosine residues (protein tyrosine kinases). The activation of 
individual protein kinases causes the phosphorylation of specific substrate 
proteins in target neurons. In some cases these substrate proteins, or 
third messengers, represent the immediate effector for the biological 
response. In other cases they produce the biological response indirectly 
through fourth, fifth, sixth, and other messengers.
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4Finally, there are receptors for a variety of growth factors and for 
insulin, which are themselves tyrosine kinases.
Direct evidence for the involvement of these protein kinases in 
the regulation of specific physiological responses to various first and 
second messengers has been obtained, by monitoring the effects of 
intracellular injections of the purified protein kinases and specific 
protein kinase inhibitors, using electrophysiological recording 
techniques. These studies have demonstrated a causal role for cAMP- 
dependent protein kinase (Castelluci et al.. 1981, 1982; Kaczmarek et 
al.. 1980), cGMP-dependent protein kinase (Bartfai et al.. 1985; 
Paupardin-Tritsch et al.. 1986), calcium/calmodulin-dependent protein 
kinase II (Llinas et al.. 1985), and protein kinase C (DeRiemer et al.. 
1985; Hammond et al.. 1987; Hu et al.. 1987) in the regulation of 
specific physiological functions of neurons. Thus, the results of these 
studies provide direct evidence for a relationship between protein 
phosphorylation and physiological responses in the nervous system.
DIACYLGLYCEROL AS A SECOND MESSENGER
Hokin and Hokin (1953) first showed that acetylcholine induces a 
32
rapid incorporation of P into phosphatidylinositol and phosphatidic 
acid in pancreas. Later experiments showed that this incorporation 
results from the enhanced breakdown and resynthesis of inositol 
phospholipids (for reviews see Hokin and Hokin, 1964; Michell, 1975; 
Hawthorne and Pickard, 1979; Irvine et al.. 1982; Berridge, 1987).
Durell et al. (1969) suggested a potential role for this response in
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5receptor functions, and Michell (1975) postulated that the phospholipid 
breakdown might open a calcium gate. In 1983, Berridge and his 
coworkers (Streb et al.. 1983; Berridge and Irvine, 1984) demonstrated 
that one of the two direct products of phosphatidylinositol 4,5- 
bisphosphate (PIP2) hydrolysis, namely inositol-1,4,5-trisphosphate 
(IP^), serves as a mediator for calcium mobilization from an 
intracellular compartment. Nishizuka and his coworkers demonstrated 
that the other product of PIP2 hydrolysis, namely 1 ,2-diacylglycerol, 
activates protein kinase C; they also demonstrated that this protein 
phosphorylation system is separate from (but often acts synergistically 
with), the calcium signaling pathway in the control of various cellular 
functions (Takai et al.. 1979; Kishimoto et al.. 1980; Mori et al..
1980; Kawahara et al.. 1980; Sano et al.. 1983). Therefore, a key 
feature of the inositol lipid signaling system is that both products of 
PIP2 hydrolysis function as second messengers. Figure 2 depicts this 
bifurcating signal pathway of PI turnover.
Receptor-mediated hydrolysis of inositol phospholipids (PI 
turnover) has recently been appreciated to be a common mechanism for the 
transduction of various extracellular signals into the cell. 
Extracellular messengers which achieve their effects via PI turnover 
include certain hormones, neurotransmitters, antigens, growth factors, 
and many other biologically active substances (detailed lists of these 
stimuli may be found in Berridge, 1984; Berridge and Irvine, 1984;
Downes and Michell, 1985; Hokin, 1985; Nahorski, 1986). In neural 
tissues (for review see Fisher and Agranoff, 1987), K+ -induced 
depolarization in the presence of calcium results in PI turnover.
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Figure 2. This scheme depicts the production of the protein 
kinase C activator diacylglycerol in the bifurcating signal pathway of 
PI turnover. The transduction unit within the plasma membrane consists 
of three main components: a receptor that detects the oncoming signal, 
the G protein G that serves to couple the receptor to the third 
component, and ?he phosphoinositidase responsible for cleaving the lipid 
precursor. When an agonist occupies the receptor, it activates G , 
which then binds GTP as part of the reaction leading to the stimufation 
of phosphoinositidase, which hydrolyzes PIP. into the two second 
messengers diacylglycerol and IP,. Diacylglycerol activates protein 
kinase C, and IP^ serves as a mediator for calcium mobilization from an 
intracellular compartment. Therefore, a key feature of this signaling 
system is that both products of PIP^ hydrolysis function as second 
messengers. Both second messengers can be metabolized rapidly back to 
phosphatidylinositol.
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7Nervous system receptors demonstrated to be coupled to PI turnover 
include M^ and muscarinic cholinergic, adrenergic, 
histaminergic, 5-HT2 and 5-HT^c serotonergic, and glutaminergic; 
receptors purported to be coupled to PI turnover include those for 
substance K, neurotensin, cholecystokinin, substance P, vasopressin, 
bradykinin, TRH, vasoactive intestinal peptide, and angiotensin; 
receptors not coupled to PI turnover include histaminergic, 5-HT^ 
serotonergic, f } -adrenergic, -adrenergic, nicotininc cholinergic, and 
GABAergic (see Fisher and Agranoff, 1987).
The transduction unit within the plasma membrane consists of three 
main components (for review see Berridge, 1987): 1. the receptor that 
detects the oncoming signal, 2. a G protein (G^) that serves to couple 
the receptor to the third component, and 3. the phosphodiesterase 
responsible for cleaving the lipid precursor. In order to avoid 
confusion with the nomenclature employed in the cAMP field, where 
phosphodiesterase is used to describe the enzyme that degrades cAMP to 
AMP, Downes and Michell (1985) have introduced the term phos­
phoinositidase to describe the enzyme that hydrolyzes PIP^.
PROTEIN KINASES
The effects of cAMP are achieved through activation of cAMP- 
dependent protein kinase, which phosphorylates many substrate proteins. 
Some, but not all, of the effects of cGMP are achieved through 
activation of cGMP-dependent protein kinase, which phosphorylates a 
number of specific substrate proteins.
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8The second messenger actions of calcium are more complex. A few 
of the second messenger actions of calcium are achieved through 
regulation of physiological effectors other than protein kinases (see 
Chapter 5). However, it appears that many of the second messenger 
actions of calcium are achieved through activation of the two subclasses 
of calcium-dependent protein kinases, namely calcium/calmodulin- 
dependent protein kinases and protein kinase C.
The existence of calcium/calmodulin-dependent protein kinase(s) 
was independently reported by different research groups in 1978 
(Dabrowska et al., 1978; Schulman and Greengard, 1978; Yagi et al..
1978; Cohen et al.. 1978; Perry et al.. 1978). A number of 
calcium/calmodulin-dependent protein kinases have subsequently been 
identified in various tissues; these kinases include phosphorylase 
kinase (Cohen et al.. 1978); myosin light chain kinase (Dabrowska, 1978; 
Yagi et al.. 1978; Nairn and Perry, 1979); calcium/calmodulin-dependent 
protein kinase I (Nairn and Greengard, 1987), which phosphorylates site 
I on synapsin I, a synaptic vesicle-associated protein (De Camilli et 
al-. 1983a,b; Huttner et al.. 1983); calcium/calmodulin-dependent 
protein kinase II (McGuinness et al.. 1983; Bennett et al.. 1983; 
McGuinness et al.. 1985), which phosphorylates site II on synapsin I, 
and which appears to be an isozyme of a family of related multifunc­
tional enzymes which phosphorylate several proteins, including glycogen 
synthase, microtubule-associated protein 2, and tyrosine hydroxylase 
(McGuinness et al. . 1983; Bennett et al.. 1983; McGuinness et al.. 1985; 
Ahmad et al.. 1982; Fukunaga et al.. 1982; Yamauchi and Fujisawa, 1983; 
Payne et al.. 1983; Gorelick et al.. 1983; Goldenring et al.. 1983;
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9Kuret and Schulman, 1984); and calcium/calmodulin-dependent protein 
kinase III (Naim et al.. 1985a), which phosphorylates a protein which 
has recently been shown to be identical to elongation factor 2 (Nairn 
and Palfrey, 1987). Most of the calcium/calmodulin-dependent protein 
kinases appear to have a limited substrate specificity, i.e. each kinase 
phosphorylates one or two proteins, with the notable exception of 
calcium/calmodulin-dependent protein kinase II, which has a somewhat 
broader substrate specificity.
PROTEIN KINASE C
The other subclass of calcium-dependent protein kinase, protein 
kinase C (for recent reviews see Woodgett et al.. 1987; Kikkawa and 
Nishizuka, 1986; Niedel and Blackshear, 1986), is activated by the 
second messengers calcium and diacylglycerol and requires the presence 
of phosphatidylserine for activity.
Identification of protein kinase C . The initial major discoveries 
concerning protein kinase C were all accomplished by Nishizuka and 
colleagues, including its description as a protein kinase activatable in 
vitro by proteolysis (Inoue et al.. 1977; Takai et al.. 1977); the 
demonstration that the kinase can be stimulated by calcium and acidic 
phospholipids (Takai et al.. 1979b); the discovery that diacylglycerol 
stimulates the activity of the kinase by increasing its affinity for 
calcium and phospholipids (Takai et al.. 1979a; Kishimoto et al.. 1980); 
and the discovery that tumor-promoting phorbol esters can activate the 
kinase by substituting for diacylglycerol (Castagna et al.. 1982).
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10
Protein kinase C was soon found by a number of researchers to be the 
major, and perhaps the only, tumor-promoting phorbol ester receptor 
(Ashendel et al.. 1983a,b; Niedel et al.. 1983; Leach et al.. 1983;
Sando and Young, 1983; Kikkawa et al.. 1983b). The discovery of protein 
kinase C as the major phorbol ester receptor will allow the biochemical 
effects of tumor promotion to be probed in greater detail (for reviews 
see Nishizuka, 1984a,b; Ashendel,1985; Castagna, 1987).
Protein kinase C is broadly distributed among the tissues of
vertebrates and throughout the phyla of the animal kingdom (Kuo et al..
1980; Minakuchi et al.. 1981). The enzyme was first partially purified
from bovine heart (Wise et al.. 1982), then was purified to homogeneity
from tissues in which it is more abundant, namely rat brain (Kikkawa et
al.. 1982) and pig spleen (Schatzman et al.. 1983). The enzyme is most
often isolated from brain (Kikkawa et al.. 1983a, 1986; Le Peuch et al..
1983; Parker et al.. 1984a; Walsh et al.. 1984; Wolf et al.. 1984; Jeng
et al.. 1986; Woodgett and Hunter, 1987) or adrenal gland (Uchida and
Filburn, 1984). The purified enzyme from these preparations appears as
a single or double protein staining band of 77,000-83,000 upon
NaDodSO^ polyacrylamide gel electrophoresis (PAGE), behaves as a monomer
of 77,000 upon sedimentation analysis, and behaves as a monomer of
87,000 upon gel filtration chromatography; its pi is about 5.6 (Kikkawa
et al.. 1982; Wise et al.. 1982). The pH optimum for its activity is
between 7.5 and 8, and its K for ATP is about 10 yM (Kikkawa et al..m ------
1982; Wise et al.. 1982).
Activation of protein kinase C. The activation of protein kinase 
C by a cation is specific for calcium (Takai et al.. 1979b; Wise et al..
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1982). Studies of the in vitro activation of protein kinase C by 
phospholipids and diacylglycerol in aqueous buffers are complicated by 
solubility issues. In studies with sonicated phospholipids, protein 
kinase C can be activated in the presence of calcium by acidic 
phospholipids, preferentially phosphatidylserine, while basic 
phospholipids are ineffective (Takai et al.. 1979b; Wise et al.. 1982; 
Kaibuchi et al.. 1981). Diacylglycerol alone does not activate protein 
kinase C, but in the presence of phosphatidylserine, diacylglycerol 
lowers the calcium requirement of the enzyme from approximately 100 pM 
to less than 1 /iM (Takai et al.. 1979b; Kishimoto et al.. 1980). In the 
presence of diacylglycerol and 2 f iM calcium, phosphatidylserine is the 
only activating phospholipid (Kaibuchi et al.. 1981). Other lipophilic 
compounds, e.g. unsaturated fatty acids, have been reported to 
substitute for phospholipids (Ohkubo et al.. 1984; McPhail et al.. 1984;
Horn et al.. 1985; Murakami and Routtenberg, 1985; Hansson et al.. 1986;
Shoyab, 1985; Wightman and Raetz, 1984), but their role in the
physiological activation of protein kinase C is unclear. More recent 
studies with defined, stable vesicles of phosphatidylserine: 
phosphatidylcholine (1:4) (Boni and Rando, 1985) and with defined 
phosphatidylserine-.Triton X-100 mixed micelles (Hannun et al. . 1985,
1986), have shown that in the presence of calcium (and 
phosphatidylserine), there is close to an absolute dependence on 
diacylglycerol for activity.
Sn-1,2-diacylglycerols stereospecifically activate protein kinase 
C (Takai et al.. 1979a; Kishimoto et al.. 1980; Rando and Young, 1984; 
Couturier et al.. 1984). The 3-OH group and 1,2-carbonyls are required
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for activation (Cabot and Jaken, 1984; Ganong et al.. 1986). A long- 
chain fatty acid is required for at least one (either) of the 1,2 
positions (Mori et al.. 1982), with activity increasing from 3 to 11 
carbons (Hannun et al.. 1986). Diacylglycerols which have long enough 
fatty acid chains to activate protein kinase C, but whose chains are not 
so long as to have solubility problems when used in an intact cell 
system, are called permeant diacylglycerols. l-01eoyl-2-acetyl-glycerol 
(OAG) (Mori et al.. 1982) and sn-l,2-dioctanoylglycerol (DiCg) (Ganong 
et al.. 1986) are often used. Diacylglycerol increases the affinity of 
the enzyme for phospholipid 2-3-fold and, as mentioned above, decreases 
the for calcium about 100-fold (Kishimoto et al.. 1980; Wise et al.. 
1982; Hannun et al.. 1986). Conversely both phospholipid and calcium 
increase the affinity of the enzyme for diacylglycerol (Hannun et al..
1986). A model has been proposed (Bell, 1986) in which a "primed" 
(protein kinase C)^(phosphatidylserine)^ (calcium)^ complex is formed, 
to which one molecule of diacylglycerol binds to activate the enzyme. 
Therefore, active protein kinase C appears to exist as a quarternary 
complex comprising the enzyme, phosphatidylserine, calcium, and 
diacylglycerol.
Protein kinase C can also be activated by proteolysis. Protein 
kinase C was initially isolated as a protease-activated protein kinase 
(Takai et al.. 1977). Incubation with calcium-dependent neutral 
protease (calpain I), or trypsin, generates a 50 kDa catalytic fragment, 
called protein kinase M, that is no longer dependent on calcium or 
phospholipid for activity (Kishimoto et al.. 1983). Sustained 
proteolysis destroys activity. Proteolytic cleavage is enhanced in the
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presence of calcium and diacylglycerol, which suggests that the active 
form of the enzyme is more susceptible to proteolysis (Kishimoto et al..
1983). A 35 kDa regulatory domain of protein kinase C can also be 
generated upon proteolysis (Hoshijima et al.. 1986; Huang and Huang,
1986; Woodgett et al.. 1987).
Like other protein kinases, protein kinase C undergoes an 
autophosphorylation reaction in vitro in the presence of magnesium, ATP, 
calcium, phosphatidylserine, and diacylglycerol (Kikkawa et al.. 1982; 
Woodgett and Hunter, 1987; Huang et al.. 1986a). Both serine and 
threonine residues are labeled (Kikkawa et al.. 1982; Huang et al.. 
1986a). Protein kinase C autophosphorylation has a K for ATP (1.5 fiW) 
lower than that for the phosphorylation of exogenous substrates, and the 
reaction appears to be intramolecular (Huang et al.. 1986a). The 
autophosphorylated enzyme still depends on calcium and phospholipid for 
maximal activity; however, the autophosphorylated kinase has a lower K 
for calcium and a higher affinity for the binding of phorbol ester than 
the nonphosphorylated form (Huang et al.. 1986a). These findings 
suggest that autophosphorylation of protein kinase C may be important in 
the regulation of the enzymic activity subsequent to signal 
transduction.
Translocation of protein kinase C. Upon subcellular fractionation 
of protein kinase C from rat brain in the presence of EGTA and EDTA, 
about 40% of protein kinase C activity is found in the soluble fraction, 
and 60% is found in the particulate fraction, although the particulate 
kinase can be detected only after treatment of the particulate fraction 
with Triton X-100 (Kikkawa et al.. 1982). The significance of this
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detergent-solubilized fraction of protein kinase C is unknown. In the 
presence of calcium, the EGTA-solubilized fraction of the kinase is 
found to be associated with the particulate fraction (Takai et al..
1979b; Takai et al.. 1979c). Experiments with inside-out erythrocyte 
vesicles showed that calcium controls the binding of protein kinase C to 
membranes, that phorbol esters and diacylglycerol control both binding 
and activity, and that calcium and phorbol esters each potentiate the 
other's ability to stabilize the association of the kinase to membranes 
(Wolf et al.. 1985a,b). Therefore, it appears that part of the 
activation process involves the binding of protein kinase C to 
membranes. Although the calcium-mediated association of the cytosolic 
fraction of protein kinase C with membranes or phosphatidylserine 
vesicles is reversible by the removal of calcium, the enzyme is not 
easily removed when it is activated by diacylglycerol or phorbol ester 
(see Bell, 1986); release of the enzyme from membranes occurs by a 
process that is enhanced by ATP and magnesium (Wolf et al.. 1985b).
Phorbol esters and permeant diacylglycerols applied extracel- 
lularly result in protein kinase C activation (Castagna et al.. 1982; 
Kaibuchi et al.. 1983; Ebeling et al.. 1985), and produce translocation,
i.e. decreases in cytosolic and increases in particulate protein kinase 
C (Kraft et al.. 1982; Kraft and Anderson, 1983; McCaffrey et al.. 1984; 
Shoji et al.. 1986). In contrast, several different patterns of protein 
kinase C localization have been seen in response to extracellular 
signals which activate phosphatidylinositol 4,5-bisphosphate (PIP2) 
hydrolysis, including translocation from soluble to particulate 
fractions (Hirota et al.. 1985; Farrar and Anderson, 1985; Farrar et
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al.. 1985; Nel et al.. 1986; Fearon and Tashjian, 1985; for review see 
Anderson et al.. 1985), "reverse" translocation from membranes to the 
soluble fraction (Vilgrain et al.. 1984; Costa-Casnellie et al.. 1985), 
and no apparent change (Halsey et al.. 1986). The molecular mechanisms 
of these diverse responses remain to be determined.
Another interesting question is the cellular site(s) of attachment 
of protein kinase C to membranes. The phospholipid composition of 
membranes may determine which cellular membranes can support binding of 
protein kinase C. Since the inner leaflet of the plasma membrane is 
particularly rich in acidic phospholipids, and other membranes contain 
greater proportions of phosphatidylcholine, one might predict that the 
enzyme will exhibit a higher affinity for the former (Woodgett et al.. 
1987), which is also the sight of agonist-induced diacylglycerol 
production. However, Takai et al. (1979c) found that intracellular 
membranes could also activate protein kinase C, and after subcellular 
fractionation, phorbol ester binding (Dunphy et al.. 1981) and protein 
kinase C activity (Kikkawa et al.. 1982) were found in all particulate 
fractions. In addition, studies of the distribution of fluorescent 
derivatives of phorbol esters have suggested that active phorbol esters 
are taken up rapidly by the cells and stain intensely the entire 
cytoplasm, while the nucleus is unstained (Liskamp et al.. 1985). 
Finally, recent experiments with immunofluorescent microscopy with 
antibodies directed against protein kinase C have suggested that there 
are differences in the responses of different cell types to phorbol 
esters, in terms of intracellular localization of the immunoreactive 
kinase (Halsey et al.. 1986; Shoji et al.. 1986). Therefore, it may be
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that in vivo localization and activation of protein kinase C at any one 
time depends on such factors as intracellular calcium concentration, 
diacylglycerol concentration, and the phospholipid composition of the 
cellular membranes.
Down-regulation of protein kinase C . A property of the phorbol 
ester receptor related to translocation is down-regulation in response 
to the treatment of certain intact cells with phorbol ester (Shoyan and 
Todaro, 1980; Jaken et al.. 1981; Solanki et al.. 1981; Collins and 
Rozengurt, 1982; Yamasaki et al.. 19S2). Cells in which the receptor 
has been down-regulated are refractory to further stimulation by phorbol 
esters or other agonists of protein kinase C. This property has been 
exploited to determine the involvement of protein kinase C in different 
cellular processes (see e.g. Rozengurt et al.. 1983; Coughlin et al..
1985) . The mechanism for down-regulation has recently been elucidated, 
with use of antibodies to protein kinase C (Ballester and Rosen, 1985; 
Woodgett et al.. 1987). The protein kinase which has been translocated 
and activated has a much shorter half-life than the kinase in the 
resting cell (1-5 h vs. longer than 24 h), probably due to an increased 
rate of degradation, since down-regulation is inhibited by leupeptin 
(see Woodgett et al.. 1987). There is no decrease in protein kinase 
synthesis or mRNA levels (see Woodgett et al.. 1987) in cells treated 
with TPA. Persistent stimulation with phorbol ester causes newly 
synthesized protein kinase C to move to the membrane and be subject to 
the faster degradation rate.
Inhibition of protein kinase C . The activity of protein kinase C 
can be inhibited by a variety of compounds. 1. Inhibitors of
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phospholipid binding. One class of inhibitors interferes with 
phopholipid binding to protein kinase C. Within this class, there is a 
subset of inhibitors which are not specific because they are all potent 
inhibitors of other cellular functions, including calcium/calmodulin- 
dependent protein phosphorylation. These include members of the 
phenothiazine drug family (Mori et al.. 1980; Schatzman et al.. 1981; 
Uratsuji et al.. 1985), W7 (Tanaka et al.. 1982), and R-24571 (Mazzei et 
al.. 1984). Another subset of inhibitors which interact with 
phospholipids include surface active polypeptides such as marine worm 
cytotoxin AIV (Kuo et al.. 1983), cobra cytotoxin 1 (Kuo et al.. 1983), 
the antibiotic polymixin B (Mazzei et al.. 1982), gossypol, which is 
also an adenylate cyclase inhibitor (Kimura et al.. 1985), and 
tamoxifen, which is also a cAMP phosphodiesterase inhibitor (O'Brian et 
al.. 1985). Toxicity restricts the usefulness of this subset of 
compounds in vivo. Another compound which interferes with phospholipid 
binding is sphingosine (Hannun et al.. 1986), the specificity and 
usefulness of which are still being investigated.
2. Competitors of ATP. Another class of inhibitors competes with 
ATP. A series of isoquinolinesulphonamide compounds have been reported 
to inhibit several protein kinases with different selectivities (Hidaka 
et al.. 1984). For example, H-8 inhibits cyclic nucleotide-dependent 
protein kinases 15-30-fold more potently than protein kinase C, while H- 
7 inhibits protein kinase C with a similar potency to the other protein 
kinases (Hidaka et al.. 1984). Unfortunately, in vitro none of the 
compounds selectively inhibit protein kinase C.
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3. Synthetic peptides. Protein kinase C phosphorylates a number 
of synthetic peptides corresponding to phosphorylation site sequences of 
substrates (O'Brian et al.. 1984; Ferrari et al.. 1985; Kishimoto et
al.. 1985; Turner et al.. 1985; Woodgett et al.. 1986). Substitution of 
the phosphorylated residue in such peptides with a non-phosphorylatable 
residue such as alanine results in the formation of selective but rather 
weak inhibitors of the enzyme which are competitive with respect to 
substrates (O'Brian et al.. 1984; Su et al.. 1986).
4. Staurosporine. The most potent inhibitor thus far described is 
staurosporine, an antifungal microbial alkaloid (Tamaoki et al.. 1986), 
but this compound also potently inhibits cAMP-dependent protein kinase 
and is toxic to cell growth.
5. Calcium-binding proteins. Finally, protein kinase C activity 
can be inhibited by certain calcium-binding proteins. The first 
observation of inhibition by calmodulin of calcium/phospholipid- 
dependent protein phosphorylation was made in the nervous system by Wu 
et al. (1982). Chapter 5 of this thesis presents further characteriza­
tion of this inhibition of protein kinase C by calcium-binding proteins, 
with use of purified components. There have been other reports of 
inhibition of protein kinase C by calmodulin (Saitoh and Dobkins, 1986), 
by troponin C (Mazzei and Kuo, 1984), and by SlOOb protein (Baudier et 
al.. 1986). A novel calcium-binding protein of M 17,000 that inhibits 
protein kinase C activity has been purified from brain and characterized 
extensively (McDonald and Walsh, 1985a,b,1986; McDonald et al.. 1987). 
There have also been reports of inhibition of protein kinase C activity 
by unidentified low molecular weight proteins isolated from brain
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(Schwantke and LePeuch, 1984) and from stomach (Holian et al.. 1986). 
This topic is discussed in greater detail in Chapter 5.
Isozvmes of protein kinase C . The existence of multiple forms of 
protein kinase C was found recently by a number of research groups, with 
use of complementary DNA cloning in rat brain (Ono et al.. 1986; Knopf 
et al.. 1986), bovine brain (Parker et al.. 1986; Coussens et al..
1986), and rabbit brain (Ohno et al.. 1987); and with use of biochemical 
techniques in rat brain (Huang et al.. 1986b; Woodgett and Hunter,
1987). At least three different cDNA clones have been identified (for 
review see Carpenter et al.. 1987), and additional forms of protein 
kinase C may be generated by alternate splicing of mRNA (Ohno et al..
1987). Regions of similarity exist in the reported sequences, such that 
the distribution of conserved residues allows the division of the 
protein into four conserved (C1-C4) and five variable (VI-V5) regions 
(Carpenter et al.. 1987). C3 and C4, in the carboxy-terminal region of 
the protein, have the greatest homology with cAMP- and cGMP-dependent 
protein kinases, and there is a likely cleavage site for calpain I, 
which would divide the protein into an amino-terminal regulatory domain 
and a carboxy-terminal catalytic domain (Carpenter et al.. 1987) Other 
than sequence, the only clear difference recognized among these forms so 
far has been distribution, with one type found specifically in brain, a 
second type found in all tissues examined, and a third type found in 
many tissues, but not in as widespread a distribution as the second type 
(Huang et al.. 1986b; Ohno et al.. 1987; Brandt et al.. 1987; Huang et 
al.. 1987).
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Distribution of protein kinase C within brain. Immunological and 
phorbol ester binding studies of the regional and subcellular 
distribution of protein kinase C within the brain have yielded 
conflicting results. Studies with polyclonal antisera found that the 
enzyme was distributed broadly in different brain regions, but the 
enzyme was found to be concentrated in granule cells in the hippocampus, 
in mossy fibers, Golgi II neurons, and Purkinje neurons in the 
cerebellum, and in axons and cells resembling oligodendroglia in white 
matter regions (Girard et al.. 1985; Wood et al.. 1986). These studies 
also found the enzyme to be concentrated presynaptically in nerve 
terminals, with little staining post-synaptically, and to be present 
inside the nucleus (Girard et al.. 1985; Wood et al.. 1986). A study 
using phorbol ester binding found discrete binding sites primarily 
associated with neurons; evidence was presented for localization to 
intrinsic neurons of the cortex and hippocampus, terminals of the 
striatonigral projection, a projection to the molecular layer of the 
dentate gyrus, and to dendrites of Purkinje cells; thus, this study 
showed binding primarily associated with neurons, within the cerebellum 
within Purkinje cells, and subcellularly within terminals and dendrites 
(Worley et al.. 1986). These results were in general agreement with a 
regional distribution of protein kinase C measured biochemically (Walaas 
et al.. 1983a,b), with regional phorbol ester binding measured in 
homogenates (Nagle et al.. 1981), and with a preliminary study of 
phorbol ester binding by Nagle and Blumberg (1983). In another study 
with monoclonal antibodies, the authors postulated that their antibodies 
recognized only the nervous tissue-specific isozyme of protein kinase C
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(Kitano et al.. 1987). They found the enzyme to be primarily in nervous 
tissue; in cerebellum, it was primarily in Purkinje cells; and in 
Purkinje cells, it was present throughout the cytoplasm, including 
dendrites and axons, but was poorly represented in the cell nucleus 
(Kitano et al.. 1987). Thus, these results were consistent with those 
of Worley et al. (1986). Finally, a study using a series of monoclonal 
antibodies found three distinct antibody-staining patterns; one antibody 
excusively labeled astroglial elements, including astrocytes, tanycytes, 
and cerebellar radial glia; another exclusively labeled neural cells, 
including cortical and hippocampal pyramidal dendrites and Purkinje 
cells of the cerebellum; a third stained more limited regions including 
thalamic neurons, and astroglial structures in brain, spinal cord, and 
cerebellum (Mochly-Rosen et al.. 1987). It is possible that these 
staining patterns reflect isozymes of protein kinase C (Mochly-Rosen et 
al.. 1987). Huang et al. (1987) have reported that one isozyme is 
highly concentrated in cerebellum, hippocampus, and amygdala, another is 
highly concentrated in caudate, frontal and motor cerebral cortices, 
substantia nigra, and the thalamus, and a third is highly concentrated 
in the in olfactory bulb. In summary, there is disagreement about the 
distribution of protein kinase C in neurons vs. neurons and glia, about 
the exclusive distribution in Purkinje vs. other cells in the 
cerebellum, and about the presence or absence of protein kinase C in 
nuclei and in post-synaptic elememts. Further study will be required to 
resolve these questions.
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POSSIBLE ROLES FOR PROTEIN KINASE C IN CELLULAR RESPONSES
Since protein kinase C is activated by tumor-promoting phorbol 
esters, protein kinase C has been postulated to have a role in all of 
the previously known effects of phorbol esters, such as carcinogenesis, 
mitogenesis, cell differentiation, cell morphology, gene expression and 
cell proliferation. In many of these cases, further experimentation 
with permeant diacylglycerols will be necessary as the next step for 
elucidating the role of protein kinase C in these processes (Woodgett et 
al.. 1987).
Synergism with Calcium for Secretion. Under appropriate 
conditions, protein kinase C activation and calcium mobilization can be 
induced selectively and independently by the application of a permeant 
diacylglycerol or phorbol ester for the former and a calcium ionophore 
such as A23187 or ionomycin for the latter. By using this procedure it 
has been shown that the two signal pathways are both essential to elicit 
full cellular responses. The role of protein kinase C in stimulus- 
response coupling was first demonstrated for the release of serotonin 
from platelets (Kaibuchi et al.. 1983) and was subsequently shown for 
release reactions from a wide variety of cell types (for list see 
Kikkawa and Nishizuka, 1986), including neural tissues, e.g. 
catecholamine secretion from adrenal medulla (Knight and Baker, 1983; 
Brocklehurst et al.. 1985; Houchi et al.. 1985; Pocotte et al.. 1985), 
acetylcholine release from ileal nerve endings (Tanaka et al.. 1984) and 
caudate nucleus (Tanaka et al.. 1986), dopamine release from PC12 cells
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(Pozzan et al.. 1984) and neurons (Zurgil and Zisapel, 1985), and 
transmitter release from a neuromuscular preparation (Publicover, 1985).
Modulation of Membrane Functions. It has been proposed that 
protein kinase C plays a role in extrusion of calcium immediately after 
its mobilization into the cytosol, and that calcium-transport ATPase is 
a possible target. Studies with many cell types, including vascular 
smooth muscle and platelets, have shown that when receptors are 
stimulated, the appearance of calcium is transient (Morgan and Morgan, 
1982; Johnson et al.. 1985; see Berridge, 1987). In various cell types, 
the cytosolic calcium concentration is frequently decreased by the 
addition of phorbol ester (Sagi-Eisenberg et al.. 1985; Drummond, 1985; 
Tsien et al.. 1982; Moolenar et al.. 1984; Lagast et al.. 1984; Albert 
and Tashjian, 1985). From experiments with sarcoplasmic reticulum 
preparations from heart, it has been proposed that calcium-transport 
ATPase is activated by the addition of protein kinase C (Limas, 1980; 
Iwasa and Hosey, 1984; Movsesian et al.. 1984). In contrast, this 
protein kinase may take part in the enhancement of calcium entry in 
invertebrates, since microinjection of protein kinase C into bag cell 
neurons from Anlvsia enhances the voltage-sensitive calcium current 
(DeRiemer et al.. 1985); and the kinase has been shown to decrease a 
calcium current in Hermissenda (Hammond et al.. 1987).
Similarly, a role for protein kinase C in activating sodium- 
transport ATPase in peripheral nerve has been suggested (Greene and 
Lattimer, 1986). The Na+/H+ exchange protein appears to be another 
target that is activated by phorbol ester or by permeant diacylglycerol 
and, thus, protein kinase C may function to regulate cytoplasmic pH
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(Burns and Rozengurt, 1983; Rosoff et al.. 1984; Moolenar et al.. 1984; 
Besterman et al.. 1985). An additional example is obtained with 
photoreceptor cells of Hermissenda (Farley and Auerbach, 1986) and rat 
hippocampal pyramidal neurons (Baraban et al.. 1985). In these cells, 
treatment with phorbol ester or permeable diacylglycerol, as well as 
intracellular injection of protein kinase C, reduces calcium-dependent 
K+ conductance. Thus, protein kinase C has been proposed to play a role 
in the expression of plasticity, particularly in hippocampal neural 
activity (Routtenberg et al.. 1985; Akers et al.. 1986; Reymann et al.. 
1985) and learning in Hermissenda (Farley and Auerbach, 1986).
Negative feedback control. A major function of protein kinase C 
appears to involve negative feedback control. The application of 
phorbol ester can inhibit the subsequent response to occupation of 
receptors that are coupled to PI turnover, and this inhibition has been 
reported to occur in many cell types (for reviews see Kikkawa and 
Nishizuka, 1986; Nishizuka, 1986; Woodgett et al.. 1987), including 
pituitary cells, hippocampal slices, PC12 cells, and astrocytoma cells. 
The biochemical basis of this negative feedback control remains to be 
clarified. The discovery that hormonal activation of phospholipase C is 
mediated through a G protein, termed G^ for phospholipid, introduces a 
potential target for regulation by analogy with the G^ and Gg proteins 
of adenylate cyclase (Cockroft and Gomperts, 1985; Litosch et al..
1985). The negative regulation by protein kinase C also extends to 
receptors of other signaling systems. For example, protein kinase C 
phosphorylates the EGF receptor with a concomitant decrease in both its 
tyrosine kinase activity and growth factor binding activity (see below).
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Interaction between signaling systems. Cellular responses may be 
divided into several modes (see Nishizuka, 1986) based on the 
interaction between the class of receptors that result in the generation 
of cAMP and the class of receptors that result in PIP2 hydrolysis. In 
one control system the two classes of receptor counteract each other, 
whereas in another control system the two classes potentiate each other. 
In cell types such as platelets, neutrophils, and lymphocytes, the 
signals that induce PIP2 hydrolysis activate release reactions and 
cellular proliferation, but the signals that produce cAMP usually 
antagonize such activation. In these cells the signal-induced PI 
turnover and subsequent events leading to cellular proliferation are all 
blocked by cAMP. In another group of cells, such as avian erythrocytes, 
Leydig cells, and glioma C6 cells, protein kinase C inhibits and 
desensitizes the adenylate cyclase system. In several other cell types, 
including pinealocytes, pituitary cells, and lymphoma S49 cells, protein 
kinase C potentiates cAMP production. There is as yet no obvious 
example of a tissue in which cAMP potentiates signal-induced PI 
turnover. For the most part the molecular mechanisms for these negative 
and positive actions between the cyclic nucleotide and phosphoinositide 
pathways remain to be elucidated. As mentioned above, the discovery 
that hormonal activation of phospholipase C is mediated through a G 
protein introduces a potential target for regulation (Cockroft and 
Gomperts, 1985; Litosch et al.. 1985).
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SUBSTRATES FOR PROTEIN KINASE C
In order to understand the mechanisms of responses to activation 
of protein kinase C, the proteins that are phosphorylated by this kinase 
must be identified. This has not been an easy task since the purified 
enzyme phosphorylates many potential substrates presented to it in 
vitro. Hence a long list of substrates has been created which includes 
proteins of a variety of functions, subcellular locations, and 
structures. The reported substrates for protein kinase C may be divided 
into three categories: 1. substrates for protein kinase C in vitro. 2. 
proteins whose phosphorylation is stimulated by phorbol ester in vivo, 
and 3. proteins phosphorylated by protein kinase C in vitro and whose 
phosphorylation is stimulated by phorbol ester in vivo (for detailed 
lists see Woodgett et al. (1987)).
1. The reported substrates for protein kinase C in vitro include a 
number of enzymes, such as myosin light chain kinase (Ikebe et al..
1985; Nishikawa et al.. 1985) and calcium-activated neutral protease 
(Hincke and Tolnai, 1986); a number of cytoskeletal elements, including 
microtubule associated protein-2 (MAP-2) (Tsuyama et al.. 1986); and a 
number of proteins whose phosphorylation was found on NaDodSO^/PAGE in 
preparations from a number of tissues, e.g. a 36 kDa protein from lung 
(Malkinson et al.. 1985), and a 36 kDa protein from pituitary secretory 
granules (Turgeon and Cooper, 1986).
2. Proteins whose phosphorylation is stimulated by phorbol ester 
in vivo include a number of identified proteins, such as the p56 protein 
tyrosine kinase (Casnellie and Lamperts, 1986), ribosomal protein S6
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(LePeuch et al.. 1983; Blenis et al.. 1984; Trevillyan et al.. 1984; 
Padel and Soling, 1985; Parker et al.. 1985; Trevillyan et al.. 1985), 
and a number of proteins whose phosphorylation has been identified by 
NaDodSO^/PAGE, e.g. 83 kDa, 75 kDa, 47 kDa, 43 kDa, and 21 kDa proteins 
from primary rat neurons (Burgess et al.. 1986). A major caveat of this 
group of proteins is that the phosphorylated proteins may be substrates 
for kinases activated by protein kinase C rather than substrates for 
protein kinase C itself.
3. Thus far, there are relatively few proteins that are 
phosphorylated by protein kinase C in vitro and whose phosphorylation is 
stimulated by phorbol ester in vivo. Two of them, the 87-kDa protein 
and tyrosine hydroxylase, are the subjects of Chapters 2,3, and 4 of 
this thesis.
The 87-kDa protein was first described as a component of rat brain 
synaptosomes and was found to be phosphorylated in response to 
depolarization-induced calcium influx (Wu et al.. 1982). Since that 
time, a number of studies have demonstrated phosphorylation of the 87- 
kDa protein in response to stimulators of PI turnover and activators of 
protein kinase C (see Chapter 2). It has been widely used as a marker 
for the activation of protein kinase C in fibroblasts by phorbol esters 
(Bishop et al.. 1985; Blackshear et al.. 1985; Blackshear et al.. 1986; 
Halsey et al.. 1986; Rozengurt et al.. 1983; Rodriguez-Pena and 
Rozengurt, 1986; Zachary et al.. 1986; Tsuda et al.. 1985; Isacke et 
al. . 1986; Sato et al.. 1985; Coughlin et al.. 1985; Sagara et al..
1986; Wolfman and Macara, 1987; Mahadevan et al.. 1987), synthetic 
diacylglycerols (Blackshear et al.. 1986; Rozengurt et al.. 1984; Tsuda
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et al.. 1985), exogenous phospholipase C (Rozengurt et al.. 1983), serum 
(Rodriguez-Pena and Rozengurt, 1985; Sato et al.. 1985), transformation 
(Wolfman and Macara, 1987), and a number of peptides and growth factors 
(Blackshear et al.. 1985; Rozengurt et al.. 1983; Zachary et al.. 1986; 
Tsuda et al.. 1985; Isacke et al.. 1986; Sato et al.. 1985; Coughlin et 
al.. 1985; Mahadevan et al.. 1987). The protein has also been shown to 
be a substrate for protein kinase C in vitro (Wu et al.. 1982; Walaas et 
al.. 1983a,b; Blackshear et al.. 1986; Chapters 2 and 3) and to have a 
widespread distribution (Blackshear et al.. 1986; Chapter 3). The 
widespread distribution and prominent phosphorylation of the 87-kDa 
protein make it a likely mediator of a major action of protein kinase C.
Tyrosine hydroxylase is the rate-limiting enzyme in the 
biosynthesis of catecholamines (Nagatsu et al.. 1964a). Several lines 
of evidence have suggested that cAMP-dependent phosphorylation may be 
one means of activation of tyrosine hydroxylase (see Chapter 4). In 
this dissertation, protein kinase C was also found to phosphorylate and 
activate tyrosine hydroxylase (Chapter 4).
Other in vitro and in vivo substrates for protein kinase C include 
the EGF receptor (Cochet et al.. 1984), the interleukin-2 (IL-2) 
receptor (Shackelford and Trowbridge, 1984), the transferrin receptor
e r r
(Davis et al.. 1986), pp60  (Tamura et al.. 1984; Gould et al.. 1985;
Purchio et al.. 1985, 1986; Gentry et al.. 1986), p36/p35 (Summers and 
Creutz, 1985; Gould et al.. 1986; Khanna et al.. 1986; Michener et al..
1986), the 47 kDa protein (Castagna et al.. 1982; Imaoka et al.. 1983; 
Kaibuchi et al.. 1983; Sano et al.. 1983; Yamanishi et al.. 1983), 
myosin light chain (MLC) (Castagna et al.. 1982; Endo et al.. 1982; Naka
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et al.. 1983; Yamanishi et al.. 1983; Nishikawa et al.. 1984), vinculin 
(Werth et al.. 1983, 1984), glycogen synthase (Roach and Goldman, 1983; 
Ahmad et al.. 1984; Ciudad et al.. 1984; Imazu et al.. 1984; Arino and 
Guinovart, 1986; Blackmore et al.. 1986), actin-binding protein 
(filamin) Carroll et al.. 1982; Kawamoto and Hidaka, 1984), the glucose 
transporter (Witters et al.. 1985), class I HLA antigens (Feuerstein et 
al.. 1985; Rouis et al.. 1986; Shackelford and Trowbridge, 1986), and 
the 31.5 kDa component of NADPH oxidase (Papini et al.. 1985).
In most cases, the physiological consequences of phosphorylation 
of exact site(s) by protein kinase C remain to be elucidated. In view 
of the difficulties in evaluating whether a protein is a true substrate 
for protein kinase C, Woodgett et al. (1987) have proposed the following 
criteria, based on those originally suggested by Krebs for substrates of 
cAMP-dependent protein kinase (see Krebs and Beavo, 1979). (A) The
specific site(s) phosphorylated by protein kinase C in vitro must be 
identified, and (B) the protein should be shown to be rapidly 
phosphorylated at the same site(s) identified in (A) in vivo, in 
response to agonists of protein kinase C. Additional corroborative data 
are useful, e.g. time course consistent with that of the agonist, loss 
of phosphorylation with "down-regulation" of protein kinase C, at least 
a fraction of the protein of interest being associated with the 
cytoplasmic face of the membrane, and, if possible, the correlation of 
an activity change upon phosphorylation in vitro and in vivo.
One protein which thus far meets these criteria is the EGF 
receptor. In many mitogenically responsive cell types, phorbol ester 
reduces EGF binding (Lee and Weinstein, 1978; Brown et al.. 1979; Shoyab
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et al. . 1979), EGF-induced tyrosine phosphorylation of the receptor, and 
the receptor tyrosine kinase activity towards exogenous substrates 
(Friedman et al.. 1984; Cochet et al.. 1984; Decker, 1984; Downward et 
al.. 1985), and can induce transient, reversible internalization of the 
receptor (Beguinot et al.. 1985). The site of phosphorylation has been 
identified as threonine 654 (Hunter et al.. 1984; Davis and Czech,
1985). That phosphorylation of threonine 654 is responsible for the 
documented effects of tumor promotors on the EGF receptor was recently 
confirmed by the generation of mutant receptor molecules in which 
threonine 654 was replaced with a non-phosphorylatable alanine residue. 
Cells transfected with this mutant DNA no longer lost their high 
affinity EGF-binding component upon treatment with tumor promotor, nor 
were the receptors internalized in response to the tumor promotor (Lin 
et al.. 1986). EGF-induced internalization of the mutant receptor was 
unaffected. The effects of phorbol ester on EGF affinity and 
phosphorylation of the receptor were mimicked by synthetic 
diacylglycerols (McCaffrey et al.. 1984; Davis et al.. 1985; Sinnett- 
Smith and Rozengurt, 1985), PDGF and bombesin (Brown et al.. 1984).
OBJECTIVES OF THE DISSERTATION
The studies described in this dissertation were undertaken to 
analyze the role of protein kinase C in the nervous system. Three 
different approaches were employed. First, a major endogenous substrate 
for protein kinase C in brain, the 87-kDa protein, was identified, 
purified and characterized with respect to its physicochemical
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properties and distribution (Chapters 2 and 3). Second, the effect of 
phosphorylation by protein kinase C was examined with a nervous system 
protein of known function, namely tyrosine hydroxylase (Chapter 4). 
Third, the regulation of protein kinase C activity by calcium-binding 
proteins was examined (Chapter 5).
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Chapter 2. PURIFICATION AND PHYSICOCHEMICAL CHARACTERIZATION OF
THE 87-kDa PROTEIN
The 87-kDa protein is a major substrate for protein kinase C in 
vivo and in vitro, and thus fulfills the criteria of a true substrate 
for protein kinase C as outlined by Woodgett et al. (1987) (see Chapter 
1.).
Phosphorylation of the 87-kDa protein has been shown to occur in 
vivo in response to biological manipulations which initiate PI turnover. 
In the nervous system, where the protein was first described as a 
component of rat brain synaptosomes (Wu et al.. 1982), phosphorylation 
of the 87-kDa protein was found to be increased in intact rat brain 
synaptosomes by depolarization-induced calcium influx (Wu et al.. 1982; 
Wang et al.. 1985), and in adrenal chromaffin cells (Haycock et al..
1987) and rat brain slices by acetylcholine (Mobley, 1986). In 
fibroblasts, in experiments with proteins which are most likely to be 
identical to the 87-kDa protein (see Chapter 3), phosphorylation was 
found to be increased in response to serum (Rodriguez-Pena and 
Rozengurt, 1985; Sato et al.. 1985), transformation (Wolfman and Macara,
1987), and a number of peptides and growth factors (Blackshear et al.. 
1985; Rozengurt et al.. 1983; Zachary et al.. 1986; Tsuda et al.. 1985; 
Isacke et al.. 1986; Sato et al.. 1985; Coughlin et al.. 1985; Mahadevan 
et al.. 1987); and in lymphocytes in response to treatment with 
concanavalin A and calcium (Denis et al.. 1986).
32
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The 87-kDa protein has also been shown to be phosphorylated in 
vivo in response to treatment with tumor promoting phorbol esters or 
permeant diacylglycerols. Thus, in the nervous system, phosphorylation 
of the 87-kDa protein was found to be increased by phorbol esters or 
permeant diacylglycerols in intact rat brain synaptosomes (Wang et al.. 
1985; Nichols et al.. 1987), in adrenal chromaffin cells (Haycock et 
al.. 1987), in astrocytes (Mobley and Harrison, 1987), and in rat 
superior cervical ganglion (A. Cahill and R. Perlman, personal 
communication). Increased phosphorylation of the 87-kDa protein was 
also shown to correlate with increased calcium-dependent, evoked 
neurotransmitter release in response to phorbol ester treatment of rat 
brain synaptosomes (Nichols et al.. 1987). In fibroblasts, 
phosphorylation of the 87-kDa protein was found to be increased by 
phorbol esters (Bishop et al.. 1985; Blackshear et al. . 1985; Blackshear 
et al.. 1986; Halsey et al.. 1986; Rozengurt et al.. 1983; Rodriquez- 
Pena and Rozengurt, 1986; Zachary et al.. 1986; Tsuda et al.. 1985; 
Isacke et al.. 1986; Sato et al.. 1985; Coughlin et al. . 1985; Sagara et 
al.. 1986; Wolfman and Macara, 1987; Mahadevan et al. . 1987), synthetic 
diacylglycerols (Blackshear et al.. 1985; Rozengurt et al. . 1984; Tsuda 
et al.. 1985), and exogenous phospholipase C (Rozengurt et al.. 1983).
In vitro, the 87-kDa protein was found to be phosphorylated by 
protein kinase C in crude preparations from brain (Wu et al. . 1982; 
Walaas et al.. 1983a,b) and other tissues (Chaper 3, Blackshear et al..
1986). Phosphorylation of the 87-kDa protein by protein kinase C in 
vitro has been observed in nerve growth cone preparations (Katz et al.. 
1985), and in response to activation of protein kinase C by a protein
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modulator (Kligman and Patel, 1986). In addition, phosphopeptide maps 
generated from the phosphorylation of the 87-kDa protein in intact cells 
have been found to be identical to those obtained in vitro following 
phosphorylation of the protein by protein kinase C (Wu et al.. 1982; 
Blackshear et al.. 1985; Blackshear et al.. 1986; Rodriquez-Pena and 
Rozengurt, 1986; Mahadevan et al.. 1987; Haycock et al.. 1987; Wang et 
al.. 1988).
There is little information concerning the biochemical events 
mediating the proposed connection between protein kinase C activation 
and cellular responses. It is important, therefore, to characterize the 
physiological substrates for protein kinase C. The prominent 
phosphorylation of the 87-kDa protein in response to activators of 
protein kinase C makes it a likely mediator for some major action(s) of 
protein kinase C. The purification and characterization of the 87-kDa 
protein described in this chapter was undertaken as a step toward 
identifying the role of this protein in the actions of protein kinase C.
MATERIALS AND METHODS
Materials. Fresh rat forebrain was dissected from a stunned and 
decapitated male Sprague-Dawley rat. Fresh calf brains were delivered 
on ice from a local slaughterhouse. Rabbit brain calmodulin was a gift 
from Dr. Angus Nairn. Antifoam A, ATP, bovine serum albumin (BSA), 
CaC^, bovine erythrocyte carbonic anhydrase, Coomassie Brilliant Blue 
R-250, bovine heart cytochrome c, dimethylsulfoxide (DMSO), 
dithioerythritol (DTE), 1,2 diolein, EGTA, HI histone, molecular weight
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protein standards for polyacrylamide gel electrophoresis (PAGE), sodium 
dodecyl sulfate (NaDodSO^), bovine brain L-a-phosphatidyl-l-serine, and 
Tris were from Sigma. Ethylene glycol, formic acid, glycerol, KP^, Mg 
acetate, NaCl, NaN^, and sucrose were from Fisher. DEAE-Sephacel, fast 
protein liquid chromatography (FPLC) system and ProRPC 5/10 column, gel 
filtration calibration kit for high molecular weight proteins, Phenyl- 
Sepharose, and Sephacryl S-400 Superfine were from Pharmacia.
Other reagents were purchased from the following sources: DE-52
DEAE-cellulose (Whatman); Bio-Gel HTP hydroxylapatite and Affi-Gel Blue
(blue agarose) (Bio-Rad); EDTA and 2-mercaptoethanol (Baker); Ultrapure
32 125
(NH^^SO^ (Bethesda Research Laboratories); [7- P]ATP and I-labeled 
protein A (New England Nuclear); antipain, chymostatin, leupeptin, and 
pepstatin (Chemicon, El Segundo, CA); Trasylol (FBA Pharmaceuticals, New 
York); phenylmethylsulfonyl fluoride (PMSF) and thermolysin (Calbiochem- 
Behring); Staphylococcus aureus V8 protease (Miles); isopropyl alcohol 
(American Burdick & Jackson, Muskegon, MI); trifluoroacetic acid (TFA) 
(Pierce); 20 x 20 cm cellulose thin-layer chromatography plates 
(Eastman); nitrocellulose, pore size 0.2 ^m (Schleicher & Schuell); and 
Nonfat dry milk (Carnation).
Measurement of endogenous calcium/phospholipid-dependent protein 
phosphorylation. Fresh rat and bovine forebrain were homogenized at 0- 
4°C with 12 strokes of a glass-Teflon homogenizer at 2100 rpm in a 10 x 
volume of 10 mM Tris*HCl (pH 7.6), 2 mM EDTA, 14 mM 2-mercaptoethanol, 
Trasylol (25 Kallikrein Inhibitor Units (K.I.U.) per ml), and 100 pH 
PMSF. The homogenates were centrifuged in a Ti50 rotor in a Beckman L2 
centrifuge at 150,000 x g for 30 min. The endogenous phosphorylation
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reaction mixture (final volume 100 /il) contained 20 mM Tris*HCl (pH
7.4), 10 mM Mg acetate, 2 mM DTE, 1 mM EGTA, 50 /j1 of supernatant, and,
where indicated, 5 f ig rabbit brain calmodulin, 1.5 mM CaC^, and 5 f ig
phosphatidylserine. The mixture was preincubated for 1 min at 30°C.
32
The reaction was initiated by the addition of [7- P]ATP (final
3
concentration, 2 /xM; specific activity 50-100 x 10 cpm/pmol), carried 
out for 1 min, and terminated by the addition of 20 /xl of NaDodSO^ stop 
solution (20% (vol/vol) glycerol/10% (wt/vol) 2-mercaptoethanol/0.25 M 
Tris*HCl, pH 6.7, containing a trace of bromophenol blue) and heating in 
a boiling water bath for 5 min.
Proteins in the samples were electrophoresed on NaDodSO^/8% 
polyacrylamide gels by the method of Laemmli (1970). The gels were 
stained, destained, dried, and subjected to autoradiography as described 
(Ueda and Greengard, 1977).
Buffers. All buffers were cold (0-4°C), and contained 14 mM 2- 
mercaptoethanol, 0.02% NaN^, and the following protease inhibitors:
25,000 K.I.U. per liter of Trasylol, 100 fiM. PMSF (plus 0.1% isopropyl 
alcohol to dissolve the PMSF), 0.001% leupeptin, 0.001% antipain,
0.0002% pepstatin, and 0.0017% chymostatin (plus 0.1% DMSO to dissolve 
the pepstatin and chymostatin). Buffer A: 10 mM Tris*HCl pH 7.6, 2 mM 
EDTA, and 0.5 mM EGTA; Buffer B: 10 mM Tris*HCl pH 7.6, and 1 mM EDTA; 
Buffer C: Buffer B with 10% ethylene glycol; Buffer D: 25 mM Tris*HCl pH 
7.6, 5 mM MgCl^, 0.5 mM EGTA, and 15% ethylene glycol; Buffer E: 20 mM 
Tris*HCl pH 7.5, 0.5 mM EDTA, 0.5 mM EGTA, 15% ethylene glycol, 1.5 M 
NaCl, and no Trasylol; Buffer F: 20 mM Tris*HCl pH 7.5, 0.5 mM EDTA, 0.5
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mM EGTA, 25% ethylene glycol, no NaCl, and no Trasylol; and Buffer G: 25 
mM Tris*HCl pH 7.6, 1 mM EDTA, 300 mM NaCl, and 10% ethylene glycol.
Measurement of Protein Kinase C Activity. The protein kinase C
activity reaction mixture (final volume, 100 ji1) contained: 20 mM
Tris*HCl pH 7.4, 10 mM Mg acetate, 1 mM EGTA, 2 mM DTE, 0.1% leupeptin,
50 ;ig BSA, 20 jig Histone HI (Sigma III-S), 10 /il of a 1:50 dilution of
protein kinase C, minus or plus 5 jig phosphatidylserine/0.1 jig diolein
and 1.5 mM CaC^. The reaction was initiated by the addition of [7- 
32
P]ATP (final concentration 50 jiM; specific activity 900-2500 cpm/pmol)
and the simultaneous transfer of the tube from 0° to 30°C. The reaction
was carried out for five minutes and stopped by the addition of 20 jil of
125 mM EDTA/5 mM ATP and the return of the tube to 0°. A 60 jil aliquot
2
from each tube was pipetted onto a 2 cm x 2 cm piece of P81 Whatman 
phosphocellulose paper. The papers were washed with running distilled 
water for 25 min and dried under a lamp. The radioactivity on the 
papers was counted in a scintillation counter, either in scintillation 
fluid, or dry for the Cerenkov counts on the tritium channel (usually 
30-40% of the counts obtained with scintillation fluid).
Purification of Protein Kinase C . Protein kinase C was purified 
to homogeneity from bovine forebrain by modification of the procedure of 
Kikkawa et al. (1982) as follows. All purification steps were carried 
out at 0-4°C. Each centrifugation was carried out in a Sorvall RC-5B 
centrifuge, using a GSA rotor.
Step 1. Homogenization. 1 kg of forebrain was homogenized in 4 
volumes of Buffer A for 60 sec with a Polytron. The homogenate was
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centrifuged for 45 min at 27,000 x g (13,000 rpm), and the pH of the 
clear red supernatant was adjusted from 6.8 to 7.6 with 1 N NaOH.
Step 2. DE-52 batch adsorption. The supernatant was diluted 1:1 
with 10 mM Tris*HCl pH 7.5 and was stirred for 1 hr with 1 liter DE-52 
which had been equilibrated with Buffer A. The resin was washed on a 
Buchner funnel with 2 liters of Buffer A, then was stirred for 1 hr in 1 
liter Buffer A plus 150 mM NaCl.
Step 3. (NH^^SO^ precipitation. The suspension was filtered on a 
Buchner funnel followed by a 1-liter wash with Buffer A plus 150 mM 
NaCl. The clear yellow filtrate was taken to 35% saturation with solid 
(NH^^SO^ and stirred for 1 hr. The sample was centrifuged for 30 min 
at 16,000 x g (10,000 rpm), and the supernatant was taken to 60% 
saturation with solid (NH^^SO^ and stirred for 1 hr. After 
centrifugation for 30 min at 16,000 x g, the pellet was resuspended in 
250 ml Buffer B and dialyzed overnight against 2 x 5.5 liters of Buffer 
B.
Step 4. DEAE-Sephacel chromatography. After a 20 min, 16,000 x g, 
centrifugation to remove particulate material, the dialyzed sample was 
applied at 90 ml/hr to a DEAE-Sephacel column (2.5 x 25 cm) previously 
equilibrated with Buffer B. After a 125-ml wash with Buffer B, the 
kinase was eluted with a 1 liter linear gradient of 0-200 mM NaCl in 
Buffer C. The kinase eluted in a broad peak at about 75 mM NaCl.
Step 5. Bio-Gel HTP chromatography. The pooled sample from the 
DEAE-Sephacel column was applied directly at 90 ml/hr to a Bio-Gel HTP 
column (2.5 x 25 cm) previously equilibrated in Buffer C. After washes 
with 125 ml each of Buffer C, Buffer C plus 1 M NaCl, and Buffer C, the
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kinase was eluted with a 1-liter linear gradient of 0-250 mM KP^ in 
Buffer C. The peak of kinase activity eluted at about 165 mM KP^.
Step 6 . Affi-Gel Blue chromatography. The pooled Bio-Gel HTP 
sample was brought to 10 mM M g C ^  and diluted 1:3 with Buffer D. The 
sample was applied to an Affi-Gel Blue column (1.5 x 17 cm) previously 
equilibrated in Buffer D. After a 30-ml wash with Buffer D, the kinase 
was eluted with a 400-ml linear gradient of 0-2.5 M NaCl in Buffer D.
The kinase eluted in a broad peak between 1.75 and 1.93 M NaCl.
Step 7. Phenyl-Sepharose chromatography. The pooled Affi-Gel Blue 
sample was applied directly to a Phenyl-Sepharose column (1.5 x 17 cm) 
previously equilibrated in Buffer E. After a 30-ml wash with Buffer E, 
the kinase was eluted with a 200-ml linear gradient of Buffer E to 
Buffer F, followed by a 100-ml wash with Buffer F. The kinase eluted in 
a sharp peak at about 0.1 M NaCl. The pooled purified fraction was 
quickly divided into aliquots, frozen in liquid nitrogen, and stored in 
a liquid nitrogen freezer. The final specific activity was usually 
about 2.8 pmol/min/mg protein, and the yield about 400 f i g pure protein.
Phosphorylation Assay for the 87-kDa Protein. The 87-kDa protein 
phosphorylation reaction mixture (final volume 100 f i1) contained 20 mM 
Tris*HCl pH 7.4, 10 mM Mg acetate, 1.0 mM EGTA, 2 mM DTE, 0.1% 
leupeptin, 0.1% antipain, 1.5 mM CaC^, 5 f ig phosphatidylserine/0.2 f i g  
diolein, 3 ng of protein kinase C, and an aliquot of sample containing
the 87-kDa protein. The reaction was initiated by the addition of [7-
32 . 6
P]ATP (final concentration 10 f iK ; specific activity 5x10 cpm/nmol)
and was carried out for 30 min at 30°C. The reaction was terminated by
the addition of 20 /xl of NaDodSO^ stop solution (20% (vol/vol)
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glycerol/10% (wt/vol) NaDodS0^/10% (vol/vol) 2-mercaptoethanol/0.25 M 
Tris*HCl, pH 6.7, containing a trace of pyronin y) and heating in a 
boiling water bath for 5 min. NaDodSO^/8% PAGE was performed according 
to the method of Laemmli (1970). Gels were stained with Coomassie 
Brilliant Blue R-250 (0.1% in 50% methanol, 10% acetic acid) and 
destained in 30% methanol, 10% acetic acid, or were stained with silver 
by the procedure of Poehling and Neuhoff (1981), with the silver reagent 
of Ohsawa and Ebata (1983). Gels were dried onto filter paper in vacuo, 
and autoradiography was performed at room temperature or at -70°C (with 
Du Pont Cronex Lightning Plus intensifying screens) using Kodak XAR-5 x- 
ray film. Bands containing the 87-kDa protein were excised from the 
gels, and the radioactivity was quantitated by liquid scintillation 
counting. Gel pieces containing phosphorylated 87-kDa protein were 
subjected to one-dimensional phosphopeptide mapping using S . Aureus V8 
protease as described (Huttner and Greengard, 1979), or to two- 
dimensional phosphopeptide mapping as described (Huttner and Greengard, 
1979), except that thermolysin (150 pg/ml) was used instead of trypsin. 
The phosphorylated amino acid was identified as described (Hemmings et 
al.. 1984b; Nairn and Greengard, 1987).
Preparation of Antiserum against the 87-kDa Protein. The 87-kDa 
protein that was injected for the preparation of antiserum was purified 
as described below with the following exceptions. Proteins were eluted 
from the DE-52 batch adsorption in Buffer A plus 0.3 M NaCl; for 
precipitation, the (NH^jSO^ saturation used was 35-55%; proteins were 
eluted from the DEAE-Sephacel column with a gradient of 0-300 mM NaCl in 
Buffer C; proteins in the DEAE-Sephacel pool were subjected to pH 4:6
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
41
extraction before the Bio-Gel HTP step; proteins in the Bio-Gel HTP pool 
were precipitated and applied to an Ultrogel AcA34 (LKB) gel filtration 
column; proteins in the Ultrogel Aca34 pool were subjected to 
chromatography on an FPLC Mono Q column; and the pure 87-kDa protein was 
dialyzed against 20 mM NH^HCO^ and lyophilized. Antiserum against the 
87-kDa protein was prepared in a New Zealand female rabbit by 
intradermal injection into multiple sites of 75 p g of the purified 
protein emulsified in complete Freund's adjuvant. The rabbit was given 
a booster injection with 50 p g of purified 87-kDa protein at 7 weeks 
after the first injection, and was bled at weekly intervals thereafter. 
The bleedings at 9-12 weeks after the first injection were used for the 
studies described in this thesis. The antiserum was specific in that it 
recognized only the 87-kDa protein when proteins in homogenates of 
bovine brain, spleen, adrenal, and testis were subjected to two- 
dimensional gel electrophoresis (see Chapter 3.) followed by 
immunoblotting.
Immunoblotting of the 87-kDa Protein. Immediately following
NaDodSO^/ 8% PAGE, proteins were transferred onto nitrocellulose sheets
(pore size 0.2 pm) at 200 mA for 12 hr using the buffer system of Towbin
et al. (1979). All immunoblotting steps were performed at room
temperature in blotting buffer (Johnson et al.. 1984) (20 mM Tris*HCl pH
7.4, 5% (wt/vol) Nonfat dry milk, 0.02% NaN^, and 0.01% Antifoam A) as
follows: 1 hr in buffer, 2 hr in buffer with a 1:200 dilution of 87-kDa
125protein antiserum, 3 x 20 min in buffer, 12 hr in buffer with I- 
labeled protein A (2000 cpm/10 p i  buffer), and 5 x 20 min in buffer.
The sheets were air dried and autoradiography was performed as described
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above. Bands containing the 87-kDa protein were excised from the 
sheets, and the radioactivity was quantitated by counting in a 
Micromedic Systems Automatic Gamma Counter. Quantitative immunoblotting 
was performed by including a standard curve of purified 87-kDa protein 
(50-250 ng) on each gel.
Protein determinations. Protein was determined by the method of 
Peterson (1977) using BSA as standard.
Amino Acid Analysis. Purified 87-kDa protein was dialyzed 
extensively against 1^0. Amino acid analysis was performed by Donna 
Atherton of The Rockefeller University Protein Sequencing Facility as 
follows: 2 and 4 pg of protein were hydrolyzed for 10, 24, and 72 hr 
each. Amino acids were derivatized, separated and identified as 
described (Bidlingmeyer et al.. 1984). For determination of cysteine,
10 p g of 87-kDa protein was subjected to performic acid oxidation 
(Moore, 1963) followed by amino acid analysis. A blank contained 10 pg  
of 87-kDa protein treated with formic acid only, followed by amino acid 
analysis.
Determination of Stokes Radius by Gel Filtration. Gel filtration 
was carried out by the method of Whittaker (1963) in a column (2.5 x 90 
cm) of Sephacryl S-400 previously equilibrated with Buffer D. The 
column was calibrated with the following standards: bovine thyroid 
thyroglobulin (85.0 A), horse spleen ferritin (61 A), bovine liver 
catalase (52.2 A), and rabbit muscle aldolase (48.1 A). Determination 
of the Stokes radius of the 87-kDa protein was carried out according to 
the method of Laurent and Killander (1964).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
43
Determination of Sedimentation Coefficient bv Linear Sucrose 
Density Gradient Ultracentrifugation. Ultracentrifugation was carried 
out at 45,000 rpm for 21 hr at 4°C in a Beckman L3-50 Ultracentrifuge 
using an SW 50.1 rotor. Samples plus standards (150 p i )  were layered 
onto 5-ml linear sucrose gradients (5 to 20%) which were made in 50 mM 
Tris*HCl pH 7.6, 0.2 mM EDTA, 50 mM NaCl, and 14 mM 2-mercaptoethanol. 
The standard proteins were: BSA (4.3 S), bovine erythrocyte carbonic 
anhydrase (2.85 S), and bovine heart cytochrome c (1.83 S). After 
centrifugation, 0.25 ml fractions were collected from the bottom of the 
tubes and analyzed by the phosphorylation assay for the 87-kDa protein 
followed by NaDodS0^/13% PAGE and protein staining. The sedimentation 
coefficient was determined by the method of Martin and Ames (1961).
Time Course and Stoichiometry of Phosphorylation of the 87-kDa
Protein. The phosphorylation assay for the 87-kDa protein was
performed, except that the reaction mixture contained 1.5 p g of purified
32
87-kDa protein, 80 ng of protein kinase C, and 200 pM [7- P]ATP 
(specific activity 0.2x10^ cpm/nmol). The tubes were preincubated for 1 
min at 30°C, and the reaction was stopped after various times from 20 
sec to 70 min.
RESULTS
Identification of the 87-kDa Protein in Bovine Forebrain. The 87- 
kDa protein was originally identified as a component of rat brain 
synaptosomes (Wu et al.. 1982). The protein was also shown to be 
present in all regions of the rat brain (Walaas et al.. 1983a,b). For
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this work, bovine forebrain was investigated as a source of starting 
material for the large-scale purification of the 87-kDa protein.
When endogenous phosphorylation was studied in a crude supernatant 
fraction from rat forebrain, the addition of calcium plus phosphatidyl- 
serine greatly stimulated the phosphorylation of a band in the 85- 
90,000 range (Fig. 3), previously identified as the 87-kDa protein.
There was no background phosphorylation in the absence of calcium, 
calmodulin, or phosphatidylserine. The addition of calcium alone or 
calcium plus calmodulin resulted in a small, variable, degree of 
phosphorylation of bands in the M 87,000 range (Fig. 3). When 
endogenous phosphorylation was studied in a crude supernatant fraction 
from bovine brain, the addition of calcium plus phosphatidylserine 
greatly stimulated the phosphorylation of a band in the 85-90,000 
range (Fig. 3), which was identified as the 87-kDa protein. There was 
some background phosphorylation of the 87,000 band in the absence of 
calcium, calmodulin, and phosphatidylserine. The addition of calcium or 
calcium plus calmodulin resulted in a decrease in phosphorylation of the 
87,000 band (Fig. 3). The background phosphorylation in the bovine 
preparation was most likely due to endogenous protein kinase M. The 
decrease in phosphorylation upon the addition of calcium was most likely 
due to inhibition of the kinase by endogenous calcium-binding proteins 
(see Chapter 5). Treatment of rat or bovine supernatant with cAMP or 
cGMP did not result in phosphorylation of the 87-kDa protein.
Therefore, the 87-kDa protein was a prominent substrate for endogenous 
phosphorylation by protein kinase C in both rat and bovine forebrain 
supernatant.
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Figure 3. Autoradiograms showing phosphorylation of the 87-kDa 
protein in rat and bovine forebrain supernatant. The endogenous 
calcium/phospholipid-dependent protein phosphorylation assay was carried 
out. The indicated additions wejj^ present in the following final 
concentrations: free calcium (Ca ), 0.5 mM; rabbit brain calmodulin 
(CaM), 1 n g / 1 0 0  fj. 1; phosphatidylserine (PS), 5 pg/100 n 1. After 
termination of the phosphorylation reaction, samples were subjected to 
one-dimensional NaDodSO^/8% PAGE, followed by autoradiography. -», 
position of the 87-kDa protein. Molecular size markers are shown in 
kilodaltons.
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Purification of the 87-kDa Protein from Bovine Forebrain. All 
purification steps were carried out at 0-4°C. Each centrifugation was 
carried out in a Sorvall RC-5B centrifuge, using a GSA rotor.
Step 1. Homogenization. 1 kg of forebrain was homogenized in 4 
volumes of Buffer A for 60 sec with a Polytron. The homogenate was 
centrifuged for 45 min at 27,000 x g, and the pH of the clear red 
supernatant was adjusted from 6.8 to 7.6 with 1 N NaOH.
Step 2. DE-52 batch adsorption. The supernatant was stirred for 1 
hr with 1 liter DE-52 which had been equilibrated with Buffer A. The 
resin was washed on a Buchner funnel with 2 liters of Buffer A, then was 
stirred for 1 hr in 1 liter of Buffer A plus 0.5 M NaCl.
Step 3. (NH^^SO^ precipitation. The suspension was filtered on a 
Buchner funnel followed by a 1-liter wash with Buffer A plus 0.5 M NaCl. 
The clear yellow filtrate was taken to 30% saturation with solid 
(NH^^SO^ and stirred for 1 hr. The sample was centrifuged for 30 min 
at 16,000 x g, and the supernatant was taken to 60% saturation with 
solid (NH^^SO^ and stirred for 1 hr. After centrifugation for 30 min 
at 16,000 x g, the pellet was resuspended in 250 ml of Buffer B and 
dialyzed overnight against 2 x 5.5 liters of Buffer B.
Step 4. DEAE-Sephacel chromatography. After a 20 min, 16,000 x g, 
centrifugation to remove particulate impurities, the dialyzed sample was 
applied at 90 ml/hr to a DEAE-Sephacel column (2.5 x 25 cm) previously 
equilibrated with Buffer B. After a 125-ml wash with Buffer B, the 87- 
kDa protein was eluted with a 1-liter linear gradient of 0-500 mM NaCl 
in Buffer C. The 87-kDa protein eluted in a broad peak between 150 and 
250 mM NaCl, with the apex between 180 and 200 mM NaCl (Fig. 4).
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Figure 4. Chromatography of step 3 pool on DEAE-Sephacel. The 
flow rate was 90 ml/hr and 5-ml fractions were collected. The 
phosphorylation assay for the 87-kDa protein was carried out with 
aliquots (20 p i )  from every fifth fraction.
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Step 5. Bio-Gel HTP chromatography. The pooled sample (140 ml) 
from the DEAE-Sephacel column was applied directly at 120 ml/hr to a 
Bio-Gel HTP column (2.5 x 25 cm) previously equilibrated in Buffer C. 
After washes with 125 ml each of Buffer C, Buffer C plus 1 M NaCl and 5 
mM MgC^, and Buffer C, the 87-kDa was eluted with a 1-liter linear 
gradient of 0-350 mM KP^ in Buffer C. The 87-kDa protein eluted in a 
sharp peak at 150 mM KP^ (Fig. 5).
Step 6. Sephacryl S-400 chromatography. The proteins in the 
pooled Bio-Gel HTP sample (80 ml) were precipitated with (NH^^SO^ (65% 
saturation) and resuspended in 5 ml of Buffer G. The sample was applied 
to a Sephacryl S-400 column (2.5 x 90 cm) previously equilibrated in 
Buffer G, and the 87-kDa protein was eluted with Buffer G. One major 
peak (peak A) of 87-kDa protein was eluted at 300 ml and one smaller 
peak (peak B) (about 30% of the total) was eluted at 360 ml (Fig. 6). 
Further purification was performed on the major peak.
Step 7. FPLC ProRPC chromatography. The pooled sample (40 ml) 
from the Sephacryl S-400 column was dialyzed against 2 x 6  liters of 10 
mM NH^HCO^ plus protease inhibitors (100 /xM PMSF (plus 0.1% isopropyl 
alcohol to dissolve the PMSF), 0.001% leupeptin, 0.001% antipain,
0.0002% pepstatin, and 0.0017% chymostatin (plus 0.1% DMSO to dissolve 
the pepstatin and chymostatin); then was dialyzed against another 1 x 6 
liters of 10 mM NH^HCO^ plus 0.001% leupeptin and 0.001% antipain. The 
sample was concentrated to 15 ml under in an Amicon Ultrafiltration 
unit fitted with a PM 10 membrane. This sample was split into 5 x 3 ml 
aliquots. Each aliquot was diluted with 9 ml ^ 0 /  0.1% TFA, filtered 
through a Millex-GV 0.22 /xm filter unit (Millipore), and applied at 18
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Figure 5. Chromatography of step 4 pool on Bio-Gel HTP. The flow 
rate was 90 ml/hr and 5-ml fractions were collected. The phosphoryla­
tion assay for the 87-kDa protein was carried out with aliquots (20 p i )  
from every fifth fraction.
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Figure 6. Chromatography of step 5 pool on Sephacryl S-400. The 
flow rate was about 30 ml/hr and 3-ml fractions were collected. The 
phosphorylation assay for the 87-kDa protein was carried out with 
aliquots (20 pi) from every fifth fraction. The arrows denote the 
positions of elution of: 1 , blue dextran (void volume); 2, bovine 
thyroid thyroglobulin (85 A); 3, horse spleen ferritin (61 &)• 4, bovine 
liver catalase (52.2 S); and 5, rabbit muscle aldolase (48.1 A).
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ml/hr to an FPLC ProRPC 5/10 column previously equilibrated in ^ 0 /  0.1% 
TFA. After the column was washed with 12 ml U ^ O / 0.1% TFA, the 87-kDa 
protein was eluted at 12 ml/hr with a 40-ml linear gradient of 0-50% 
isopropyl alcohol/ 0.1% TFA. The pH of each fraction was adjusted to 
=8, with an appropriate volume of 1.87 M Tris*HCl pH 8.9, as it was 
collected. The 87-kDa protein eluted as a pure protein in a sharp peak 
at about 23% isopropyl alcohol/ 0.1% TFA (Fig. 7). The fractions 
containing the purified 87-kDa protein were pooled, the volume was 
reduced in a Speed Vac Concentrator (Savant), the sample was dialyzed 
extensively against a buffer of 20 mM Tris*HCl pH 7.6, 14 mM 2- 
mercaptoethanol, and protease inhibitors (100 pM PMSF (plus 0.1% 
isopropyl alcohol to dissolve the PMSF), 0.001% leupeptin, 0.001% 
antipain, 0.0002% pepstatin, and 0.0017% chymostatin (plus 0.1% DMSO to 
dissolve the pepstatin and chymostatin), and the final sample was stored 
at 0-4°C. The purified sample was stable at 0-4°C, whereas it was 
partially degraded after any freeze/thaw procedure tested.
The purification procedure for the 87-kDa protein is summarized in 
Table 1. The protein was purified 500-fold from the crude supernatant. 
Figure 8 shows the protein staining pattern of samples from each step of 
the purification procedure. Figure 9 shows the purified 87-kDa protein 
after Coomassie Blue staining (lane 1) and silver staining (lane 2), and 
an autoradiogram of the protein after phosphorylation by protein kinase 
C (lane 3). In each case there was a single band which electrophoresed 
with an M^ value of 90,000 on these NaDodSO^/8% polyacrylamide gels.
When the purified phosphorylated 87-kDa protein was subjected to one­
dimensional peptide mapping using S . Aureus V8 protease, phosphopeptides
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Figure 7. Chromatography of step 6 pool on FPLC ProRPC. The flow 
rate was 12 ml/hr and 1-ml fractions were collected. The phosphoryla­
tion assay for the 87-kDa protein was carried out with aliquots (40 f i l )  
from every fraction.
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Table 1. Purification of the 87k protein from 1 kg of bovine brain
Purification step Volume Protein
*
87k protein Purity Purification Yield
ml mg mg % -fold %
1. 27,000xg supernatant 4000 20400 35 0.2 1 100
2. DE-52 2250 7200 10 0.15 1 29
3. (NH^^SO^ precipitation 250 3500 6.3 0.2 1 18
4. DEAE-Sephacel 140 800 5.0 0.6 3 14
5. Bio-Gel HTP 80 33 1.6 5.0 25 4.6
6. Sephacryl S-400 40 8 0.4 5.0 25 1.1
7. FPLC+ , ProRPC 5/10 7.5 0.3 0.3 100 500 0.9
Determined by quantitative immunoblotting 
FPLC = fast protein liquid chromatography
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Figure 8 . NaDodS0,/8% polyacrylamide gel stained with Coomassie 
Brilliant Blue showing the protein staining pattern at each step of the 
purification. Protein values were determined by the method of Bradford 
(1976) for pools 1-6 and by the method of Peterson (1977) for pool 7. 
Pools: 1, 27,000 x g supernatant (16.2 f i g ) ; 2, DE-52 batch adsorption 
(10.9 f i g ) ; 3, (NH ).S0, precipitation (5.3 f i g ) ; 4, DEAE-Sephacel pool 
(72.4 f i g ) ; 5, Bio-Gel HTP pool (69.3 f i g ) ; 6 , Sephacryl S-400 peak A pool 
(12.5 f i g ) ; 7, FPLC ProRPC pool (4 f i g). Molecular size markers are shown 
in kilodaltons.
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Figure 9. NaDodS0^/8% polyacrylamide gel stained with Coomassie 
Brilliant Blue (lane 1) showing the purified 87-kDa protein (4 f i g ) , and 
an autoradiogram (lane 3) showing phosphorylation of the same sample by 
protein kinase C. The phosphorylation assay for the 87-kDa protein was 
performed, except that the reaction mixture contained 85 mM Tris*HCl and 
4 ng protein kinase C, and the reaction was carried out for 2 min. 
Another NaDodSO^/ 8% polyacrylamide gel stained with silver (lane 2) 
showing the purified 87-kDa protein (1 f i g ) . Molecular size markers are 
shown in kilodaltons.
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of 13,000 and 9,000 were generated (Fig. 10A). When the 
phosphorylated protein was subjected to two-dimensional phosphopeptide 
mapping using thermolysin, two phosphopeptides were generated, one 
acidic and one basic; the acidic peptide was about twice as radioactive 
as the basic (Fig. 10B). Interestingly, two-dimensional phosphopeptide 
mapping of either of the 13,000 or 9,000 one-dimensional digest 
peptides yielded the same pattern as two-dimensional phosphopeptide 
mapping of the whole protein. The phosphorylated amino acid was 
identified as serine (Fig. 10C). The same one- and two-dimensional 
phosphopeptide maps and phosphorylated amino acid were found upon 
digestion of the 87,000 band from the rat or bovine crude supernatant 
(Wu et al.. 1982; Chapters 3 and 5), indicating that the purified 87-kDa 
protein was identical to the protein whose phosphorylation was 
stimulated by calcium plus phosphatidylserine in the crude supernatant.
The 87-kDa protein was also found to have a membrane-bound 
fraction (see Chapter 3). Upon extraction from the particulate fraction 
with a nonionic detergent such as 1% Triton X-100, the extracted 87-kDa 
protein behaved similarly to the soluble protein on DE-52 and Bio-Gel 
HTP chromatography.
Amino Acid Analysis. The amino acid composition of the 87-kDa 
protein is shown in Table 2. The composition was remarkable for its 
very high content of alanine (28.6 mol%), and its high content of 
glutamate/glutamine (18.1 mol%). The protein was also found to be rich 
in glycine (12.6 mol%) and proline (11.3 mol%). The partial specific 
volume calculated from the amino acid composition was 0.702 ml/g.
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Figure 10. Phosphopeptides from purified 87-kDa protein 
phosphorylated by protein kinase C. (A) Autoradiogram showing 
phosphopeptide map after limited proteolysis with S . aureus V8 protease. 
Phosphorylated 87-kDa protein, located by autoradiography, was excised 
and subjected to proteolysis during NaDodSO^/15% PAGE. 13 and 9, 
positions of the major and minor phosphorylated fragments derived from 
the 87-kDa protein. (B) Autoradiogram showing phosphopeptide map after 
proteolysis with thermolysin. Phosphorylated 87-kDa protein, located by 
autoradiography, was excised and subjected to thermolytic digestion 
followed by separation in two dimensions on a cellulose plate, first by 
electrophoresis in the horizontal direction (positive pole, left; 
negative pole, right) and then by ascending chromatography in the 
vertical dimension. (C) Autoradiogram after one-dimensional 
phosphoamino acid anaylsis of the phosphorylated 87-kDa protein. 
Electrophoresis was carried out on a cellulose plate, 6 cm at pH 1.9, 
then 6 cm at pH 3.5. Ser (P), phosphoserine; Thr (P), phosphothreonine; 
Tyr (P), phosphotyrosine: positions of the phosphorylated amino acid 
standards by ninhydrin staining.
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Table 2. Amino acid composition of the 87k protein
Amino acid Mol %
Asx 4.1
Glx 18.1
*
Ser 9.4
Gly 12.6
His 0.2
Arg 0.7
*
Thr 2.0
Ala 28.6
Pro 11.3
Tyr 0.2
Val* 3.0
Met 0.2
Cys 1.8
lie* 0.0
Leu^ 0.6
Phe 1.3
Lys 8.8
Trp N.D. !
Obtained by extrapolation to zero time
^Value at 72 h
!
'N.D. - not determined
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Molecular Weight Determination. It was important to determine the 
molecular weight of the 87-kDa protein, since the relative molecular 
weight on NaDodSO^/PAGE had been reported to vary with acrylamide 
concentration (Blackshear et al.. 1986). The Stokes radius of peak A on 
the Sephacryl S-400 column was calculated to be 85 A (identical value 
for 2 determinations) (Fig. 11), which for a typical globular protein 
would correspond to a molecular weight of 669 kDa. The sedimentation 
coefficient of peak A was calculated to be 2.11 ± 0.05 S (n=3) (Fig.
12), which for a typical globular protein would correspond to a 
molecular weight of about 16 kDa. The Stokes radius, sedimentation 
coefficient, and partial specific volume were used to calculate the 
molecular weight of the 87-kDa protein according to equation 1 of Siegel 
and Monty (1966). A molecular weight of approximately 68 kDa for a 
monomer was calculated (Table 3). The frictional ratio (f/f^) was 
calculated by equation 2 of Siegel and Monty (1966) to be 3.2 (Table 3), 
which corresponds to an axial ratio of 60 for a prolate ellipsoid 
(Schachman, 1959) (Table 3). All of these data are consistent with a 
very asymmetric, highly elongated tertiary structure.
The same properties were examined for peak B. The Stokes radius 
was calculated to be 56 A (identical value for two determinations) (Fig. 
11), which for a typical globular protein would correspond to a 
molecular weight of about 320 kDa. The sedimentation coefficient was 
calculated to be 2.01 ± 0.25 S (n - 3) (Fig. 12), which for a typical 
globular protein would correspond to a molecular weight of about 14 kDa. 
Using these values, a molecular weight of about 43 kDa for a monomer was 
calculated. The frictional ratio was calculated to be 2.45, which
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Figure 11. Determination of the Stokes radius of the Sephacryl S- 
400 peaks of the 87-kDa protein. The column was calibrated with the 
following standard proteins: 1, rabbit muscle aldolase (48.1 X); 2 , 
bovine liver catalase (52.2 X); 3, horse spleen ferritin (61 X); and 4 , 
bovine thyroid thyroglobulin (85 X). A,B: the positions of peaks A and 
B of 87-kDa protein. The data were treated as described by Siegel and 
Monty (1966).
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Table 3. Summary of physical and chemical properties of the 87k protein
Property Method of determination Value
Molecular weight (M^) NaDodSO^/8% PAGE 87,000-90,000
*
(M) Stokes radius, sedimentation coefficient 
and partial specific volume
68 kDa
Stokes radius (c<) Gel filtration 00 ^
0
Sedimentation coefficient (s.. )
20,w
Sucrose density gradient centrifugation 2.11 S
Frictional ratio (f/f^) Stokes radius, partial specific volume 
and molecular weight
3.2
+
Axial ratio 1 Frictional ratio 60
Amino acid composition High Ala/Glx/Gly/Pro
Partial specific volume (V’) Amino acid composition 0.702 ml/g
Phosphoamino acid Phosphorylation by protein kinase C Ser
Stoichiometry of phosphorylation Phosphorylation by protein kinase C 2.2
Calculated according to Siegel and Monty (ref. 43) 
Value for a prolate ellipsoid (ref. 44)
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Figure 12. Determination of the sedimentation coefficient (s~n ) 
of Sephacryl S-400 peak A 87-kDa protein by sucrose density gradient ,w 
ultracentrifugation. The standard proteins were: bovine serum albumin 
(4.3 S), bovine erythrocyte carbonic anhydrase (2.85 S), and bovine 
heart cytochrome c (1.83 S). Abscissa, fraction number; ordinate, s„n 
(S) ; -*■, position of the 87-kDa protein. ,w
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
63
corresponds to an axial ratio of 33 for a prolate ellipsoid. These data
are also consistent with an asymmetric, elongated teriary structure.
Stoichiometry of Phosphorylation. The stoichiometry of
phosphorylation by protein kinase C of the purified 87-kDa protein
(using a value of 68 kDa for the molecular weight) was calculated to be 
322.2 mol P incorporated per mol 87-kDa protein after 70 min (Fig. 13). 
The addition of another aliquot of kinase at 50 min did not 
significantly increase the stoichiometry of phosphorylation at 70 min. 
The only amino acid residue phosphorylated by protein kinase C was 
serine.
DISCUSSION
The 87-kDa protein, a major, specific substrate for protein kinase 
C, was purified to apparent homogeneity from bovine forebrain 
supernatant (Table 1, Fig. 9). Preparation of an apparently homogeneous 
protein with only a 500-fold purification indicates that the 87-kDa 
protein is highly abundant in brain, comprising 0.2% of total soluble 
protein. The purification procedure included batch adsorption to DE-52, 
(NH^^SO^ precipitation, and chromatography on DEAE-Sephacel, Bio-Gel 
HTP, Sephacryl S-400, and an FPLC ProRPC column (Table 1). The DE-52 
and (NH^^SO^ precipitation steps did not result in any overall fold- 
purification, but were necessary for the efficient use of the DEAE- 
Sephacel step. The Sephacryl S-400 step removed certain minor 
impurities which were not removed by the FPLC step. The FPLC ProRPC 
column provided a high degree of purification (20-fold), but the
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Figure 13. Time course and stoichiometry of phosphorylation of 
purified 87-kDa protein by protein kinase C. The phosphorylation assay 
for the 87-kDa protein (0.22 ^M) was carried out for the indicated 
periods of time. After termination of the phosphorylation reaction, 
samples were subjected to one-dimensional NaDodS0^/8.% PAGE, followed by 
autoradiography. Bands containing the 87-kDa protein were excised from 
the gels, and the radioactivity was quantitated by liquid scintilation 
counting.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
65
chromatography also exposed the protein to acid conditions (pH 2.5 for 
about 3 h) and an organic solvent (up to 23% isopropyl alcohol). 
Therefore, each property of the 87-kDa protein was examined with the 
sample considered to be most appropriate. The Stokes radius and 
sedimentation coefficient were determined on the Sephacryl S-400 peaks. 
At this stage of the preparation the sample had not been exposed to any 
denaturing agents (such as heat, acid, detergents, or organic solvents), 
so that the values obtained should reflect the native conformation of 
the protein. Phosphorylation by protein kinase C was examined with the 
FPLC-purified pool because the purified preparation was free of 
endogenous kinase activities.
The hydrodynamic properties of the 87-kDa protein were as follows: 
for Sephacryl S-400 peak A, a Stokes radius of 85 A, sedimentation 
coefficient of 2.11 S, and frictional ratio of 3.2; for Sephacryl S-400 
peak B, a Stokes radius of 56 A, sedimentation coefficient of 2.05 S, 
and frictional ratio of 2.45. The molecular weight calculated from 
these properties was about 68 kDa for peak A and about 43 kDa for peak 
B, although they electrophoresed with the same apparent molecular weight 
on NaDodSO^/ PAGE. The significance of the difference between the peaks 
is unclear. The sedimentation coefficient, phosphorylation 
characteristics, and behavior on other chromatographic systems were 
similar for both Sephacryl S-400 peaks. It is possible that the two 
peaks represent subpopulations of the 87-kDa protein that have minor 
structural differences. It is less likely that the major peak 
represents a dimer of 87-kDa protein, while the minor peak represents a 
monomer. In this case one would expect a significant difference in the
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sedimentation coefficient and a greater difference in the calculated 
molecular weight. Thus, while the difference between the Sephacryl S- 
400 peaks may be of interest, the majority of the 87-kDa protein behaved 
as a very asymmetric, highly elongated monomer with a calculated 
molecular weight of 68 kDa.
The amino acid composition (Table 2) of the 87-kDa protein was 
notable for a very high content of alanine (28.6 mol %), and a high 
content of glutamate/glutamine (18.1 mol %), the majority of which is 
likely to be glutamate, since the 87-kDa protein has an acidic pi 
(multiple forms varying from 4.4 to 4.9) (see Chapter 3). The protein 
was also found to be rich in glycine (12.6 mol %) and proline (11.3 mol 
%). Together, alanine, glutamate/glutamine, glycine, and proline 
comprised 70% of the protein.
The purified 87-kDa protein was phosphorylated by protein kinase C
32to a stoichiometry of 2.2 mol P per mol 87-kDa protein (calculated 
using a molecular weight of 68 kDa), exclusively on serine residues.
Thus there were two or three serine residues phosphorylated by protein 
kinase C.
Two other major endogenous substrates for protein kinase C have 
been examined in detail. A platelet protein of 40,000 was first 
described by the laboratory of Nishizuka (for reviews see Nishizuka, 
1984a,b, 1986), was purified by Imaoka et al. (1983), and has recently 
been identified by Connolly et al. (1986) as the inositol trisphosphate 
5'-phosphomonoesterase which hydrolyzes inositol 1,4,5-trisphosphate. A 
brain protein, most often referred to as B-50 (Zwiers et al.. 1980), FI 
(Chan et al. . 1986), or GAP-43 (Skene, 1984), has been purified by
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Zwiers et al. (1980), Chan et al. (1986), and Benowitz et al. (1987), 
and has been hypothesized to modulate the activity of phos- 
phatidylinositol 4-phosphate kinase (Van Dongen et al.. 1985). It will 
be of interest to determine whether the 87-kDa protein also has a 
function related to the modulation of phosphoinositide metabolism.
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Chapter 3. SPECIES, TISSUE, AND SUBCELLULAR DISTRIBUTION OF
THE 87-kDa PROTEIN
As described Chapter 2, phosphorylation of the 87-kDa protein has 
been shown to occur in intact cells in response to stimulators of PI 
turnover and activators of protein kinase C. The 87-kDa protein was 
also shown to be a substrate for protein kinase C in vitro (Wu et al.. 
1982; Walaas et al.. 1983a,b; Chapter 2), and was shown to be present in 
all regions of the rat brain (Walaas et al.. 1983a,b). The study of the 
species, tissue, and subcellular distribution of the 87-kDa protein 
described in this chapter, was undertaken as a step toward identifying 
the role of this protein in the actions of protein kinase C.
MATERIALS AND METHODS
Materials and methods were as described in Chapter 2 with the 
following exceptions.
Materials. Frozen cerebral cortex from Macaque monkey brain was a 
gift from Dr. Tamas Bartfai (Stockholm, Sweden). Fresh rat tissues were 
dissected from stunned and decapitated male Sprague-Dawley rats. Fresh 
bovine tissues were obtained from a local slaughterhouse and were 
transported to the laboratory either on ice, in liquid nitrogen, or as a 
preparation already homogenized in boiling 1% NaDodSO^. The heat-stable
68
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protein inhibitor of cAMP-dependent protein kinase (Walsh inhibitor) was 
a gift from Dr. Angus Nairn.
Other materials were purchased from the following commercial 
sources: benzamidine and Nonidet P-40 (NP-40) (Sigma); calmidazolium 
(Boehringer Mannheim); Hepes and S . aureus cells (Pansorbin)
(Calbiochem-Behring); NaDodSO^ (Bio-rad). All other chemicals used were 
reagent grade.
Preparation of Tissue Samples for Phosphorylation. Monkey 
cerebral cortex (stored at -70°C), fresh rat cerebral cortex, and bovine 
tissue samples (stored in a liquid nitrogen freezer), were homogenized 
at 0-4°C for 60 sec with a Polytron homogenizer in a lOx volume of 20 mM 
Hepes pH 7.4, 100 mM NaCl, 2 mM EDTA, 0.5 mM EGTA, Trasylol (50 
K.I.U./ml), 100 f M PMSF, 0.001% leupeptin, and 0.0017% chymostatin (plus 
0.1% DMSO to dissolve the chymostatin), and filtered through 
cheesecloth. Protein concentration was determined by the method of 
Bradford (1976).
Phosphorylation Assay for Endoeenous Substrates of Protein Kinase
C. The reaction mixture (final volume 100/*1) contained 20 mM Tris*HCl
pH 7.4, 10 mM Mg acetate, 1.0 mM EGTA, 2 mM DTE, 0.72 f i g Walsh
inhibitor, 5 pM calmidazolium, 0.001% leupeptin, and 100 f i g tissue
protein, in the absence or presence of 1.5 mM CaCl^, 5 f i g
phosphatidylserine/0.2 f i g diolein, and 4 ng protein kinase C. The
32
reaction was initiated by the addition of [7- P]ATP (final 
concentration 2 fiM.; specific activity 22x10  ^cpm/nmol), and was carried 
out for 60 sec at 30°C. The reaction was terminated by the addition of 
20 f i l  of NaDodSO^ stop solution (20% (vol/vol) glycerol/10% (wt/vol)
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NaDodSO^/10% (wt/vol) 2-mercaptoethanol/0.25 M Tris»HCl, pH 6.7, 
containing a trace of bromophenol blue) and heating in a boiling water 
bath for 5 min.
Proteins (50 f i g ) in the samples were separated by one-dimensional 
electrophoresis on NaDodSO^/6-12% mixed exponential-linear gradient 
polyacrylamide gels by the method of Kelly and Luttges (1975). The gels 
were stained, destained, dried, and subjected to autoradiography as 
described (Ueda and Greengard, 1977). Radioactivity in phosphorylated 
proteins was quantitated by analysis of the gels with an AMBIS Beta 
Scanning System (Automated Microbiology Systems, Inc., San Diego, CA).
For two-dimensional gel electrophoresis, proteins (50 f i g ) in the 
samples were precipitated with 90% ice-cold acetone, solubilized, and 
separated by the method of O'Farrell (1975), using isoelectric focusing 
on a pH 3.5-5.8 gradient in the first dimension and NaDodSO^/PAGE in the 
second dimension as described above.
Immunoprecipitation of the 87-kda Protein. Proteins in the 
samples were phosphorylated as described above except that the reaction 
was terminated by the addition of NaDodSO^ (final concentration 1%). 
Samples were then prepared for immunoprecipitation by the addition of an 
equal volume of phosphatase inhibitor buffer, pH 7.4 (10% (wt/vol) NP- 
40, 360 mM NaCl, 20 mM NaH2P04> 100 mM NaF, 4 mM EDTA, 4 mM EGTA). 
Antiserum was prepared for use in the immunoprecipitation by the 
addition of 50 mM NaF, 2 mM EGTA, 2 mM EDTA, 50 mM benzamidine, and
0.02% NaN^. Solutions for immunoprecipitation: Solution 1: 15 mM HEPES
pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.5% NP-40, and 1% (wt/vol) BSA;
Solution 2: Solution 1 without BSA; Solution 3: Solution 2 except with
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2.5% NP-40 and 0.5% NaDodSO^. Immunoprecipitation was performed as 
follows. All steps were carried out at 0-4°C; all centrifugations were 
carried out for 3 min at 10,000 x g in a Beckman Microfuge 12. 
Preparation of Pansorbin: an aliquot of Pansorbin was pelleted and 
resuspended in Solution 3. After 15 min, the Pansorbin was pelleted and
resuspended in Solution 1. After 15 min, the Pansorbin was pelleted and
resuspended in Solution 2. The Pansorbin was ready for use after
another cycle of centrifugation and resuspension in Solution 2. 
Preclearing of samples: Pansorbin was added to samples (20 y  1 
Pansorbin/220 /xl sample). After 20 min, samples were centrifuged and 
the supernatant fractions retained. Precipitation: 40 y l  of 87-kDa
protein antiserum was added to each precleared sample. After 20 min, 80 
y l  Pansorbin was added to each sample. After 20 min, the samples were 
centrifuged, and the pellets were washed twice with Solution 2. The 
pellets were then resuspended in NaDodSO^ stop solution (4% (vol/vol) 
glycerol/2% (wt/vol) NaDodSO^/2% (vol/vol) 2-mercaptoethanol/50 mM 
Tris*HCl pH 6.7, containing a trace of pyronin y), and the samples were 
heated in a boiling water bath for 5 min, and then recentrifuged. 
Proteins in the final supernatant were subjected to NaDodSO^/PAGE. 
Radioactivity in phosphorylated proteins was quantitated by analysis of 
the gels with an AMBIS Beta Scanning System.
Immunoblotting of the 87-kDa Protein. Fresh bovine tissues were 
homogenized at the slaughterhouse with an Ultra-Turrax homogenizer in a 
lOx volume of boiling 1% NaDodSO^, and heated for another 5 min in a 
boiling water bath. Protein concentration was determined by the method 
of Peterson (1977). Proteins (50 y g ) in the samples were separated by
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one-dimensional electrophoresis on NaDodSO^/6-12% mixed exponential-
linear gradient polyacrylamide gels. The proteins were
electrophoretically transferred to nitrocellulose sheets at 350 mA for
12 h using the buffer system of Towbin et al. (1979). Immunoblotting
125
was performed with [ I]-Protein A as described in Chapter 2. 
Radioactivity in labeled proteins was quantitated by analysis of the 
blots with the AMBIS Beta Scanning System.
Preparation of Subcellular Fractions. Subcellular fractions were 
prepared from fresh bovine cerebral cortex as described (Whittaker and 
Barker, 1972). The crude synaptosomal fraction (P£) was subdivided into 
particulate (P£-P) and cytosol (P2-S) fractions by hypotonic lysis in 
buffer (10 mM Hepes pH 7.4, 2 mM EDTA, 1 mM DTE, and Trasylol (50 
K.I.U./ml)) followed by centrifugation at 35,000 x g for 30 min. 
Extraction of proteins from the particulate fraction into the same 
buffer containing 0.5 M NaCl or 1% NP-40 was performed as described 
(Walaas et al.. 1986). Each particulate fraction was resuspended in a 
volume of buffer equal to that of the final supernatant (S^)• Proteins 
in aliquots (10 /j1) of the fractions were separated by one-dimensional 
NaDodSO^/6-12% mixed exponential-linear gradient PAGE and subjected to 
immunoblotting as described above.
Immunocvtochemistrv. The immunocytochemical technique by Ouimet 
et al. (1988) was carried out as follows: Male Sprague-Dawley rats (150
g) were anesthetized with chloral hydrate (350 mg/kg) and perfused via a 
cannula placed through the heart into the aorta with a fixative 
containing 2% formaldehyde and 1.25% glutaraldehyde in 0.01 NaPO^ buffer 
(pH 7.4). For light microscopy perfusion with 500 ml of fixative was
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preceded by perfusion with 150 ml of 0.1 M NaPO^ buffer. This step was 
omitted for electron microscopic studies. Fixative was delivered at a 
pressure of 120 mm Hg with a peristaltic pump. Brains were allowed to 
postfix for 1 hr. in situ and were then cut in the coronal plane into 
slabs 3 mm thick. The slabs were subsequently cut into sections 100 jtm 
thick on a vibratome and collected in phosphate buffered saline (PBS) 
containing 0.01 M NaPO^ and 0.15 M NaCl (pH 7.4). The sections were 
then immersed in Na borohydride (1% in PBS) for 30 min, rinsed in PBS (3 
x 15 min), and incubated with affinity-purified antibody to the 87-kDa 
protein in PBS containing 1% normal horse serum (18 h at room 
temperature on a tissue shaker). Although the antibody to the 87-kDa 
protein was already diluted about 1:200 by the process of affinity 
purification (method of Olmsted (1981)), the effect of further dilutions 
on immunostaining, ranging from 1:10 to 1:10,000, were assessed. Best 
results were obtained with a 1:25 dilution of the purified antibody. 
Following incubation with primary antibody, the sections were washed in 
PBS (3 x 10 min) and incubated with secondary and tertiary antibody 
solutions from a Vector ABC Kit (Vector Laboratories) according to their 
instructions. Sections were incubated with biotinylated horse anti­
rabbit IgG (1 h) followed by avidin/biotin/horseradish peroxidase 
complex (1 h). PBS washes (3 x 10 min) were used between steps and a 
penultimate wash in PBS (3 x 10 min) was followed by a final wash in 0.1 
M NaPO^ buffer (pH 7.4) (3 x 10 min). The sections were then immersed 
in 50 ml of 0.1 M NaPO^ buffer containing 25 mg of 3,3 diaminobenzidine 
and 10 n l  of 30% #2®2 ^°r ^ min > anc* washed in NaPO^ buffer (3 x 10 
min). For light microscopy, sections were then mounted on subbed
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slides, coverslipped with Permount, and examined. For electron 
microscopy, sections were osmicated (2% osmium tetroxide in 0.1 M P0^ 
buffer) (20 min), dehydrated in a graded series of ethanol solutions, 
and embedded in EMBED-812 (Electron Microscopic Sciences). Sections 80 
nm thick were cut on an ultratome and examined in a Zeiss JEOL lOOcx 
electron microscope without prior staining in lead citrate or uranyl 
acetate. The specificity of the staining protocol was assessed by the 
substitution of the following for the primary antibody: diluent without 
primary antibody, normal rabbit serum (1 :1000), and serum antibodies 
directed against irrelevant antigens. Potential contamination of the 
primary antibody with antibodies against other antigens was avoided by 
affinity purification of the primary antibody. Omission of the second 
antibody or of the avidin/biotin/horseradish peroxidase complex produced 
a total lack of staining.
RESULTS
Species Distribution of the 87-kDa Protein. The 87-kDa protein 
was observed as a major endogenous substrate for protein kinase C in 
homogenates from monkey, rat, and bovine brain (Fig. 14A). The of 
the 87-kDa protein varied depending on the sample buffer, the gel 
system, and the acrylamide concentration used. In this NaDodSO^/6-12% 
mixed exponential-linear gradient polyacrylamide gel, the protein from 
monkey and bovine brain had an M value of 90,000, whereas that from rat 
brain had an M^ _ value of 83,000 (Fig. 14A). This difference was 
consistent, since in all experiments the phosphorylated 87-kDa proteins
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Figure 14. (A) Autoradiogram showing phosphorylation of
endogenous substrates for protein kinase C in homogenates of monkey, 
rat, and bovine brain. The phosphorylation assay for endogenous 
substrates was carried out in the absence (-) or presence (+) of calcium 
(500 /iM free), phosphatidylserine (5 fig/100 ;zl)/diolein (0.2 f i g / 1 0 0  f i l ), 
and protein kinase C (4 ng/100 /zl). After termination of the 
phosphorylation reaction by the addition of NaDodSO^ stop solution, 
samples (50 fig protein) were subjected to one-dimensional 
electrophoresis on NaDodSO^/6-12% mixed exponential-linear gradient 
polyacrylamide gels, followed by autoradiography. (B) Autoradiogram 
showing specificity of the immunoprecipitation of the 87-kDa protein 
from the mixture of endogenous substrates for protein kinase C in 
monkey, rat, and bovine brain. Phosphorylation was carried out as in 
(A) except that the reaction was terminated by the addition of NaDodSO^ 
(1% final concentration). Samples were then subjected to im­
munoprecipitation with 40 f i l  of 87-kDa protein antiserum, followed by 
gel electrophoresis as in (A). 90k, position of the 87-kDa protein from
monkey and bovine brain in this gel; 83k, position of the 87-kDa protein 
from rat brain in this gel. Molecular size markers are shown in 
kilodaltons.
B.
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from rat or mouse brain always had values 4000-7000 lower than those 
from monkey, bovine, or human brain. Because of the variablility in 
of the 87-kDa protein, the small, consistent difference between the 
rodent and bovine 87-kDa proteins could be appreciated only when samples 
were in the same buffer and were electrophoresed in adjacent lanes on 
the same gel. The 87-kDa antiserum precipitated a single phosphorylated 
protein from preparations from monkey, rat and bovine brain (Fig. 14B) 
and from human cerebral cortex. This immunoprecipitation confirmed that 
the protein from each species was similar immunologically and that the 
rat protein had an value 4000-7000 lower than the proteins from the
other species. When subjected to isoelectric focusing, the 
phosphorylated proteins from each species were found to be acidic with 
multiple (at least three) phosphorylated spots, with pi's ranging from 
4.5-4.8 in the human, 4.4-4.8 in the monkey and bovine, and 4.3-4.6 in 
the rat. When subjected to limited digestion with S . aureus V8 protease 
or limit digestion with thermolysin, the 87-kDa protein from each 
species generated the same phosphopeptide maps as the purified 87-kDa 
protein (Chapter 2). These same S. aureus V8 protease and thermolytic 
maps were also generated upon digestion of a similar protein from 
Torpedo californica electric organ (R. Huganir, personal communication). 
The protein from T. californica electric organ had the same M value as 
the proteins from monkey, bovine, and human brain. Therefore, the only 
detectable differences between the 87-kDa proteins from different 
species were that the rodent protein had an M value 4000-7000 lower, 
and was slightly more acidic, than the proteins from the other species 
tested.
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Tissue Distribution of 87-kDa Protein. Endogenous proteins in 
homogenates of ten bovine tissues were assayed with exogenous protein 
kinase C. The 87-kDa protein was a prominent substrate in the brain and 
lung, and was visible as a substrate in the adrenal, spleen, and testis 
(Fig. 15A, Table 4). When proteins in homogenates from the same tissues 
were subjected to immunoblotting, the 87-kDa protein was detected in all 
tissues examined (Fig. 15B, Table 4), although the relative 
concentration varied among the tissues. The concentration was highest 
in brain, spleen, and lung; moderate (about 30-50% of that in brain) in 
testis, pancreas, adrenal, kidney, and liver; and lowest (less than 15% 
of that in brain) in heart and skeletal muscle. Therefore, while the 
phosphorylation and immunoblotting results were generally in good 
agreement, they showed some differences in the apparent relative amounts 
of the 87-kDa protein in the various tissues, e.g. the spleen protein 
was less prominent by phosphorylation than by immunoblotting. Possible 
causes for these differences include masking of phosphorylated 87-kDa 
protein by other substrates of similar Mr ; differences in ATPase, 
phosphoprotein phosphatase, or protein kinase inhibitor activities among 
the tissues; and differences in proteolytic activities among the 
tissues. Evidence for the latter possibility was obtained in some 
experiments when less fresh bovine tissues were used (prepared more than 
five hours after removal from the animal); in these cases a major 
proteolytic product of M 47,000 was detected by immunoprecipitation and 
immunoblotting.
The 87-kDa proteins from the various bovine tissues were identical 
by all criteria examined. When subjected to one-dimensional
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Figure 15. (A) Autoradiogram showing phosphorylation of
endogenous substrates for protein kinase C in homogenates of bovine 
tissues. The phosphorylation assay for endogenous substrates was 
carried out in the presence of calcium (500 /j.K free), phosphatidylserine 
(5 Mg/100 Ml)/diolein (0.2 Mg/100 m!), and protein kinase C (4 ng/100 
Ml)- After termination of the phosphorylation reaction by the addition 
of NaDodSO^ stop solution, samples (50 Mg protein) were subjected to 
one-dimensional electrophoresis on NaDodSO^/6-12% mixed exponential- 
linear gradient polyacrylamide gels, followed by autoradiography. (B) 
Autoradiogram of immunoblot showing the distribution of the 87-kDa 
protein in bovine tissues. Tissue samples were homogenized in a lOx 
volume of boiling 1% NaDodSO^, and aliquots (50 Mg protein) were 
subjected to one-dimensional electrophoresis on NaDodSO^/6-12% mixed 
exponential-linear gradient polyacrylamide gels. The proteins were then 
transferred to nitrocellulose sheets and subjected to immunoblotting 
w | ^  a 1:200 dilution of the 87-kDa protein antiserum followed by 
[ I]-Protein A overlay. Lane numbers represent the following tissues: 
1 and 11, cerebral cortex; 2. adrenal; 3, pancreas; 4, lung; 5, liver;
6, spleen;, 7, heart; 8, kidney; 9, testis; 10, skeletal muscle. 87k, 
position of the 87-kDa protein. Molecular size markers are shown in 
kilodaltons.
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Table 4. Distribution of the 87-kDa protein in bovine tissues
Tissue Immunoblot Phosphorylation
Brain 100 100
Lung 64 111
Spleen 83 45
Testis 32 55
Pancreas 37 34
Adrenal 27 35
Kidney 24 30
Liver 20 26
Heart 14 4
Skeletal Muscle 7 5
All values are expressed as % of value in brain. Samples were
analyzed as described in the legend to Fig. 15.
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electrophoresis on a NaDodSO^/6-12% mixed exponential-linear gradient 
gel, each protein was seen as a broad band of Mr 90,000 (Fig. 15B).
When subjected to isoelectric focusing, the phosphorylated protein from 
each tissue was found to be acidic with multiple spots (at least three) 
within the range of pi 4.4-4.9. Examples from brain, testis, and 
adrenal are shown in Fig. 16. The pi of the major phosphorylated spot 
from each tissue varied from experiment to experiment; in the experiment 
shown, the major phosphorylated spot was more acidic in the brain than 
in testis or adrenal (Fig. 16). This variability may have been the 
result of a post-translational modification, perhaps phosphorylation 
itself. The 87-kDa protein antiserum precipitated a single 
phosphorylated protein of similar from each tissue. Examples from 
brain, testis, and adrenal are shown in Fig. 17A; each protein had an M 
value of 80,000 in this NaDodSO^/8% polyacrylamide gel. Limited 
proteolysis with S . aureus V8 protease of the immunoprecipitated 
phosphorylated protein from each tissue generated an identical 
phosphopeptide map with major and minor phosphopeptides with M values 
of 13,000 and 9,000 respectively. Examples from brain, testis, and 
adrenal are shown in Fig. 17B.
Analysis of rat tissues with similar techniques gave comparable 
results. Phosphorylation of endogenous substrates with exogenous 
protein kinase C showed that the 87-kDa protein was most prominent in 
brain, was prominent in lung, spleen, and vas deferens, and was 
detectable in testis, pancreas, and liver. The value was 80,000 when 
proteins were subjected to one-dimensional NaDodSO^/7-12% linear 
gradient polyacrylamide gel electrophoresis. The 87-kDa protein
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Figure 16. Autoradiogram showing heterogeneity of the 87-kDa 
protein upon isoelectric focusing. Phosphorylation was carried out as 
described in the legend to Figure 15. After termination of the 
phosphorylation reaction, samples (50 f i g protein) were precipitated with 
acetone and subjected to two-dimensional electrophoresis using 
isoelectric focussing in the first dimension (pH range 3.5-6) followed 
by electrophoresis on NaDodSO^/6-12% mixed exponential-linear gradient 
polyacrylamide gels in the second dimension. Arrowheads, major 
radioactive species in each case. 1, cerebral cortex; 2 , testis; and 3, 
adrenal.
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Figure 17. (A) Autoradiogram showing specificity of the
immunoprecipitation of the 87-kDa protein from various bovine tissues. 
Phosphorylation was carried out as described in the legend to Figure 15. 
After termination of the phosphorylation reaction by the addition of 
NaDodSO^ (1% final concentration), samples were subjected to 
immunoprecipitation with 40 f i l  of the 87-kDa protein antiserum, followed 
by NaDodS0^/8% PAGE. 87k, the 87-kDa protein. Molecular size markers 
are shown m  kilodaltons. (B) Autoradiogram showing phosphopeptide maps
after limited proteolysis with S . aureus V8 protease, of im- 
munoprecipitated phosphorylated 87-kDa protein from various bovine 
tissues. Immunoprecipitation was carried out as in (A). Phosphorylated 
87-kDa protein, located by autoradiography, was excised and subjected to 
limited proteolysis during NaDodSO^/15% PAGE. 13k and 9k, positions of 
the major and minor phosphorylated fragments derived from the 87-kDa 
protein. Molecular size markers are shown in kilodaltons. 1, cerebral 
cortex; 2, testis; and 3, adrenal.
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antiserum precipitated a single M 80,000 phosphoprotein from each 
tissue. When subjected to isoelectric focussing, the phosphoprotein 
from each rat tissue generated multiple acidic spots (within the pH 
range of 4.0-4.7), and when subjected to limited proteolysis with S. 
aureus V8 protease, generated the same phosphopeptide map as the bovine 
protein. The 87-kDa protein has also been identified by similar 
techniques in bovine vascular endothelial cells (Mackie et al.. 1985). 
Therefore, within a given species the 87-kDa protein from each tissue 
was identical, although the concentration varied among the tissues, and 
the protein from rat tissues was of lower than the protein from 
bovine tissues.
Subcellular Distribution of the 87-kDa Protein. The 87-kDa 
protein from bovine cerebral cortex was found to be distributed as 
follows: crude nuclear fraction (P^), 20%; crude synaptosomal membrane 
(P2’P). 40%; crude synaptosomal cytosol (P^-S), 10%; crude microsomal 
fraction (P^), 5%; and cytosol (S^), 25% (Fig. 18A). This distribution 
is similar to that of Synapsin I, a synaptic vesicle-associated protein, 
except that there is no Synapsin I in the cytosol (S^) (Huttner et al.. 
1983). The 87-kDa protein was not extracted from the crude synaptosomal 
membrane (P2-P) by 0.5 M NaCl (Fig. 18B), but was almost completely 
extracted by nonionic detergents such as 1% NP-40 (Fig. 18B). In 
contrast, Synapsin I, a peripheral membrane protein, behaved in an 
opposite manner, being extracted by 0.5 M NaCl but not by nonionic 
detergents (Huttner et al.. 1983). In fractionation of a non-neuronal 
tissue (testis), the 87-kDa protein partitioned roughly equally between 
the particulate and soluble fractions; again, the particulate protein
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Figure 18. (A) Autoradiogram of immunoblot showing the
distribution of the 87-kDa protein in subcellular fractions from bovine 
cerebral cortex. Proteins in aliquots (10 f i l )  from the fractions were 
subjected to one-dimensional electrophoresis and immunoblotting as 
described in the legend to Figure 15. Radioactivity in labeled proteins 
was quantitated by analysis of the blots with the AMBIS Beta Scanning 
System. P^, crude nuclear fraction; P^, crude synaptosomal fraction; 
?2-P and 1*2'^’ Part^culate an(i soluble fractions, respectively, after 
lysis of P^ followed by centrifugation at 35,000xg for 30 min; P.,, crude 
microsomal fraction; S^, cytosol. % of total, cpm in each fraction xlOO 
divided by the sum of cpm in all fractions shown. (B) Autoradiogram of 
immunoblot showing extraction of the 87-kDa protein from membrane by 
nonionic detergent but not by salt. Fractions were prepared by 
resuspension of the P£-P fraction in buffer containing 0.5 M NaCl or 1% 
Nonidet P-40 (NP-40), incubation at 30°C for one hour, and centrifuga­
tion at 200,000 x g at 4°C for 30 min. Proteins in aliquots (10 ( i l )  
from the fractions were subjected to electrophoresis and immunoblotting 
as in (A). NaCl-P and NaCl-S, particulate and soluble fractions, 
respectively, after resuspension of P2-P in buffer containing 0.5 M NaCl 
followed by centrifugation. NP-40-P and NP-40-S, particulate and 
soluble fractions, respectively, after resuspension of buffer
containing 1% NP-40 followed by centrifugation. % of cPm each
fraction xlOO divided by cpm in Posit:ion of the 87-kDa
protein.
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was not extracted by 0.5 M NaCl but was extracted by 1% NP-40. Further 
evidence for the presence of the 87-kDa protein in the membrane was 
obtained by phase separation in Triton X-114 (Bordier, 1981) using rat 
cerebellum; the 87-kDa protein partitioned between the detergent and 
water phases, whereas Synapsin I was found in the water phase.
Therefore, the 87-kDa protein behaved both as a cytosolic protein and as 
an integral membrane protein.
Additional evidence for a membrane-bound fraction of the 87-kDa 
protein has recently been obtained by immunocytochemistry. Light 
microscopy results indicated that the protein was present in all regions 
of the brain, but was particularly enriched in hypothalamus and 
cingulate cortex (Ouimet et al.. 1988). Electron microscopy was used to 
examine the hypothalamus, the cingulate cortex, and the CA1 region of 
the hippocampal complex. Results were similar in all three areas. For 
example, results within hypothalamus showed staining in glial sheaths 
(cell type not yet identified), in small dendrites and spines, and in 
axons and nerve terminals (Ouimet et al.. 1988). The staining in 
dendrites was found throughout the cytoplasm, possibly in association 
with microtubules, and was also found along the inner surface of the 
plasma membrane (Fig. 19). (Tissues other than brain have yet to be 
examined, and the exact subcellular localizations of the 87-kDa protein 
by immunocytochemistry will be confirmed by further experiments).
One possible explanation for the membrane binding of a fraction of 
the 87-kDa protein involves post-translational modification. In 
collaboration with Dr. Alan Aderem, in the murine macrophage, a protein 
that was recently identified as the 87-kDa protein was found to be
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Figure 19. Electron micrograph of a segment of rat hypothalamus 
showing staining of the 87-kDa protein in small dendrites and glial 
sheaths as revealed by immunoperoxidase. 100-jtm-thick frozen coronal
sections were stained with affinity-purified antibody to the rat brain 
87-kDa protein. Peroxidase reaction product, which appears black in the 
micrograph, is visible in the cytosol of small dendrites (C), along the 
inner surface of the membrane of small dendrites (M), and within glial 
sheaths (G). Figure from Ouimet et al. (1988).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
87
phosphorylated in response to treatment with phorbol ester, and was 
found to be myristoylated in response to treatment with bacterial 
lipopolysaccharide (LPS) (Aderem et al.. 1988). The function of 
protein-bound myristic acid is only beginning to be understood (for 
recent review see Sefton and Buss (1987)), but it has been shown to have
a role in targeting proteins to the membrane (Pellman et al.. 1985;
Cross et al.. 1984; Kamps et al.. 1985; Rein et al.. 1986). Consistent 
with this possibility was the finding in the murine macrophage that the 
vast majority (> 90%) of the myristoylated 87-kDa protein was found in
the membrane (Fig. 20). Thus it is possible that the particulate
fraction of the 87-kDa protein is bound to the membrane by 
myristoylation. In these same experiments, the majority (> 75%) of the 
phosphorylated 87-kDa protein was found in the cytosol (Fig. 20). The 
relationship of myristoylation and phosphorylation to subcellular 
distribution of the 87-kDa protein requires further study.
DISCUSSION
The 87-kDa protein was previously identified as a major endogenous 
substrate for protein kinase C in broken cell preparations from rat 
brain (Walaas et al.. 1983a,b) and was found to be phosphorylated in 
intact nerve terminals (Wu et al.. 1982; Wang et al.. 1988). In this 
chapter, the 87-kDa protein was identified in tissues from a number of 
species. Thus the 87-kDa proteins from monkey, rat, and bovine brain, 
and from a number of rat and bovine tissues, were found to have similar 
properties: each was phosphorylated by protein kinase C and was of
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Figure 20. Autoradiograms showing subcellular distribution of 
immunoprecipitated 87-kDa protein after treatment of a murine macrophage 
preparation with lipopolysaccharide (LPS) followed by phorbol 12- 
myristate 13-acetate (PMA). Murine resident macrophages were isolated 
by peritoneal lavage and incubated with H-myristate and S . abortus eoui 
LPS (10 ng/ml) (MA) or with P. and LPS (Pi) for 90 min. PMA (10 
ng/ml) was then added for an additional 30 min. After 2 hr the cells 
were lysed by sonication and the membrane (MEM) and cytosol (CYT) 
fractions were separated by centrifugation at 100,000 x g for 30 min.
The 87-kDa protein was immunoprecipitated from the fractions and 
electrophoresed on NaDodSO^/6-12% PAGE as described (Aderem et al.. 
1986). The murine macrophoage 87-kDa protein electrophoresed at M 
68,000 on these gels. -*•, positions of detectable bands; it is likely 
that the bands of M lower than 68,000 represent proteolytic products of 
the 87-kDa protein m  this preparation. Molecular size markers are 
shown in kilodaltons. Figure from (Aderem et al.. 1988).
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variable Mr depending on the sample buffer, gel system, and acrylamide 
concentration used; each was recognized by the 87-kDa protein antiserum; 
each was acidic and heterogeneous, with multiple phosphorylated spots of 
pi within the range 4.3-4.9; and each generated a characteristic 
phosphopeptide map upon limited digestion with V8 protease, with major 
and minor peptides of Mr 13,000 and 9,000, respectively. The 87-kDa 
protein was also identified in mouse and human brain and in T. 
califomica electric organ. The only detectable differences among the 
87-kDa proteins were 1) that the relative concentration varied among the 
tissues, such that it was highest in brain, spleen, and lung, moderate 
in testis, pancreas, adrenal, kidney, and liver, and lowest in heart and 
skeletal muscle; and 2) that the protein from all rodent tissues had an 
M value 4,000-7,000 lower, and was slightly more acidic, than the 
protein from tissues in the other species examined.
Similar results were obtained by Blackshear et al. (1986). They 
identified an acidic, 80,000 substrate for protein kinase C in heat- 
stable fractions from a number of rat tissues, which was most prominent 
in brain. This substrate had a lower value and was slightly more 
acidic in rat or mouse brain, fibroblasts, or fat pads, than in bovine 
brain or fibroblasts, or than in porcine, human, or rabbit brain. In 
addition, an antiserum to their bovine brain Mr 80,000 protein 
recognized purified bovine brain 87-kDa protein from our laboratory (P. 
J. Blackshear and L. Wen, personal communication).
Of particular interest is the subcellular distribution of the 87- 
kDa protein. In bovine cerebral cortex, most of the 87-kDa protein was 
found in the crude synaptosomal fractions and the cytosol. When
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subfractionation of the synaptosomal fractions was carried out, about 
80% of the synaptosomal 87-kDa protein was found in the synaptosomal 
particulate preparation; this fraction was almost quantitatively 
extracted with nonionic detergents but not with NaCl. Further evidence 
for the membrane localization of a portion of the protein was obtained 
in a Triton X-114 phase separation, in which the 87-kDa protein 
partitioned between the detergent and water phases. In addition, by 
immunocytochemistry, a portion of the staining of the 87-kDa protein in 
dendrites was found along the inner surface of the plasma membrane.
Therefore, the 87-kDa protein behaves both as an integral membrane 
and a soluble protein. A mechanism for the membrane binding of the 87- 
kDa protein has been suggested in murine macrophages by the finding that 
the protein can be myristoylated. Also of interest is the finding that 
the majority of the myristoylated protein is membrane-bound, while the 
majority of the phosphorylated protein is cytosolic. It is tempting to 
speculate that in carrying out its function(s), the 87-kDa protein may 
translocate among subcellular compartments. Myristoylation of the 87- 
kDa protein has also been found in rat neuronal cultures (A. Aderem, 
K.A.A. , and N. Rosen, data not shown; Perrone-Bizzozero et al.. 1987), 
indicating that myristoylation of the protein is likely to be involved 
in its function in nervous tissue.
The species, tissue, and subcellular distribution reported here 
for the 87-kDa protein follows very closely the reported distribution of 
protein kinase C itself (Kikkawa et al.. 1982; Minakuchi et al.. 1981; 
Kuo et al.. 1980; Katoh and Kuo, 1982), although the two proteins are 
distinct (Chapter 2; Blackshear et al.. 1986). This localization
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pattern, coupled with the phosphorylation of the 87-kDa protein in 
response to activators of PI turnover, makes the 87-kDa substrate a 
likely mediator for certain functions of protein kinase C. It will be 
of interest to determine whether the distribution of the 87-kDa protein, 
within brain and within other tissues, follows closely one of the 
isozymes of protein kinase C. Given the widespread tissue and species 
distribution of the protein reported here, its function(s) probably 
include cellular activities common to many cells. Further characteriza­
tion of this 87-kDa protein, a major endogenous substrate for protein 
kinase C, will undoubtedly provide information about the actions of 
protein kinase C at the molecular level.
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Chapter 4. PHOSPHORYLATION AND ACTIVATION OF TYROSINE HYDROXYLASE BY
PROTEIN KINASE C
Nerve stimulation and neurotransmitters have been demonstrated to 
accelerate catecholamine biosynthesis in central and peripheral nervous 
tissue, adrenal medulla, and pheochromocytoma cells (Ip et al.. 1982; 
Weiner et al.. 1970; Murrin and Roth, 1976; Greene and Rein, 1978).
This acceleration is thought to result from an increase in the catalytic 
activity of tyrosine hydroxylase (tyrosine 3-monooxygenase, EC 
1.14.16.2) (cf. Weiner, 1970), the rate-limiting enzyme in the 
biosynthesis of catecholamines (Nagatsu et al.. 1964a).
Several lines of evidence had suggested that cAMP-dependent 
phosphorylation might be one means of activation of tyrosine hydroxylase 
in situ (cf. Haycock et al.. 1982a,b and references therein). Thus, 
analogues of cAMP accelerated catecholamine biosynthesis in intact 
tissue preparations (Goldstein et al.. 1976; Meligeni et al.. 1982; 
Chalfie et al.. 1979; Ikeno et al.. 1981). In broken cell preparations, 
tyrosine hydroxylase could be activated, in the presence of ATP and 
magnesium, by cAMP or cAMP-dependent protein kinase (e.g., see Goldstein 
et al.. 1976; Morgenroth et al.. 1975). Finally, purified tyrosine 
hydroxylase had been shown to be phosphorylated and activated by 
purified cAMP-dependent protein kinase (Markey et al.. 1981; Vulliet et 
al.. 1980; Edelman et al.. 1981).
92
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Other evidence had suggested a role for calcium as well as cAMP in 
the activation of tyrosine hydroxylase in situ (Haycock et al.. 1982a,b; 
El Mestikawy et al. . 1983). The work in this chapter was undertaken to 
analyze the potential role for protein kinase C in the regulation of 
tyrosine hydroxylase activity. It was found that purified protein 
kinase C phosphorylated and activated partially purified tyrosine 
hydroxylase, in a manner similar to cAMP-dependent protein kinase.
MATERIALS AND METHODS
Materials and methods were as described in Chapters 2 and 3 with 
the following exceptions.
Materials. The catalytic subunit of cAMP-dependent protein kinase 
and calcium/calmodulin-dependent protein kinase I were gifts from Dr. 
Angus Naim. Calcium/calmodulin-dependent protein kinase II was a gift 
from Yvonne Lai and Teresa McGuinness.
Other reagents and enzymes were obtained from the following 
commercial sources: catalase (Sigma); DL-6-methyl-5,6 ,7,8- 
tetrahydropterine (6-MePH^) and dopamine (Calbiochem-Behring); L- 
tyrosine (Eastman); Ag 50W-X8 cation-exchange resin (200-400 mesh, dry, 
hydrogen form), and Bio-Rex 9 anion-exchange resin (200-400 mesh, dry,
chloride form) (Bio-Rad); trypsin and chymotrypsin (Worthington); L-
3
[3,5- H]tyrosine (New England Nuclear). All other chemicals used were 
reagent grade.
Partially purified tyrosine hydroxylase was prepared in the 
laboratory of Dr. Menek Goldstein, and had been partially purified as
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described (Markey et al.. 1980), from the cytosol of cultured PC 12 
pheochromocytoma cells, by two cycles of (NH^^SO^ fractionation (80% 
and 25-35% saturation) and Sepharose 4B chromatography. At this stage 
of purification, the Mr 62,000/60,000 doublet of tyrosine hydroxylase 
constituted approximately 75% of the total protein present (estimated 
from Coomassie blue protein stain of a NaDodSO^/8% polyacrylamide gel) 
(Fig. 2lA). The specific activity of the fresh preparation, when 
measured at pH 6.0, was 0.12 /xmol of dopa formed per min per mg of 
protein. The protein was stored at -70°C for up to three months before 
use.
Measurement of Tyrosine Hvdroxvlase Phosphorylation. The reaction
mixture (final volume 100 f i l )  contained 20 mM Tris*HCl pH 7.4, 10 mM Mg
acetate, 1.0 mM EGTA, 1.5 mM CaC^, 5 f i g phosphatidylserine/0.1 f i g
diolein, 2 mM DTE, 50 f i g BSA, 0.001% leupeptin, and 18 f i g of tyrosine
hydroxylase, in the absence or presence of 72 ng protein kinase C. The
32reaction was initiated by [7 - P]ATP (final concentration, 500 /xM; 
specific activity, 175 cpm/pmol) and carried out for 15 min at 30°C.
The reaction was terminated by the addition of 20 f i l  NaDodSO^ stop 
solution (20% (vol/vol) glycerol/10% (wt/vol) NaDodS0^/10% (vol/vol) 2- 
mercaptoethanol/0.25 M Tris»HCl, pH 6.7, containing a trace of 
bromophenol blue) and heating in a boiling water bath for 5 min.
The samples were electrophoresed on NaDodSO^/8% polyacrylamide 
gels by the method of Laemmli (1970). The gels were stained, destained, 
dried, and subjected to autoradiography as described (Ueda and 
Greengard, 1977). The phosphorylated M^ 62,000/60,000 tyrosine
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Figure 21. (A) Coomassie blue protein stain of the partially-
purified tyrosine hydroxylase preparation (9.2 f i g ) . (B) Autoradiogram 
showing phosphorylation of tyrosine hydroxylase by protein kinase C.
The tyrosine hydroxylase phosphorylation assay was carried out with the 
following modifications: 21.6 f i g of tyrosine hydroxylase and 2.4 ng of 
protein kinase C were used, and calcium (0.5 mM free) and phosphatidyl- 
serine (5 f i g / 1 0 0 /il)/diolein (0.1 f ig/100 f i l )  were^present as indicated. 
The reaction was initiated by the addition of [7  ^ P]ATP (final 
concentration, 10 f iK; specific activity, 15 x 10 cpm/pmol) and carried 
out for 2 min. TH, tyrosine hydroxylase. Molecular size markers are 
shown in kilodaltons.
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hydroxylase doublet was located by autoradiography and excised, and the 
radioactivity was quantitated by liquid scintillation counting.
Measurement of Tyrosine Hvdroxvlase Activity. Tyrosine 
hydroxylase activity was measured by a two-step assay. In the first 
step (preincubation), the tyrosine hydroxylase phosphorylation reaction 
was carried out as described above, except that nonradioactive ATP was 
used, and the reaction was terminated by the addition of 10 pi of 250 mM 
EDTA. To initiate the second step (incubation) (Nagatsu et al..1964b). 
two aliquots (50 pi each) of the stopped phosphorylation mixture were 
immediately added to tubes containing the reaction mixture for the 
measurement of tyrosine hydroxylase activity. This reaction mixture 
(final volume, 110 pi) contained (final concentrations) 200 mM Na 
phosphate buffer (pH 7.0), 0.1 mM 6-MePH^, 100 pM L-[3,5-^H]tyrosine 
(specific activity, 1 pCi/4 nmol), 800 units of catalase, and 90 mM NaF. 
The reaction was carried out at pH 7.0 rather than pH 6.0, because 
tyrosine hydroxylase activity at pH 6.0 in the absence of protein kinase 
C was too high to obtain a reliable activation curve. The reaction was 
carried out for 5 min at 37 °C and terminated by the addition of 200 pi 
of 0.1 M NaOH. The stopped reaction mixtures were passed through ion 
exchange columns (0.1 x 1.5 cm) consisting of equal volumes of anion 
exchange resin (Bio-Rex 9, upper layer) and cation exchange resin (Ag 
50W-X8, lower layer). The columns were washed with 0.5 ml, then 1.0 ml, 
of water. Tritiated water was measured in the flow-through by liquid 
scintillation counting.
Additional Methods. Two-dimensional peptide mapping was performed 
as described (Huttner and Greengard, 1979), except that chymotrypsin (50
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H g / m l ) was used in addition to trypsin (75 jig/ml). Protein 
determination was performed by the method of Peterson (1977) with BSA as 
standard.
RESULTS
Phosphorylation of Tvrosine Hvdroxvlase. In the presence of
calcium, protein kinase C phosphorylated tyrosine hydroxylase in a
phosphatidylserine/diolein-dependent manner (Fig. 21B). The maximum
stoichiometry achieved with this preparation of tyrosine hydroxylase was 
32
about 0.5 mol of P per mol of 62,000/60,000 doublet. Basal 
phosphorylation of tyrosine hydroxylase (in the absence of added protein 
kinase C (not shown), or in the presence of added protein kinase C 
without activators (Fig. 21B)), constituted less than 20-25% of the 
phosphorylation seen in the presence of protein kinase C with activators 
(Fig. 21B). The basal phosphorylation of tyrosine hydroxylase seen in 
the absence of added protein kinase C was not affected by the addition 
of calcium, phosphatidylserine/diolein, calmodulin, or Walsh inhibitor.
Measurement of Phosphorylation and Activity of Tvrosine 
Hvdroxvlase in the Absence and Presence of Protein Kinase C . The 
phosphorylation and activity of tyrosine hydroxylase were measured in 
parallel by the two-step assay, in which phosphorylation was carried out 
in the first step and tyrosine hydroxylase activity was measured in the 
second step. In the presence of protein kinase C, the phosphorylation 
of tyrosine hydroxylase increased with time and reached a plateau after 
about 20-30 min (Fig. 22A). Addition of a second aliquot of protein
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Figure 22. Time course of phosphorylation (A) and activation (B) 
of tyrosine hydroxylase by protein kinase C. (A) The first step of the 
two-step assay (the preincubation ste^to phosphorylate tyrosine 
hydroxylase) was carried out with [7- P]ATP (specific activity, 175 
cpm/pmol) at 30°C for the times indicated and was terminated by the 
addition of 20 jil of NaDodSO^ stop solution. After gel electrophoresis, 
the M 62,000/60,000 tyrosine hydroxylase doublet, located by 
autoradiography, was excised, and the radioactivity was quantitated by 
liquid scintillation counting. (B) The first step (preincubation) of 
the standard assay was carried out with nonradioactive ATP at 30°C for 
the times indicated, followed by the second step (incubation) at 37°C 
for 5 min. Each point represents the mean of duplicate samples. *, In 
the presence of protein kinase C; o, in the absence of protein kinase C; 
1, addition of a second aliquot of protein kinase C.
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kinase C at 40 min resulted in a further increase in phosphorylation, 
indicating that the first plateau was attributable to inactivation of 
the kinase.
Tyrosine hydroxylase activity in the presence of protein kinase C 
increased along with phosphorylation up to 15 min (Fig. 22B), after 
which there was a sharp decline in activity. Addition of a second 
aliquot of protein kinase C at 40 min did not restore activity. A 
decrease in activity with increasing time of phosphorylation has also 
been reported in studies with cAMP-dependent phosphorylation of tyrosine 
hydroxylase (e.g. see Vrana and Roskoski, 1983), and has been attributed 
to an increased susceptibility to denaturation of the phosphorylated 
form of the enzyme relative to the dephosphorylated form (Vrana and 
Roskoski, 1983). There was little or no change in tyrosine hydroxylase 
activity as a function of time of preincubation in the absence of 
protein kinase C (Fig. 22B). Calcium/calmodulin-dependent protein 
kinase I (Nairn and Greengard, 1987) did not phosphorylate or activate 
tyrosine hydroxylase, and calcium/calmodulin-dependent protein kinase II 
phosphorylated but did not activate tyrosine hydroxylase, probably 
because the necessary protein activator was not present (see below).
Effect of Phosphorylation of Tvrosine Hvdroxvlase on Its Affinity
for 6-MePH^. The for 6-MePH^ was determined for tyrosine hydroxylase
in the absence and presence of protein kinase C by the two-step assay
(with the first step carried out for 15 min), except that the
concentration of 6-MePH. was varied from 0.1 mM to 1.0 mM. The K for
4 m
6-MePH^ was 0.45 mM in the absence of protein kinase C and 0.11 mM in
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the presence of protein kinase C (Fig. 23). There was no change in 
V
max
Effect of Phosphorylation of Tvrosine Hvdroxvlase on Its Affinity
for Tvrosine. The for tyrosine was determined for tyrosine
hydroxylase in the absence and presence of protein kinase C by the two-
step assay (with the first step carried out for 15 min), except that the
concentration of tyrosine was varied from 10 to 100 pM, and the second
step was carried out for 6 min. Protein kinase C did not significantly
alter the K value for tyrosine, but it did cause a 30% increase in 
m
apparent V (Fig. 24). This small increase in apparent V probably m&x max
resulted from the increased affinity for 6-MePH^ (see above), which was 
subsaturating in these assays.
Effect of Phosphorylation of Tvrosine Hvdroxvlase on Its 
Suscentibitv to Inhibition by Dooamine. The for dopamine inhibition 
of tyrosine hydroxylase activity in the absence and presence of protein 
kinase C was determined by the two-step assay with the following 
exceptions: the first step was carried out for 13 min and the second 
step for 6 min; dopamine concentration was varied from 2 to 80 pM; two 
concentrations of 6-MePH^ (0.1 and 1.0 mM) were used; and the second 
step was carried out at pH 6.0 rather than 7.0, because tyrosine 
hydroxylase activity at pH 7.0 in the absence of protein kinase C was 
too low to obtain a reliable inhibition curve. The data was analyzed by 
a Dixon plot. The for dopamine in the absence of protein kinase C 
was calculated to be 4.2 pM (Fig. 25, upper panel). The data in the 
presence of protein kinase C was more complex. The data at 1.0 mM 6- 
MePH^ yielded a straight line, but the data at 0.1 mM 6-MePH^ yielded a
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Figure 23. Lineweaver-Burk plot of tyrosine hydroxylase activity 
as a function of MePH^ concentration, in the presence (•) and in the 
absence (o) of protein kinase C. Each point represents the mean of 
duplicate samples.
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Figure 24. Lineweaver-Burk plot of tyrosine hydroxylase activity 
as a function of tyrosine concentration, in the presence (•) and in the 
absence (o) of protein kinase C. Each point represents the mean of 
duplicate samples.
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Figure 25. Dixon plots of tyrosine hydroxylase activity as a 
function of dopamine and 6-MePH, concentrations, in the absence (upper 
panel) and presence (lower panel) of protein kinase C. The two-step 
assay was carried out at the indicated concentrations of dopamine and 6- 
MePH^ for 6 min. Each point represents the mean of duplicate samples.
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curve which could be resolved into two components (Fig. 25, lower 
panel). With one component, formed with the data from 25-80 pH dopamine 
(Fig. 25, lower panel, extrapolated broken line), a K. for dopamine of 
47.5 pH could be calculated. With the second component, formed with the 
data from 2-25 pH dopamine, a for dopamine of 4.7 pH could be 
calculated (Fig. 25, lower panel). The most likely explanation for 
these two components is that they represent phosphorylated (K^ 47.5 pH)  
and dephosphorylated (K^ 4.7 pH) pools of tyrosine hydroxylase within 
the reaction mixture. Thus, phosphorylation of tyrosine hydroxylase by 
protein kinase C causes an increase in the for dopamine.
Comparison of Phosphopeptide Maps of Tyrosine Hvdroxvlase 
Phosphorylated by Protein Kinase C and by the Catalytic Subunit of cAMP- 
Dependent Protein Kinase. Tyrosine hydroxylase, after phosphorylation 
by protein kinase C, the catalytic subunit of cAMP-dependent protein 
kinase, or both, was subjected to tryptic/chymotryptic digestion and 
subsequent two-dimensional separation on celloluse plates. The pattern 
in each case was identical (Fig. 26), indicating that the two kinases 
probably phosphorylated the same site(s) on tyrosine hydroxylase. 
Furthermore, analysis of phosphorylated amino acids indicated that only 
serine residues were phosphorylated.
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Figure 25. Autoradiogram showing tryptic/chymotryptic 
phosphopeptide maps of tyrosine hydroxylase phosphorylated by the 
catalytic subunit of cAMP-dependent protein kinase (40 ng) (A); by 
protein kinase C (72 ng) (B); and by the catalytic subunit of cAMP- 
dependent protein kinase (40 ng) plus protein kinase C (72 ng) (C).
Both steps of the two-step assay, namely phosphorylation and tyrosine 
hydroxylase activity, were carried out before phosphopeptide mapping, so 
that the pattern of phosphorylation could be analyzed at a point 
equivalent to that at which tyrosine hydroxylase activity had been 
measured. The two-step assay was carried out as described (Materials 
and Methods), with the following exceptions: b ^ h  steps were carried out 
for 10 min; BSA and catalase were omitted; [7- P]ATP (specific 
activity, 175 cpm/pmol) and nonradioactive tyrosine were used; the 
second step was terminated by the addition of NaDodSO, stop solution. 
After gel electrophoresis, the M 62,000/60,000 tyrosine hydroxylase 
doublet, located by autoradiography, was excised and subjected to 
tryptic/chymotryptic digestion followed by separation on cellulose 
plates, first by electrophoresis in the horizontal direction (negative 
pole left, positive pole right), and then by ascending chromatography in 
the vertical direction, o, Origin.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
_  o
§1
CO ^
o  *
< o 
t  cc<  Q_ 
<-> +
o
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
106
DISCUSSION
The results in this chapter supported and extended the data of
Raese et al. (1979), which had suggested that protein kinase C might
phosphorylate and activate tyrosine hydroxylase. We found that
phosphorylation and activation of tyrosine hydroxylase by protein kinase
C was characterized by a decrease in the K for the 6-MePH. cofactor, anJ m 4
increase in the for dopamine, no change in the for tyrosine, and
little or no change in apparent vmax under any of the conditions tested.
Similar effects on the kinetics of tyrosine hydroxylase were found
previously when the enzyme was phosphorylated in vitro by cAMP-dependent
protein kinase (e.g., see Vulliet et al.. 1980; Ames et al.. 1978).
Moreover, the cAMP-dependent activation of tyrosine hydroxylase in situ
had also been characterized by a decrease in K for the cofactor with noJ m
change in Km for tyrosine and no change in V (e.g., see Goldstein et 
al.. 1976; Meligeni et al.. 1982).
Studies of the sites of phosphorylation have also been useful in 
correlating activation of tyrosine hydroxylase with a variety of 
treatments. In this chapter, the phosphopeptide maps of tyrosine 
hydroxylase were found to be identical whether in vitro phosphorylation 
was catalyzed by protein kinase C, the catalytic subunit of cAMP- 
dependent protein kinase, or both (Fig. 26). Thus, the similar kinetic 
effects of the two kinases may be attributable to phosphorylation of the 
same site(s) on the substrate. Reports from other laboratories have 
confirmed this finding (Vulliet et al.. 1985; Campbell et al. . 1986).
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There is general agreement that stimulation with cAMP increases 
the phosphorylation of tyrosine hydroxylase at a single site whether 
examined in chromaffin cells (Haycock et al.. 1982a,b) or PC 12 cells 
(Tachikawa et al.. 1986; Griffith et al.. 1985). This site matches the 
site specificity of phosphorylation by cAMP-dependent protein kinase in 
vitro (Vulliet et al.. 1985; Tachikawa et al.. 1986; Griffith et al.. 
1985). The site has been identified by peptide sequencing and 
comparison to the sequence obtained from the rat cDNA sequence as 
serine-40 (Campbell et al.. 1986).
Activation of protein kinase C in situ, by the addition of phorbol 
esters, leads to the phosphorylation and activation of tyrosine 
hydroxylase (Pocotte and Holz, 1986; Griffith et al.. 1985). Since 
muscarinic agonists stimulate PI turnover and increase tyrosine 
hydroxylase activity (Horwitz et al.. 1984), it is possible that protein 
kinase C is a mediator of muscarinic action in this case. The same site 
as the site phosphorylated by cAMP-dependent protein kinase, serine-40, 
is phosphorylated by stimulation of cells in situ with phorbol esters 
(Griffith et al.. 1985) and by protein kinase C in vitro (Campbell et 
al.. 1986; Griffith et al.. 1985). Phosphorylation of serine-40 by 
protein kinase C is consistent with a requirement for arginine residues 
on the N-terminal side of the phosphorylated residue, as deduced from 
studies with other protein substrates and with synthetic peptides 
(Turner et al.. 1985).
There is also evidence for the involvement of calcium/calmodulin- 
dependent protein phosphorylation in the in situ activation of tyrosine 
hydroxylase (Ames et al.. 1978; Haycock et al.. 1982a,b; El Mestikawy et.
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al.. 1983; Raese et al.. 1979; Yamauchi and Fujisawa, 1981). The in
situ calcium-dependent, depolarization-induced activation of tyrosine
hydroxylase is characterized by an increase in V , with no change in
K for the cofactor (El Mestikawy et al.. 1983). It was reported and
recently confirmed that calcium/calmodulin-dependent protein kinase II
phosphorylates tyrosine hydroxylase in vitro but does not activate it
unless a protein activator is present (Yamauchi and Fujisawa, 1981;
Atkinson et al.. 1987). This phosphorylation is characterized by an
increase in V , with no change in K for the cofactor (Atkinson et 
max m
al.. 1987). Studies with phosphopeptide mapping have confirmed these 
results. Elevation of intracellular calcium leads to the phosphoryla­
tion and activation of tyrosine hydroxylase (Nose et al.. 1985;
Tachikawa et al.. 1986; Griffith et al.. 1985); the pattern of 
phosphopeptides matches the pattern obtained with calcium/calmodulin- 
dependent protein kinase II (Tachikawa et al.. 1986; Griffith et al.. 
1985). The major site of phosphorylation of tyrosine hydroxylase by 
calcium/calmodulin-dependent protein kinase II has been identified as 
serine-19 (Campbell et al.. 1986).
In summary (Fig. 28, from Atkinson et al.. 1987), protein kinase C 
and cAMP-dependent protein kinase phosphorylate tyrosine hydroxylase on 
serine-40 and activate it by increasing the affinity for the cofactor. 
Calcium/calmodulin-dependent protein kinase II, in the presence of a 
protein activator, phosphorylates tyrosine hydroxylase on serine-19 and 
activates it by increasing the v • Serine-40 is also phosphorylated 
by cGMP-dependent protein kinase (Campbell et al., 1986). In addition 
to these well-defined kinase-residue phosphorylation events of tyrosine
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Figure 27. Regulation of tyrosine hydroxylase activity by protein 
kinases. cAMP-dependent protein kinase and protein kinase C both 
phosphorylate serine-40 on tyrosine hydroxylase and activate it by a 
mechanism characterized by an increase in affinity for the cofactor with 
no change in V . Calcium might also activate tyrosine hydroxylase by 
phosphorylation on serine-19 by calcium/calmodulin-dependent protein 
kinase II. This phosphorylation requires the presence of a protein 
activator, and is characterized kinetically by an increase in V , with 
no change in affinity for the cofactor. In addition to the cAM?fX 
protein kinase C, and calcium/calmodulin-dependent phosphorylation and 
activation of tyrosine hydroxylase, there are also other sites 
phosphorylated in vivo for which kinases have not yet been identified.
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hydroxylase, there is a third site, serine 8 , which is found to be 
endogenously phosphorylated, and for which there is no known kinase 
(Campbell et al.. 1986); and there is a fourth site, which is 
phosphorylated in adrenal chromaffin cells in response to acetylcholine, 
and for which there is no known kinase (J. Haycock, personal 
communication). Therefore, additional phosphopeptides of tyrosine 
hydroxylase have yet to be well-defined in terms of kinase and 
functional consequences (McTigue et al.. 1985; Campbell et al.. 1986; 
Tachikawa et al.. 1986; Griffith et al.. 1985).
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Chapter 5. INHIBITION OF PROTEIN KINASE C BY CALCIUM-BINDING PROTEINS
It has been over 100 years since the presentation of the first 
evidence that calcium is important in muscle contraction (Ringer, 1883). 
Subsequently, calcium was shown to be involved in numerous physiological 
processes, including exocytosis (for review see Hutton, 1986).
The cell maintains its calcium homeostasis with the use of 
numerous calcium transporting systems (for review see Carafoli, 1987).
In the cytosol, calcium accomplishes its intracellular messenger 
functions by binding to specific calcium-binding proteins, many of which 
share common properties. These proteins are of relatively small M 
(10,000-20,000), are negatively charged at neutral pH (are of pi 4-5), 
and bind two to four calcium ions with high affinity. Members of this 
group include troponin C, S-100 protein, parvalbumin, and calmodulin. 
Troponin C was the first to be discovered (Ebashi and Kodama, 1965; 
Ebashi et al.. 1967), is restricted to striated muscle, and is part of 
the chain of molecular events that produces muscle contraction. S-100 
protein, discovered as a protein in glial cells (Moore, 1965), exists as 
two proteins that are dimers of highly homologous subunits, S-lOOa (a/3) 
and S-lOOb (/S/9) (Isobe and Okuyama, 1978; Isobe et al. . 1981). 
Parvalbumin, a muscle protein that is particularly abundant in fishes, 
amphibia, and reptiles, was the first whose structure was studied in 
detail, and with it, Kretsinger and his colleagues (Kretsinger and 
Nockolds, 1973; Kretsinger and Nelson, 1977) established a series of
111
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general structural principles for the high-affinity binding of calcium 
by these proteins. It is now clear that calmodulin is the most 
versatile of these proteins (for review see Klee and Vanaman, 1982). 
Calmodulin was first detected as a protein factor that stimulated the 
activity of preparations of brain cyclic nucleotide phosphodiesterase 
(Cheung, 1970). Subsequently, the calcium dependence of phosphodies­
terase was shown to be a consequence of calcium binding to calmodulin 
(Teo and Wang, 1973). Since that time, studies of calmodulin and the 
enzymes that it activates have led to an appreciation of the general 
significance of calcium as a mediator of cellular regulation. Many of 
the effects of calmodulin are achieved through stimulation of protein 
phosphorylation (see Chapter 1).
Calmodulin has also been reported to act as an inhibitor. It was 
reported to inhibit the phosphorylation of low molecular weight brain 
membrane proteins (Thayer et al.. 1983), the cAMP-dependent protein 
kinase-catalyzed activation of phosphorylase kinase (Cox and Edstrom, 
1982), and the polyamine-dependent protein kinase phosphorylation of 
ornithine decarboxylase (Atmar and Kuehn, 1983). Calmodulin has also 
been suggested to play a role in the guanine nucleotide-mediated 
inhibition of rat hippocampal adenylate cyclase (Girardot et al. . 19831). 
and to inhibit coupled NaCl transport in membrane vesicles from rabbit 
ileal brush border (Fan and Powell, 1983).
In preparations from rat brain synaptosomes, the addition of 
exogenous calmodulin was previously found to inhibit the in vitro 
phosphorylation of the 87-kDa protein by endogenous protein kinase C (Wu 
et al.. 1982). The work in this chapter was undertaken to characterize
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this inhibition with purified components, in order to begin to assess 
the possible role of calmodulin or other calcium-binding proteins as 
endogenous inhibitors of protein kinase C.
MATERIALS AND METHODS
Materials and methods were as described in Chapters 2-4, with the 
following exceptions.
Materials. Rat brain cytosol was depleted of calmodulin as 
described for rat brain synaptosomal cytosol (Wu et al.. 1982). Human 
erythrocyte calmodulin, bovine brain S-100 protein, and rat muscle 
parvalbumin were purchased from Calbiochem-Behring. Rabbit skeletal 
muscle troponin C was a gift from P. Leavis (Boston Biomedical Research 
Institute). S-100 protein, parvalbumin, and troponin C were found to be
free of calmodulin contamination by their inability to activate 
calcium/calmodulin-dependent protein kinase I (Nairn and Greengard, 
1987).
Purification of Protein kinase C and 87kDa. The enzyme was 
purified as described in Chapter 2. The 87-kDa protein was purified as 
decribed in Chapter 2 (Results) with the following exceptions: proteins 
were eluted from the DE-52 batch adsorption in Buffer A plus 0.3 M NaCl; 
no (NH^^SO^ precipitation step was performed after DE-52 batch 
adsorption; proteins were eluted from the DEAE-Sephacel column with a 
gradient of 0-350 mM NaCl in Buffer C; proteins in the DEAE-Sephacel 
pool were subjected to pH 4:6 extraction before the Bio-Gel HTP step;
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proteins were eluted from the Bio-Gel HTP column with a gradient of 0- 
300 mM KP^ in Buffer C; proteins in the Bio-Gel HTP pool were 
precipitated and applied to an Ultrogel AcA34 column; proteins in the 
Ultrogel Aca34 pool were subjected to chromatography on Phenyl-Sepharose 
as described for protein kinase C (Chapter 2); proteins in the Phenyl- 
Sepharose pool were rechromatographed on Bio-Gel HTP; and the second 
Bio-Gel HTP pool was rechromatographed on a DE-52 column. The final 
protein kinase C and 87-kDa protein electrophoresed as single protein 
bands of Mr 87,000 on NaDodS04/8% PAGE (Fig.27).
Measurement of Phosphorylation of the 87-kDa Protein by Protein 
Kinase C. The reaction mixture (final volume 100 /il) contained 20 mM 
Tris*HCl (pH 7.4), 10 mM Mg acetate, 2 mM DTE, 0.1% leupeptin, 40-80 ng 
of protein kinase C , 0.13 fig of the 87-kDa protein, 1 mM EGTA, and, 
where indicated, 5 n g rabbit brain calmodulin, 1.5 mM CaC^, and 5 f i g
phosphatidylserine. The mixture was preincubated for 1 min at 30°C.
32The reaction was initiated by the addition of [7- P]ATP (final
3
concentration, 2 /iM; specific activity 50-100 x 10 cpm/pmol), carried 
out for 1 min, and terminated by the addition of 20 f i l  of NaDodSO^ stop 
solution (20% glycerol/10% (wt/vol) 2-mercaptoethanol/0.25 M Tris*HCl, 
pH 6.7, containing a trace of bromophenol blue) and heating in a boiling 
water bath for 5 min.
The boiled samples were electrophoresed on NaDodSO^/8% 
polyacrylamide gels by the method of Laemmli (1970). The gels were 
stained, destained, dried, and subjected to autoradiography as described 
(Ueda and Greengard, 1977). Silver staining of the enzyme (Morrissey, 
1981) and of the substrate (Poehling and Neuhoff, 1981) was performed as
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Figure 28. Protein stain of the final purified preparations of 
protein kinase C and the 87-kDa protein. The proteins were subjected to 
one-dimensional NaDodSO^/8% PAGE and silver-stained. Protein kinase, 
protein kinase C; 87k, the 87-kDa protein. Molecular size markers are 
shown in kilodaltons.
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described. The phosphorylated substrate was located by the 
autoradiogram and excised, and the radioactivity was quantitated by 
liquid scintilation counting. All assay conditions were such that 
phosphorylation was linear with time, substrate concentration, and 
enzyme concentration. In all cases, a low enough ratio of enzyme to 87- 
kDa protein was used so that enzyme autophosphorylation did not 
contribute significantly to phosphorylation measured in the M 87,000 
region of the gels. Two-dimensional peptide mapping was performed as 
described (Huttner and Greengard, 1979), except that thermolysin (150 
/ig/ml) was used. Protein determination was performed by the procedure 
of Peterson (1977) with BSA as standard.
RESULTS
Inhibition by Calmodulin of Phosphorylation of the 87-kDa Protein. 
Calmodulin inhibited the calcium/phospholipid-dependent phosphorylation 
of the 87-kDa protein in a calmodulin-depleted preparation of rat brain 
cytosol (Fig. 29). The results are similar to those observed with a 
calmodulin-depleted preparation of rat brain synaptosomal cytosol (Wu et 
al.. 1982). This effect of calmodulin also could be demonstrated with 
purified preparations of protein kinase C and the 87-kDa protein (Fig. 
30) . With calmodulin at 5 f i g / 100 f i l (3 pM), an inhibition of about 80% 
was observed (Fig. 30). (This inhibition could not be explained by a 
loss of free calcium due to binding to calmodulin, because calcium 
was present in an excess of 167 x over calmodulin (such that the ratio 
of calcium/calcium-binding site in calmodulin was 42/1). In addition,
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Figure 29. Autoradiogram showing phosphorylation of the 87-kDa 
protein by protein kinase C and its inhibition by calmodulin in a 
calmodulin-depleted preparation of rat brain cytosol. The indicated 
additions wg^e present in the following final concentrations: free 
calcium (Ca ), 0.5 mM; phosphatidylserine (PS), 5 p g / 1 0 0  /*1; rabbit 
brain calmodulin, 1 /xg/100 p i .  After termination of the phosphorylation 
reaction, samples were subjected to one-dimensional NaDodSO^/6% PAGE, 
followed by^iutoradiography. 87k, the 87-kDa protein; 87k(%), relative 
amounts of P found in the 87-kDa protein band for the various 
conditions used. Molecular size markers are shown in kilodaltons.
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Figure 30. Representative autoradiogram showing phosphorylation 
of the 87-kDa protein by protein kinase C, and its inhibition by 
calmodulin, with use of purified enzyme and substrate. The experiment 
was carried out five times. The indicated^additions were present in the 
following concentrations: free calcium (Ca ), 0.5 mM; phosphatidyl- 
serine (PS), 5 pg/100 /*1; rabbit brain calmodulin, 5 pg/100 /xl. After 
termination of the phosphorylation reaction, samples were subjected to 
one-dimensional NaDodSO^/8% PAGE, followed b^2aut°tadiography. 87k, the 
87-kDa protein; 87k(%), relative amounts of P found in the 87kDa band 
for the various conditions used. Size markers are shown in kDa.
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the effect was still present when the experiment was carried out with 
higher concentrations of calcium, up to 1 mM.) Two-dimensional peptide 
mapping of the 87-kDa protein after thermolysin digestion showed the 
presence of the two phosphorylation sites (Fig. 31A, Chapter 2). The 
phosphorylation of both of these sites was inhibited by about 80% by the 
addition of calmodulin (Fig. 31B).
Inhibition by Various Calcium-Binding Proteins of Phosnhorvlation 
of the 87-kDa Protein. The ability of brain calmodulin to inhibit the 
phosphorylation of the 87-kDa protein was compared with that of several 
other calcium-binding proteins, each at 5 p g / 1 0 0  p i  (Fig. 32). Under the 
conditions used, parvalbumin was not inhibitory. The phosphorylation of 
the 87-kDa protein by protein kinase C was inhibited to varying extents 
by the other calcium-binding proteins, the S-100 protein being 
particularly potent as an inhibitor. Thus, under the conditions used, 
troponin C inhibited the phosphorylation by about 50%, brain calmodulin 
and erythrocyte calmodulin each inhibited the phosphorylation by about 
60%, and S-100 inhibited the phosphorylation by about 80%.
DISCUSSION
The results in this study indicated that calmodulin, troponin C, 
and S-100 protein, but not parvalbumin, were able to inhibit the 
phosphorylation of the 87-kDa protein by protein kinase C. These 
results and previous studies (Wu et al.. 1982) with a crude cytosol 
system raised the question of whether the inhibition by calmodulin 
reflected a direct or indirect action. The ability to demonstrate the
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Figure 31. Autoradiogram showing phosphorylation of the two major 
sites of the 87-kDa protein by protein kinase C, and inhibition of their 
phosphorylation by calmodulin, with use of purified enzyme and 
substrate. Phosphorylation was carried out in the presence of calcium 
(0.5 mM free) and phosphatidylserine (5 n g / 1 0 0  ^1) and in the absence 
(A) or presence (B) of calmodulin (5 /ig/100 f i 1). After termination of 
the phosphorylation reaction, samples were subjected to one-dimensional 
NaDodS0^/8% PAGE, followed by autoradiography. The bands of the 87-kDa 
protein, located by the autoradiogram, were excised and subjected to 
thermolytic digestion followed by separation in two dimensions on 
cellulose plates, first by electrophoresis in the horizontal direction 
(negative pole, left, positive pole, right) and then by ascending 
chromatography in the vertical dimension. 0 , origin.
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Figure 32. Autoradiogram showing phosphorylation of the 87-kDa 
protein by protein kinase C, and its inhibition by several calcium- 
binding proteins, with use of purified enzyme and substrate. The 
experiment was carried out twice. Phosphorylation was carried out in 
the presence of calcium (0.5 mM free), phosphatidylserine (5 pg/100 fi 1), 
and the indicated calcium-binding protein (5 jug/lOO f i l )  . After 
termination of the phosphorylation reaction, samples were subjected to 
one-dimensional NaDodSO^/8% PAGE, followed by autoradiography. 87k, the 
87-kDa protein; PARV, parvalbumin; TnC, troponin C; BRAIN CaM, rabbit 
brain calmodulin, RBC CaM, Human eryth^cyte calmodulin; S-100, S-100 
protein; 87k (%), relative amounts of P found in the 87-kDa protein
band for the various conditions used. No measurable phosphorylation was 
observed in the absence of calcium plus phosphatidylserine. Molecular 
size markers are shown in kilodaltons.
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effect with purified enzyme and substrate indicates that the action of 
calmodulin is direct. The concentration of calmodulin used in the 
present work (3 /*M) is higher than that required to activate the 
calmodulin-dependent enzymes that have the highest affinity for 
calmodulin (nM range) (see Klee and Vanaman, 1982). However, since the 
concentration of calmodulin in rat brain cytosol has been calculated to 
be 30 f M (Klee and Vanaman, 1982), calmodulin is present in a high 
enough concentration to be a potential endogenous inhibitor of protein 
kinase C.
There have been reports of inhibition by S-100 protein and 
calmodulin of the phosphorylation of a 73-kDa protein, termed S-100 
protein-modulated phosphoprotein, in crude supernatant fraction prepared 
from brain (Patel and Marangos, 1982; Patel et al.. 1983). On the basis 
of its reported properties (Patel and Marangos, 1983), S-100 protein- 
modulated phosphoprotein is probably identical to the 87-kDa protein.
Protein kinase C (see Chapter 1.) and the 87-kDa protein (Chapter 
3.), are present in both neurons and glia. Calmodulin (Sieghart et al.. 
1980) is present in neurons, and S-100 protein (Legrand et al.. 1981) in 
glial cells. Therefore, calmodulin and S-100 protein may be acting as 
physiological regulators of phosphorylation of the 87-kDa protein by 
protein kinase C in neurons and glia, respectively. There is little 87- 
kDa protein in muscle (Chapter 3). However, troponin C may inhibit the 
phosphorylation of muscle-specific substrates for protein kinase C.
Thus, the phosphorylation of skeletal muscle troponin I and troponin T 
by protein kinase C has been found to be inhibited by troponin C (Mazzei 
and Kuo, 1984).
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Data from other laboratories have supported and extended the work 
in this chapter. Protein kinase C in human brain was found to be 
inhibited by calmodulin (Saitoh and Dobkins, 1986), and calmodulin and 
S-lOOb protein were found to inhibit the phosphorylation of r proteins 
by protein kinase C (Baudier et al.. 1987). There have been a number of 
studies of low molecular weight, endogenous inhibitory proteins of 
protein kinase C (McDonald and Walsh 1985a,b,1986; McDonald et al..
1987; Schwantke and Le Peuch, 1984; Holian et al.. 1986; Hucho et al.. 
1987). The best-studied of these is a novel M 17,000 protein which 
shares many of the properties of the calcium-binding proteins (McDonald 
and Walsh 1985a,b,1986; McDonald et al.. 1987). This protein is more 
potent in inhibiting protein kinase C than any other calcium-binding 
protein (McDonald and Walsh, 1985b), and has a widespread distribution 
(McDonald et al.. 1987). In recent studies, injection of this protein 
kinase C inhibitor into chick sensory neurons was able to attenuate the 
norepinephrine- and OAG-induced inhibition of a calcium current (Rane et 
al.. 1987).
While these studies indicate that calcium-binding proteins can 
inhibit protein kinase C, is seems that protein kinase C can also 
regulate some calcium-dependent processes. Thus, phosphorylation and 
activation of the inositol trisphosphate 5'-phosphomonoesterase by 
protein kinase C (Connolly et al.. 1986) would be expected to turn off 
the IP^-mediated calcium release signal. Also, protein kinase C has 
been shown to partially inhibit the actin-stimulated Mg-ATPase activity 
of smooth muscle heavy meromyosin (Nishikawa et al.. 1983), which 
results from the phosphorylation of heavy meromyosin by myosin light
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chain kinase (a calcium/calmodulin-dependent protein kinase) (Nishikawa 
et al.. 1983).
Therefore, calcium-binding protein-dependent processes and 
calcium/phospholipid/diacylglycerol-dependent processes may act as 
physiological modulators of each other.
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Chapter 6. SUMMARY AND CONCLUSIONS
The studies described in this dissertation were undertaken to 
analyze the role of protein kinase C in the nervous system. Three 
different approaches were employed.
First, the 87-kDa protein, a major, endogenous, specific substrate
for protein kinase C, was identified in brain, was purified from bovine
forebrain supernatant with the use of conventional chromatographic
methods, and was characterized with respect to its physicochemical
properties and distribution. The protein was found to be very abundant
in brain, comprising 0.2% of total soluble protein. The physicochemical
properties of the 87-kDa protein indicated that the molecular weight is
68 kDa, and that the protein is an extremely elongated monomer. The
protein was phosphorylated by protein kinase C to a stoichiometry of 2.2 
32
mol P per mol protein, exclusively on serine residues.
The 87-kDa protein was characterized with respect to its species, 
tissue, and subcellular distribution. A similar protein was present in 
monkey, human, rat, mouse, and bovine brain, in Torpedo californica 
electric organ, and in a variety of non-neuronal rat and bovine tissues. 
The rat protein was of M 4,000-7,000 lower, and was slightly more 
acidic, than the bovine protein. The 87-kDa protein was found to be 
both cytosolic and membrane-bound, and the membrane-bound fraction may 
be attached to membranes via myristoylation. The distribution of the
125
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87-kDa protein was found to be widespread, and similar to the 
distribution of protein kinase C.
While the prominence of its phosphorylation makes the 87-kDa 
protein a likely candidate for a major action of protein kinase C, and 
its widespread distribution makes it a candidate for an activity common 
to many cells, the function of this protein has yet to be elucidated. 
Based on its abundance and unusual hydrodynamic properties, one might 
speculate that the 87-kDa protein is not an enzyme, but is more likely 
to have a structural or regulatory function. (One could begin to 
analyze these possibilities 1) with immunocytochemistry at the electron 
microscope level to localize the protein in a given cell type, before 
and after treatment of the cell with activators of protein kinase C , and 
2) with biochemical studies of interactions between the dephospho- and 
phosphoprotein and other proteins of known structural function, e.g. 
cytoskeletal proteins.) Alternatively, since two other endogenous 
substrates for protein kinase C have been postulated to regulate steps 
in PI turnover (see Chapter 2), one might also postulate a role for the 
87-kDa protein in the feedback regulation of PI turnover. Evidently, a 
role for this protein should be sought among the known actions of 
protein kinase C, such as secretion, modulation of membrane functions, 
feedback inhibition of receptor systems, and interactions between 
signaling systems (see Chapter 1). Further characterization of this 87- 
kDa protein, a major endogenous substrate for protein kinase C, will 
undoubtedly provide information about the actions of protein kinase C at 
the molecular level.
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Second, the effect of phosphorylation by protein kinase C was 
examined with a nervous system protein of known function, namely 
tyrosine hydroxylase. Protein kinase C was found to phosphorylate and 
activate tyrosine hydroxylase. The data support the possibility that 
protein kinase C is a physiological activator of tyrosine hydroxylase in 
response to stimulation of PI turnover, and thereby acts to accelerate 
catecholamine biosynthesis.
Third, the regulation of protein kinase C activity by calcium- 
binding proteins was examined. It was found that certain calcium- 
binding proteins inhibit protein kinase C activity. This finding 
constitutes an example of a means by which the two second messengers 
generated from PI turnover, IP^ and diacylglycerol, may regulate each 
other. Thus, as PIP2 is hydrolyzed into IP^ and diacylglycerol, signals 
for calcium release from intracellular stores and for the activation of 
protein kinase C, respectively, are generated (Fig. 33). The calcium 
released from the intracellular stores may bind to calcium-binding 
proteins and inhibit protein kinase C. Meanwhile, protein kinase C may 
phosphorylate and activate the IP^-S'-phosphomonoesterase (Connolly et 
al. . 1986; Molina y Vedia et al.. 1986), thereby terminating the signal 
to release calcium.
More generally, calcium-dependent processes and protein kinase C- 
dependent processes may modulate each other. In the nervous system, 
calcium activates the phosphoinositidase responsible for PIP2 hydrolysis 
(see Fisher and Agranoff, 1987). Activation of protein kinase C seems 
to cause a decrease in cytosolic calcium concentration, which has been 
postulated to be caused by activation of a calcium-ATPase (see
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Figure 33. Feedback interactions between protein kinase C and 
calcium. As PIP- is hydrolyzed into IP, and diacylglycerol, signals for 
calcium release from intracellular stores and for the activation of 
protein kinase C, respectively, are generated. The calcium released 
from the intracellular stores may bind to calcium-binding proteins and 
inhibit protein kinase C. Meanwhile, protein kinase C may phosphorylate 
and activate the IP^-S'-phosphomonoesterase, thereby terminating the 
signal to release calcium.
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Nishizuka, 1986). In injection experiments, protein kinase C has been 
found to modulate calcium currents and calcium-dependent potassium 
currents (see Chapter 1). Calcium and protein kinase C also cooperate 
to cause secretion (see Chapter 1).
Further characterization of the substrates for protein kinase C, 
and of the interactions between protein kinase C-dependent and calcium- 
dependent processes, will undoubtedly provide further information at the 
molecular level about the actions of protein kinase C in the nervous 
system.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
REFERENCES
Aderem, A.A., Keum, M.M., Pure, E. & Cohn, Z.A. (1986) Proc. Natl. Acad 
Sci. USA 83:5817-5821.
Aderem, A.A., Albert, K.A., Keum, M.M., Wang, J.K.T., Greengard, P. & 
Cohn, Z.A. (1988) Nature. 332: 362-364.
Ahmad, Z., DePaoli-Roach, A.A. & Roach, P.J. (1980) J. Biol. Chem. 
257:8348-8355.
Ahmad, Z., Lee, F.-T., DePaoli-Roach, A. 6c Roach, P.J. (1984) J. Biol. 
Chem. 259:8743-8747.
Akers, R.F., Lovinger, D.M., Colley, P.A., Lindern, D.J. 6c Routtenberg, 
A. (1986) Science 231:587-589.
Albert, P.R. 6c Tashjian, A.H. (1985) J. Biol. Chem. 260:8746-8759.
Ames, M., Lerner, P. 6c Lovenberg, W. (1978) J. Biol. Chem. 253:27-31.
Anderson, W.B., Estival, A., Tapiovaara, H. 6c Gopalakrishna, R. (1985)
Adv. Cyclic Nucleotide Res. 19:287-306.
Arino, J. 6c Guinovart, J.J. (1986) Biochem. Biophys. Res. Commun.
134:113-119.
Ashendel, C.L. (1985) Biochim. Biophys. Acta. 822:219-242.
Ashendel, C.L., Staller, J.M. 6c Boutwell, R.K. (1983a) Biochem. Biophys 
Res. Commun. Ill:340-345.
Ashendel, C.L., Staller, J.M. & Boutwell, R.K. (1983b) Cancer Res. 
43:4333-4337.
Atkinson, J., Richtand, N., Schworer, C., Kuczenski, R. 6c Soderling, T. 
(1987) J. Neurochem. 49:1241-1249.
Atmar, V.J. 6e Kuehn, G.D. (1983) Fed. Proc. Fed. Am. Soc. Exp. Biol. 
42:2249 (abstr.).
Ballester, R. 6c Rosen, O.M. (1985) J. Biol. Chem. 280:15194-15199.
Baraban, J.M., Snyder, S.H. 6c Alger, B.E. (1985) Proc. Natl. Acad. Sci. 
U.S.A. 82:2538-2542.
130
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
131
Baudier, J., Mochly-Rosen, D., Newton, A., Lee, S.-K., Koshland, D.E.J.
& Cole, R.D. (1987) Biochem. 26:2886-2893.
Beguinot, L., Hanover, J. A., Ito, S., Richert, N.D., Willingham, M.C. & 
Pastan, I. (1985) Proc. Natl. Acad. Sci. U.S.A. 82:2774-2778.
Bell, R.M. (1986) Cell 45:631-632.
Bennett, M.K., Erondu, N.E. 6c Kennedy, M.B. (1983) J. Biol. Chem. 
258:12735-12744.
Benowitz, L.I., Perrone-Bizzozero, N.I. & Finklestein, S.P. (1987) J. 
Neurochem. 48:1640-1647.
Berridge, M.J. (1984) Biochem. J. 220:345-360.
Berridge, M.J. (1987) Ann. Rev. Biochem. 56:159-193.
Berridge, M.J. & Irvine, R.F. (1984) Nature 312:315-321.
Besterman, J.M., May, W.S., Jr., LeVine, H., III, Cragoe, E.J., Jr. 6c 
Cuatrecasas, P. (1985) J. Biol. Chem. 260:1155-1159.
Bidlingmeyer, B.A., Cohen, S.A. 6c Tarvin, T.L. (1984) J. Chromatog. 336: 
93-104.
Bishop, R., Martinez, R., Weber, M.J., Blackshear, P.J., Beatty, S.,
Lim, R. 6c Herschman, H.R. (1985) Molec. Cell. Biol. 5:2231-2237.
Blackmore, P.F., Strickland, W.G., Bocckino, S.B. 6c Exton, J.H. (1986) 
Biochem. J. 237:235-242.
Blackshear, P.J., Witters, L.A., Girard, P.R., Kuo, J.F. 6c Quamo, S.N. 
(1985) J. Biol. Chem. 260:13304-13315.
Blackshear, P.J., Wen, L. , Glynn, B.P. 6c Witters, L.A. (1986) J. Biol. 
Chem. 261:1459-1469.
Blenis, J., Spivack, J.G. 6c Erikson, R.L. (1984) Proc. Natl. Acad. Sci. 
U.S.A. 81:6408-6412.
Boni, L.T. 6c Rando, R.R. (1985) J. Biol. Chem. 260:10819-10825.
Bordier, C. (1981) J. Biol. Chem. 256:1604-1607.
Bradford, M.M. (1976) Anal. Biochem. 72:248-254.
Brandt, S.J., Niedel, J.E., Bell, R.M. 6c Young W.S., III. (1987) Cell 
48:57-63.
Brocklehurst, K.W., Morita, K. 6c Pollard, H.B. (1985) Biochem J. 228:35- 
42.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
132
Brown, K.D., Dicker, P. & Rozengurt, E. (1979) Biochem. Biophys. Res. 
Commun. 86:1037-1043.
Brown, K.D., Blay, J., Irvine, R.F., Heslop, J.D. & Berridge, M.J.
(1984) Biochem. Biophys. Res. Commun. 123:377-384.
Burgess, S.K. Sahyoun, N., Blanchard, S.G., LeVine, H., III, Chang, K.- 
J. & Cuatrecasas, P. (1986) J. Cell Biol. 102:312-319.
Burnett, G. & Kennedy, E.P. (1954) J. Biol. Chem. 211:969-980.
Bums, C.P. 6c Rozengurt, E. (1983) Biochem. Biophys. Res. Commun. 
116:931-938.
Cabot, M.C. 6c Jaken, S. (1984) Biophys. Biochem. Res. Commun. 121:448- 
455.
Campbell, D.G., Hardie, D.G. 6c Vulliet, P.R. (1986) J. Biol Chem. 
261:10489-10492.
Carafoli, E. (1987) Ann. Rev. Biochem. 56:395-433.
Carpenter, D., Jackson, T. 6c Hanley, M.R. (1987) Nature 325:107-108.
Carroll, R.C., Butler, R.G., Morris, P.A. 6c Gerrard, J.M. (1982) Cell 
30:385-393.
Casnellie, J.E. 6c Lamperts, R.J. (1986) J. Biol. Chem. 261:7847-7851. 
Castagna, M. (1987) Biol. Cell 5£:3-14.
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K, Kikkawa, U. 6c Nishizuka, 
Y. (1982) J. Biol. Chem. 257:7847-7851.
Chalfie, M., Settipani, L. 6c Perlman, R.L. (1979) Mol. Pharmacol. 
15:263-270.
Chan, S.Y., Murakami, K. 6c Routtenberg, A. (1986) J. Neurosci. 6:3618- 
3627.
Cheung, W.Y. (1970) Biochem. Biophys. Res. Commun. 38:533-538.
Ciudad, C., Camici, M., Ahmad, Z., Wang, Y., DePaoli-Roach, A. 6c Roach, 
P. (1984) Eur. J. Biochem. 142:511-520.
Cochet, C., Gill, G.N., Meisenhelder, J., Cooper, J.A. 6c Hunter, T.
(1984) J. Biol. Chem. 259:2553-2558.
Cockcroft, S. 6c Gomperts, B.D. (1985) Nature 314:534-536.
Cohen, P., Burdrell, A., Foulkes, J.G., Cohen, P.T.W., Vanaman, T.C. 6c 
Nairn, A.C. (1978) FEBS Lett. 92:287-293.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
133
Collins, M.R.L. & Rozengert, E. (1982) J. Cell. Physiol. 112:42-50.
Connolly, T.M., Lawing, W.J., Jr. &Majerus, P.W. (1986) Cell 46:951- 
958.
Coussens, L., Parker, P.J., Rhee, L., Yang-Feng, T.L., Chen, E., 
Waterfield, M.D., Francke, U. & Ullrich, A. (1986) Science 233:859-866.
Costa-Casnellie, M.R., Segel, G.B. & Lichtman, M.A. (1985) Biochem. 
Biophys. Res. Commun. 133:1139-1144.
Coughlin, S.R., Lee, W.M.F., Williams, P.W., Giels, G.M. & Williams,
L.T. (1985) Cell 43:243-251.
Couturier, A., Bazan, S. & Castagna, M. (1984) Biophys. Biochem. Res. 
Commun. 121:448-455.
Cox, D.E. & Edstrom , R.D. (1982) J. Biol. Chem. 257:12728-12733.
Cross, F.R., Garber, E.A., Pellman, D. & Hanafusa, H. (1984) Mol. Cell.
Biol. 4:1834-1842.
Dabrowska, R., Sherry, J.M.F., Aromatorio, D.K. & Hartshorne, D.J.
(1978) Biochem. 17:253-258.
Davis, R.J. & Czech, M.P. (1985) Proc. Natl. Acad. Sci. U.S.A. 82:1974- 
1978.
Davis, R.J., Ganong, B.R., Bell, R.M. & Czech, M.P. (1985) J. Biol.
Chem. 260:5315-5322.
Davis, R.J., Johnson, G.L., Kelleher, D.J., Anderson, J.K., Mole, J.E. &
Czech, M.P. (1986) J. Biol. Chem. 261:9034-9041.
DeCamilli, P., Cameron, R. & Greengard, P. (1983a) J. Cell Biol. 
96:1337-1354.
DeCamilli, P., Harris, S.M., Huttner, W.B. & Greengard, P. (1983b) J. 
Cell Biol. 96:1355-1373.
Decker, S.J. (1984) Mol. Cell. Biol. 4:1718-1724.
Denis, G.V., Toyoshima, S. & Osawa, T. (1986) Biochim. Biophys. Acta 
885:136-145.
DeRiemer, S.A., Strong, J.A., Albert, K.A., Greengard, P. & Kaczmarek, 
L.K. (1985) Nature 313:313-315.
Downes, C. P. & Michell, R. H. (1985) In: Molecular Mechanisms of 
Transmembrane Signalling, eds. P. Cohen 6c M. Houslay, Elsevier, NY, pp. 
3-56.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
134
Downward, J., Waterfield, M.D. & Parker, P.J. (1985) J. Biol. Chem. 
260:14538-14546.
Drummond, A.H. (1985) Nature 315:752-755.
Dunphy, W.G., Kochenburger, R.J., Castagna, M., & Blumberg, P.M. (1981) 
Cancer Res. 41:2640-2647.
Durell, J., Garland, J.T. & Friedel, R. (1969) Science 165:862-866.
Ebashi, S. & Kodama, A. (1965) J. Biochem. (Tokyo) 58:107-108.
Ebashi, S., Ebashi, F. & Kodama, A. (1967) J. Biochem. (Tokyo) 62:137- 
138.
Ebeling, J.G., Vandenbark, G.R., Kuhn, L.J., Ganong, B.R., Bell, R.
& Niedel, J.E. (1985) Proc. Natl. Acad. Sci. U.S.A. 82:815-819.
Edelman, A.M., Raese, J.D., Lazar, M.A. & Barchas, J.D. (1981) J. Pharm. 
Exp. Ther. 216:647-653.
El Mestikawy, S., Glowinski, J. & Hamon, M. (1983) Nature 302:830-832.
Endo, T., Naka, M. & Hidaka, H. (1982) Biochem. Biophys. Res. Commun. 
105:942-948.
Fan, C.-C. & Powell, D.W. (1983) Proc. Natl. Acad. Sci. USA 80:5248- 
5252.
Farley, J. & Auerbach, S. (1986) Nature 319:220-223.
Farrar, W.L. & Anderson, W.B. (1985) Nature 315:233-235.
Farrar, W.L., Thomas, T.P. & Anderson, W.B. (1985) Nature 315:235-237.
Fearon, C.W. & Tashjian, A.H., Jr. (1985) J. Biol. Chem. 260:8366-8371.
Ferrari, S., Marchiori, R., Borin, G. & Pinna, L.A. (1985) FEBS Lett. 
184:72-77.
Feuerstein, N., Monos, D.S. & Cooper, H.L. (1985) Biochem. Biophys. Res. 
Commun. 126:206-213.
Fisher, S.K. & Agranoff, B.W. (1987) J. Neurochem. M:999-1017.
Friedman, B., Frackleton, A.R., Jr., Ross, A.M., Connors, J.M., Fujiki, 
J.M., Sugimura, T. & Rosner, M.R. (1984) Proc. Natl. Acad. Sci. USA 
81:3034-3038.
Fukunaga, K. Yamamoto, H., Matsui, K., Higashi, K. & Miyamoto, E. (1982) 
J. Neurochem. 39:1607-1617.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
135
Ganong, B.R., Loomis, C.R., Hannun, Y.A. & Bell, R.M. (1986) Proc. Natl. 
Acad. Sci. USA 83:1184-1188.
Gentry, L.E., Chaffin, K.E., Shoyab, M. & Purchio, A.F. (1986) Mol.
Cell. Biol. 6:735-738.
Girard, P.R., Mazzei, G.J., Wood, J.G. & Kuo, J.F. (1985) Proc. Natl. 
Acad. Sci. USA 82:3030-3034.
Girardot, J.-M., Kempf, J. & Cooper, D.M.F. (1983) J. Neurochem. 41:848- 
859.
Goldenring, J.R., Gonzalez, B., McGuire, J.S., Jr. & DeLorenzo, R.J.
(1983) J. Biol. Chem. 258:12632-12640.
Goldstein, M., Bronaugh, R.L., Ebstein, B. & Roberge, C. (1976) Brain 
Res. 109:563-574.
Gorelick, F.S., Cohn, J.A., Freedman, S.D., Delahunt, N.G., Gershoni, 
J.M. & Jamieson, J.D. (1983) J. Cell. Biol. 97:1294-1298.
Gould, K.L., Woodgett, J.R., Cooper, J.A., Buss, J.E., Shalloway, D. & 
Hunter, T. (1985) Cell 42:849-857.
Gould, K.L., Woodgett, J.R., Isacke, C.M. & Hunter, T. (1986) Mol. Cell. 
Biol. 6:2738-2744.
Grand, R.J.A. & Perry, S.V. (1980) Biochem. J. 189:227-240.
Greene, D.A. & Lattimer, S.A. (1986) Diabetes 35:242-245.
Greene, L.A. & Rein, G. (1978) J. Neurochem. 30:549-555.
Greene, L.A. & Tischler, A.S. (1976) Proc. Natl. Acad. Sci. USA 73:2424- 
2428.
Greengard, P. (1978) Science 199:146-152.
Greengard, P. (1987) Mol. Neurobiol. 1:81-117.
Greengard, P., Kuo, J.F. & Miyamoto, E. (1971) In: Advances in Enzyme 
Regulation, Vol. 9, ed. G. Weber, Pergamon, NY, pp. 113-125.
Griffith, L., Nose, P.S. & Schulman, H. (1985) Fed. Am. Soc. Exp. Biol. 
44:706 (abstr.).
Halsey, D.L., Girard, P.R., Kuo, J.F. & Blackshear, P.J. (1986) J. Biol. 
Chem. 262:2234-2243.
Hammond, C., Paupardin-Tritsch, D., Nairn, A.C., Greengard, P.
& Gershenfeld, H.M. (1987) Nature 325:809-811.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
136
Hannun, Y.A., Loomis, C.R. & Bell, R.M. (1985) J. Biol. Chem. 260:10039- 
10043.
Hannun, Y.A., Loomis, C.R., Merrill, A.H., Jr. & Bell, R.M. (1986) J. 
Biol. Chem. 261:12604-12609.
Hansson, A., Serhan, C.N., Haeggstrom, J., Ingelman-Sundberg, M. & 
Samuelsson, B. (1986) Biochem. Biophys. Res. Commun. 134:1215-1222.
Hawthorne, J. N. & Pickard, M.R. (1979) J. Neurochem. 32:5-14.
Haycock, J.W., Meligeni, J.A., Bennett, W.F. & Waymire, J.C. (1982a) J. 
Biol. Chem. 257:12641-12648.
Haycock, J.W., Bennett, W.F., George, R.J. & Waymire, J.C. (1982b) J. 
Biol. Chem. 257:13699-13703.
Haycock, J.W., Browning, M.D. & Greengard, P. (1988) Proc. Natl. Acad. 
Sci. U.S.A. 85:1677-1681.
Hemmings, H.C., Jr., Naim, A.C. , Aswad, D.W. & Greengard, P. (1984a) J. 
Neurosci. 4:99-110.
Hemmings, H.C., Jr., Nairn, A.C. & Greengard, P. (1984b) J.Biol. Chem. 
259:14491-14497.
Hidaka, M., Inagaki, M., Kawamoto, S. & Sasaki, Y. (1984) Biochem. 
23:5036-5041.
Hincke, M.T. & Tolnai, S. (1986) Biochem. Biophys. Res. Commun. 137:559- 
565.
Hirasawa, K. & Nishizuka, Y. (1985) Ann. Rev. Pharmacol. Toxicol. 
25:147-170.
Hirota, K., Hirota, T., Aguilera, G. & Catt, K.J. (1985) J. Biol. Chem. 
260:3243-3246.
Hokin, L. E. (1985) Ann. Rev. Biochem. 54:205-235.
Hokin, M.R. & Hokin, L.E. (1953) J. Biol. Chem. 203:967-977.
Hokin, M.R. & Hokin, L.E. (1964) In: The Metabolism and Physiological 
Significance of Lipids, eds. R.M.C. Dawson & D.N. Rhodes, Wiley, London, 
pp. 423-434.
Holian, 0., Kumar, R. & Nyhus, L.M. (1986) Biochem. Intl. 12:933-939.
Horwitz, J., Tsymbalov, S. & Perlman, R.L. (1984) J. Pharmacol. Exp. 
Ther. 229:577-582.
Hoshijima, M. Kikuchi, A., Tanimoto, T., Kaibuchi, K. & Takai, Y. (1986) 
Cancer Res. 46:3000-3004.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
137
Houchi, H., Nakanishi, H. , Uddin, M.M., Ohuchi, T. & Oka, M. (1985) FEBS 
Lett. 188:205-208.
Hu, G.-Y., Hvalby, 0., Walaas, S.I., Albert, K.A., Skjeflo, P.,
Andersen, P. & Greengard, P. Nature 328:426-429.
Huang, F.L. , Yoshida, Y., Nakabayashi, H. & Huang, K.P. (1987) J. Biol.
Chem. 262:15714-15720.
Huang, K.P. & Huang, F.L. (1986) J. Biol. Chem. 261:14781-14787.
Huang, K.P., Nakabayashi, H. & Huang, F.L. (1986) Proc. Natl. Acad. USA
83:8535-8539.
Hucho, F., Kruger, H., Pribilla, I. & Oberdieck, U. (1987) FEBS Lett. 
211:207-210.
Huganir, R.L., Albert, K.A. & Greengard, P. (1983) Abstr. 13th Ann. 
Meeting Soc. Neurosci. 9:578.
Hunter, T., Ling, N. & Cooper, J.A. (1984) Nature 311:480-483.
Huttner, W.B. & Greengard, P. (1979) Proc. Natl. Acad. Sci. USA 76:5402- 
5406.
Huttner, W.B., Schiebler, W., Greengard, P. & DeCamilli, P. (1983) J. 
Cell Biol. 96:1374-1388.
Hutton, J.C. (1986) Cell Calcium 7:339-352.
Ikebe, M., Inagaki, M., Kanamura, K. & Hidaka, H. (1985) J. Biol. Chem. 
260:11404-11414.
Ikeno, T., Dickens, G., Lloyd, T. & Guroff, G. (1981) J. Neurochem. 
.36:1631-1640.
Imaoka, T., Lynham, J.A. & Haslam, R.J. (1983) J. Biol. Chem. 258:11404- 
11414.
Imazu, M., Strickland, W.G., Chrisman, T.D. & Exton, J.H. (1984) J.
Biol. Chem. 259:1813-1821.
Inoue, E.G., Kishimoto, A., Takai, Y. & Nishizuka, Y. (1977) J. Biol. 
Chem. 252:7610-7616.
Ip, N.Y., Perlman, R.L. & Zigmond, R.E. (1982) J. Pharmacol. Exp. Ther. 
223:280-283.
Irvine, R.F., Dawson, R.M.C. 6c Freinkel, N. (1982) In: Contemporary 
Metabolism, Vol. 2, ed. N. Freinkel, Plenum, NY, pp. 301-342.
Isacke, C.M., Meisenhelder, J., Brown, K.D., Gould, K.L., Gould, S.J. 6c 
Hunter, T. (1986) EMBO J. 5:2889-2898.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
138
Isobe, T. & Okayama, T. (1978) Eur. J. Biochem. 89:379-388.
Isobe, T. , Ishioka, N. & Okayama, T. (1981) Eur. J. Biochem. 115:469- 
474.
Itano, T., Itano, R. & Penniston, J. (1980) Biochem. J. 189:455-459.
Iwasa, Y., Takai, Y. , Kikkawa, U. 6c Nishizuka, Y. (1980) Biochem. 
Biophys. Res. Commun. 96:180-187.
Iwasa, Y. & Hosey, M. (1984) J. Biol. Chem. 259:534-540.
Jahn, R., Schiebler, W. & Greengard, P. (1984) Proc. Natl. Acad. Sci.
USA 81:1684-1687.
Jaken, S., Tashjian, A.G., Jr. & Blumberg, P.M. (1981) Cancer Res. 
41:2175-2181.
Jerry, A.Y., Sharkey, N.A. & Blumberg, P.M. (1986) Cancer Res. 45:5714- 
5721.
Johnson, D.A., Gautsch, J.W., Sporstman, J.R. & Elder, J.H. (1984) Gene 
Anal. Tech. 1:3-8.
Johnson, P.C., Ware, J.A., Cliveden, P.B., Smith, M., Dvorak, A.M. & 
Salzman, E.W. (1985) J. Biol. Chem. 260:2069-2076.
Kaczmarek, L.K., Jennings, K.R., Strumwasser, F., Nairn, A.C., Walter,
U., Wilson, F.D. & Greengard, P. (1980) Proc. Natl. Acad. Sci. USA 
77:7492-7496.
Kaibuchi, K., Takai, Y. & Nishizuka, Y. (1981) J. Biol. Chem. 256:7146- 
7149.
Kaibuchi, K., Takai, Y., Sawamura, M., Hoshijima, M., Fujikura, T. & 
Nishizuka, Y. (1983) J. Biol. Chem. 258:6701-6704.
Kamps, M.P., Buss, J.E. & Sefton, B.M. (1985) Proc. Natl. Acad. Sci. USA 
82:4625-4628.
Katoh, N. & Kuo, J. F. (1982) Biochem. Biophys. Res. Commun. 106:590- 
595.
Katz, F., Ellis, L. & Pfenninger, K.H. (1985) J. Neurosci. 5:1402-1411.
Kawahara, Y., Takai, Y., Minakuchi, R., Sano, K. & Nishizuka, Y. (1980) 
Biochem. Biophys. Res. Commun. 97:309-317.
Kawamoto, S. & Hidaka, H. (1984) Biochem. Biophys. Res. Commun. 118:736- 
742.
Kelly, P. T. & Luttges, M. W. (1975) J. Neurochem. 24:1077-1079.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
139
Khanna, N.C., Tokuda, M., Chong, S.M. & Waisman, D.M. (1986) Biochem. 
Biophys. Res. Commun. 137:397-403.
Kikkawa, TJ., Takai, Y., Minakuchi, R. , Inohara, S. & Nishizuka, Y.
(1982) J. Biol. Chem. 257:13341-13348.
Kikkawa, U., Minakuchi, R., Takai, Y. & Nishizuka, Y. (1983a) Meth. 
Enzymol. 99:288-298.
Kikkawa, U., Takai, Y., Tanaka, Y., Miyaka, R. & Nishizuka, Y. (1983b)
J. Biol. Chem. 258:11442-11445.
Kikkawa, TJ. & Nishizuka, Y. (1986) Ann. Rev. Cell Biol. 2:149-178.
Kimura, K., Sakurada, K. 6c Katoh, N. (1985) Biophys. Biochim. Acta 
839:276-280.
Kishimoto, A., Takai, Y., Mori, T., Kikkawa, U. 6c Nishizuka, Y. (1980)
J. Biol. Chem. 255:2273-2276.
Kishimoto, A., Kajikawa, N., Shiota, M. 6c Nishizuka, Y. (1983) J. Biol. 
Chem. 258:1156-1164.
Kishimoto, A., Nishigawa, K., Nakanishi, H., Uratsuji, Y., Nomura, H., 
Takegawa, Y. 6c Nishizuka, Y. (1985) J. Biol. Chem. 260:12492-12499.
Kitano, T., Hashimoto, T., Kikkawa, U . , Ase, K., Saito, N., Tanaka, C., 
Ichimori, Y. , Tsukamoto, K. & Nishizuka, Y. (1987) J. Neurosci. 2:1520- 
1525.
Klee, C.B. 6c Vanaman, T.C. (1982) Adv. Protein Chem. 35:213-321.
Kligman, D. 6c Patel, J. (1986) J. Neurochem. 47:298-303.
Knight, D.E. 6c Baker, P.F. (1983) FEBS Lett. 160:98-100.
Knopf, J.L., Lee, M.M., Sultzman, L.A., Kriz, R.W., Loomis, C.R.,
Hewick, R.M. 6c Bell, R.M. (1986) Cell 46:491-502.
Korn, F., Gschwendt, M. 6c Marks, F. (1985) Eur. J. Biochem. 148:533-538.
Kraft, A.S., Anderson, W.B., Cooper, H.L. 6c Sando, J.J. (1982) J. Biol. 
Chem. 257:13193-13196.
Kraft, A.S. & Anderson, W.B. (1983) Nature 301:621-623.
Krebs, E.G., Love, D.S., Bratvold, G.E., Trayser, K.A., Meyer, W.L. 6c 
Fischer, E.H. (1964) Biochemistry .3:1027.
Krebs, E.G. 6c Beavo, J.A. (1979) Ann. Rev. Biochem. 4j3:923-959. 
Kretsinger, R.H. 6c Nockolds, C.E. (1973) J. Biol. Chem. 248:3313-3326.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
140
Kretsinger, R.H. & Nelson, D.J. (1977) Coord. Chem. Rev. 18:29-124.
Kuo, J.F. & Greengard, P. (1969) Proc. Natl. Acad. Sci. USA 64:1349- 
1355.
Kuo, J.F. 6c Greengard, P. (1970) J. Biol. Chem. 245:2493-2498.
Kuo, J.F., Andersson, R.C.G., Wise, B.C., Mackerlova, L., Salomonsson, 
I., Brackett, N.L., Katoh, N., Shoji, M. 6c Wrenn, R.W. (1980) Proc. 
Natl. Acad. Sci. USA 77:7039-7043.
Kuret, J. & Schulman, H. (1984) Biochemistry 23:5495-5504.
Laemmli, U.K. (1970) Nature 227:680-685.
Lagast, H., Pozzan, T., Waldvogel, F.A. 6c Lew, P.D. (1984) J. Clin. 
Invest. 73:878-883.
Laurent, T.C. 6c Killander, J. (1964) J. Chromatog. 14:317-330.
Le Peuch, C.J., Ballester, R. 6c Rosen, O.M. (1983) Proc. Natl. Acad. 
Sci. USA 80:6858-6862.
Leach, K.K., James, M.L. 6c Blumberg, P.M. (1985) Cancer Res. 45:1958- 
1963.
Lee, L. 6c Weinstein, I.B. (1978) Science 202:313-315.
Legrand, C.H., Clos, J. , Legrand, J., Langley, O.K., Ghandour, M.S., 
Labourdette, G., Gombos, G. 6c Vincendon, G. (1981) Neuropathol. Appl. 
Neurobiol. 2:299-306.
Limas, C.J. (1980) Biochem. Biophys. Res. Commun. 96:1378.
Lin, C.R., Chen, W.S., Lazar, C.S., Carpenter, C.D., Gill, G.N., Evans, 
R.M. 6c Rosenfeld, M.G. (1986) Cell 44:839-848.
Liskamp, R.M.J., Brothman, A.R., Arcoleo, J.P., Miller, O.J. 6c 
Weinstein, I.B. (1985) Biochem. Biophys. Res. Commun. 131:920-927.
Litosch, I., Wallis, C. 6c Fain, J.N. (1985) J. Biol. Chem. 260:5464- 
5471.
Llinas, R., McGuinness, T., Leonard, C.S., Sugimori, M. 6c Greengard, P.
(1985) Proc. Natl. Acad. Sci. USA 82:3035-3039.
Mackie, K., Lai, Y., Nairn, A.C., Greengard, P., Lazo, J. 6c Pitt, B.R.
(1985) Fed. Proc. Fed. Am. Soc. Exp. Biol. 44:908.
Mahadevan, L.C., Aitken, A., Heath, J. 6c Foulkes, J.G. (1987) EMBO J. 
6:921-926.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
141
Malkinson, A.M., Beer, D.S., Sadler, A.J. & Coffman, D.S. (1985) Cancer 
Res. 45:5751-5756.
Markey, K.A., Kondo, S., Shenkman, L. & Goldstein, M. (1980) Mol. 
Pharmacol. 17:79-85.
Martin, R.G. & Ames, B.N. (1961) J. Biol. Chem. 236:1372-1379.
Mazzei, G.J. and Kuo, J.F. (1984) Biochem. J. 218:361-369.
Mazzei, G.J., Katoh, N. & Kuo, J.F. (1982) Biochem. Biophys. Res. 
Commun. 109:1129-1133.
Mazzei, G.J., Schatzman, R.C., Turner, R.S., Vogler, W.R. & Kuo, J.F.
(1984) Biochem. Pharmacol. 33:125-130.
McCaffrey, P.G., Friedman, B.A. & Rosner, M.R. (1984) J. Biol. Chem. 
259:12502-12507.
McDonald, J.R. & Walsh, M.P. (1985a) Biochem. Biophys. Res. Commun. 
129:603-610.
McDonald, J.R. & Walsh, M.P. (1985b) Biochem. J. 232:559-567.
McDonald, J.R. & Walsh, M.P. (1986) Biochem. Soc. Trans. 14:585-586.
McDonald, J.R., Groschel-Stewart, U. & Walsh, M.P. (1987) Biochem. J. 
242:695-705.
McGuinness, T.L., Lai, Y., Greengard, P., Woodgett, J.R. & Cohen, P.
(1983) FEBS Lett. 163:328-334.
McGuinness, T.L., Lai, Y. & Greengard, P. (1985) J. Biol. Chem. 
260:1636-1704.
McPhail, L.C., Clayton, C.C. & Snyderman, R. (1984) Science 224:622-625.
McPherson, J.M., Whitehouse, S. & Walsh, D.A. (1979) Biochemistry 
18:4835-4844.
McTigue, M., Cremins, J. & Halegoua, S. (1985) J. Biol. Chem. 260:9047- 
9056.
Meligeni, J.A., Haycock, J.W., Bennett, W.F. & Waymire, J.C. (1982) J. 
Biol. Chem. 257:12632-12640.
Michell, R.H. (1975) Biochim. Biophys. Acta 415:81-147.
Michener, M.L., Dawson, W.B. & Creutz, C.E. (1986) J. Biol. Chem. 
261:6548-6555.
Minakuchi, R. , Takai, Y. , Yu, B. & Nishizuka, Y. (1981) J. Biochem. 
89:1651-1654.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
142
Miyamoto, E., Kuo, J.F. & Greengard, P. (1969) Science 165:63-65.
Mobley, P.L. (1986) Abstr. 16th Ann. Meeting Soc. Neurosci. 12:900.
Mobley, P.L., & Harrison, B.C. (1987) Abstr. 17th Ann. Meeting Soc. 
Neurosci. 13:1203.
Mochly-Rosen, D., Basbaum, A.I. & Koshland, D.E., Jr. (1987) Proc. Natl. 
Acad. Sci. USA 84:4660-4664.
Molina y Vedia, L.M. & Lapetina, E. (1986) J. Biol. Chem. 261:10493- 
10495.
Moolenar, W.H. , Tertoolen, L.G.J. 6c deLaat, S.W. (1984) Nature 312:371- 
374.
Moore, B.W. (1965) Biochem. Biophys. Res. Commun. 19:739-744.
Moore, S. (1963) J. Biol. Chem. 238:235-237.
Morgan, J.P. 6c Morgan, K.G. (1982) Pflugers Arch. 395:75-77.
Morgenroth, V.H., III, Hegstrand, L.R., Roth, R.H. 6c Greengard, P.
(1975) J. Biol. Chem. 250:1946-1948.
Mori, T., Takai, Y., Minakuchi, R., Yu, B. 6c Nishizuka, Y. (1980) J. 
Biol. Chem. 255:8378-8380.
Mori, T., Takai, Y., Yu, B. , Takahashi, J., Nishizuka, Y. 6c Fujikura, T. 
(1982) J. Biol. Chem. 257:7847-7851.
Morrissey, J.H. (1981) Anal. Biochem. 117:307-310.
Movesian, M.A., Nishikawa, M. 6c Adelstein, R. (1984) J. Biol. Chem. 
259:8029-8032.
Murakami, K. 6c Routtenberg, A. (1985) FEBS Lett. 192:189-193.
Murrin, L.C. 6c Roth, R.H. (1976) Mol. Pharmacol. 12:463-475.
Nagatsu, T., Levitt, M. 6c Udenfrxend, S. (1964a) J. Biol. Chem. 
239:2910-2917.
Nagatsu, T., Levitt, M. 6c Udenfriend, S. (1964b) Anal. Biochem. 9:22- 
127.
Nagle, D.S., Jaken, S., Castagna, M. 6e Blumberg, P.M. (1981) Cancer Res. 
41:89-93.
Nagle, D.S. 6c Blumberg, P.M. (1983) Cancer Lett. 18:35-40.
Nahorski, S.R., Kendall, D.A. 6c Batty, I. (1986) Biochem. Pharmacol. 
35:2447-2454.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
143
Nairn, A.C. & Greengard, P. (1983) Abstr. 13th Ann. Meeting Soc. 
Neurosci. 9:1029.
Nairn, A.C. & Greengard, P. (1987) J. Biol. Chem. 262:7273-7281.
Nairn, A.C. & Palfrey, H.C. (1987) J. Biol. Chem. 262:17299-17303.
Naim, A.C. & Perry S.V. (1979) Biochem. J. 179:89-97.
Nairn, A.C., Bhagat, B. & Palfrey, H.C. (1985a) Proc. Natl. Acad. Sci. 
USA 82:7939-7943.
Nairn, A.C., Hemmings, H.C., Jr. & Greengard, P. (1985b) Ann. Rev. 
Biochem. 54:931-976.
Naka, M., Nishikawa, M., Adelstein, R.S. & Hidaka, H. (1983) Nature 
306:490-492.
Nel, A.E., Wooten, M.W., Landreth, G.E., Goldschmidt-Clermont, P.J., 
Stevenson, H.C., Miller, P.J. & Galbraith, R.M. (1986) Biochem. J. 
233:145-149.
Nestler, E.J. & Greengard, P. (1984) Protein Phosphorylation in the 
Nervous System, Wiley, NY.
Nichols, R.A., Haycock, J.W., Wang, J.K.T. & Greengard, P. (1987) J. 
Neurochem. 48:615-621.
Niedel, J.E. & Blackshear, P.J. (1986) In: Receptor Biochemistry and
Methodology, Vol. 7, ed. J.W. Putney, Jr., Alan R. Liss, NY, pp. 47-88.
Niedel, J.E., Kuhn, L.J. & Vandenbark, G.R. (1983) Proc. Nat. Acad. Sci. 
USA 80:36-40.
Nishikawa, M., Hidaka, H. & Adelstein, R.S. (1983) J. Biol. Chem. 258: 
14069-14072.
Nishikawa, M., Sellers, J.R., Adelstein, R.S. & Hidaka, H. (1984) J. 
Biol. Chem. 259:8808-8814.
Nishikawa, M., Shirakawa, S. & Adelstein, R.S. (1985) J. Biol. Chem. 
260:8978-8983.
Nishizuka, Y. (1983) Trends Biochem. Sci. 8:13-16.
Nishizuka, Y. (1984a) Nature 308:693-698.
Nishizuka, Y. (1984a) Science 225:1365-1370.
Nishizuka, Y. (1986) Science 233:305-312.
Nose, P.S., Griffith, L.C. & Schulman, H. (1985) J. Cell Biol. 101:1182- 
1190.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
144
O'Brian, C.A., Lawrence, D.S., Kaiser, E.T. & Weinstein, I.B. (1984)
Biochem. Biophys. Res. Commun. 124:296-302.
O'Brian, C.A., Liskamp, R.M., Solomon, D.H. & Weinstein, I.B. (1985)
Cancer Res. 45:2462-2465.
0'Farrell, P.H. (1975) J. Biol. Chem. 250:4007-4021.
Ohkubo, S., Yamada, E., Endo, T., Itoh, H. & Hidaka, H. (1984) Biochem. 
Biophys. Res. Commun. 118:460-466.
Ohno, S., Kawasaki, H., Imajoh, S., Suzuki, K., Inayashi, M., Yokokima, 
H., Sakoh, T. & Hidaka, H. (1987) Nature 325:161-166.
Ohsawa, K. & Ebata, N. (1983) Anal. Biochem. 135:409-415.
Olmsted, J.B. (1981) J. Biol. Chem. 256:11955-11957.
Ouimet, C.C., Wang, J.K.T., Albert, K.A. & Greengard, P. (1988) 
manuscript in preparation.
Ono, Y., Kurokawa, T., Kawahara, K., Nishimura, 0., Marumoto, R., 
Igarashi, K., Sugino, Y., Kikkawa, U., Ogita, K. & Nishizuka, Y. (1986) 
FEBS Lett. 203:111-115.
Padel, U. & Soling, H.-D. (1985) Eur. J. Biochem. 151:1-10.
Papini, E., Grzeskowiak, M., Bellavite, P. & Rossi, F. (1985) FEBS Lett. 
190:204-208.
Parker, P.J., Stabel, S. & Waterfield, M.D. (1984) EMBO J. 3:953-959.
Parker, P.J., Katan, M., Waterfield, M.D. & Leader, D.P. (1985) Eur. J. 
Biochem. 148:579-586.
Parker, P.J., Coussens, L., Totty, N., Rhee, L. , Young, S., Chen, E., 
Stabel, S., Waterfield, M.D. & Ullrich, A. (1986) Science 233:853-859.
Patel, J. & Marangos, P.J. (1982) Biochem. Biophys. Res. Commun. 
109:1089-1093.
Patel, J. & Marangos, P.J. (1983) Abstr. 13th Ann. Meeting Soc.
Neurosci. 9:595.
Patel, J., Marangos, P.J., Heydorn, W.E., Chang, G., Verma, A. & 
Jacobowitz, D. (1983) J. Neurochem. 41:1040-1045.
Paupardin-Tritsch, D., Hammond, C., Gershenfeld, H.M., Nairn, A.C. & 
Greengard P. (1986) Nature 323:812-814.
Payne, M.E., Schworer, C.M. & Soderling, T.R. (1983) J. Biol. Chem. 
258:2376-2382.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
145
Pellman, D., Garber, E.A., Cross, F.R. & Hanafusa, H. (1985) Nature 
314:374-377.
Perrone-Bizzozero, N.I., Apostolides, P.J., Finklestein, S.P., Benowitz, 
L.I. & Bizzozero, 0. (1987) Abstr. 17th Ann. Meeting Soc. Neurosci. 
13:1478.
Perry, S.V., Cole, H.A., Frearson, H., Moir, A.J.G., Nairn, A.C. & 
Solaro, R.J. (1978) Proc. FEBS 12th Meeting 54:147-152.
Peterson, G.L. (1977) Anal.Biochem. 83:346-356.
Pocotte, S.L., Frye, R.A., Senter, R.A., TerBush, D.R., Lee, S.A. &
Holz, R.W. (1985) Proc. Natl. Acad. Sci. USA 82:930-934.
Pocotte, S.L. & Holz, R.W. (1986) J. Biol. Chem. 261:1873-1877.
Poehling, H.M. & Neuhoff, V. (1981) Electrophoresis 2:141-147.
Pozzan, T., Gatti, G., Dozio, N., Vicentini, L.M. ^ Meldolesi, J. (1984) 
J. Cell Biol. 99:628-638.
Publicover, S.J. (1985) Brain Res. 333:185-187.
Purchio, A.F., Shoyab, M. & Gentry, L.E. (1985) Science 229:1393-1395.
Raese, J.D., Edelman, A.M., Makk, G., Bruckwick, E.A., Lovenberg, W. & 
Barchas, J.D. (1979) Commun. Psychopharmacol. 3:295-301.
Rail, T.W., Sutherland, E.W. & Berthet, J. (1957) J. Biol. Chem. 
224:463-475.
Rando, R.R. & Young, Y. (1984) Biochem. Biophys. Res. Commun. 122:818- 
823.
Rane, S.G., Walsh, M.P. 6c Dunlap, K. (1987) Abstr. 17th Ann. Meeting 
Soc. Neurosci. 13:793.
Rein, A., McClure, M.R., Rice, N.R., Luftig, R.B. & Schultz, A.M. (1986) 
Proc. Natl. Acad. Sci. USA 83:7246-7250.
tt
Reymann, K.G., Malisch, R., Schulzeck, K., Brodemann, R., Ott, T. 6c 
Matt'nies, H. (1985) Brain Res. Bull. 15:249-255.
Ringer, S. (1883) J. Physiol. (London) 4:29-42.
Roach, P.J. 6c Goldman, M. (1983) Proc. Natl. Acad. Sci. USA 80:7170- 
7172.
Rodriguez-Pena, A. 6c Rozengurt, E. (1985) EMB0 J. 4: 71-76.
Rodriguez-Pena, A. 6c Rozengurt, E. (1986) EMBO J. 5: 77-83.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
146
Rosoff, P.M., Stein, L.F. & Cantley, L.C. (1984) J. Biol. Chem. 
259:7056-7060.
Rouis, M., Thomopoulos, P., Haziot, A. & Broquet, C. (1986) Exp. Cell 
Res. 164:556-561.
Routtenberg, A., Lovinger, D.M. & Steward, 0. (1985) Behav. Neur. Biol. 
43:3-11.
Rozengurt, E., Rodriguez-Pena, M. & Smith, K.A. (1983) Proc. Natl. Acad. 
Sci. USA 80:7244-7248.
Rozengurt, E., Rodriguez-Pena, A., Coombs, M. & Sinnett-Smith, J. (1984) 
Proc. Natl. Acad. Sci. USA 81:5748-5752.
Sagara, J., Yamada, K.M. & Kakunaga, T. (1986) Cancer Res. 46:5291-5296.
Sagi-Eisenberg, R., Lieman, H. & Pecht, I. (1985) Nature 313:59-60.
Saitoh, T. & Dobkins, K.R. (1986) Brain Res. 379:196-199.
Sano, K., Takai, Y., Yamanishi, J. & Nishizuka, Y. (1983) J. Biol. Chem. 
258:2010-2013.
Sando, J.J. & Young, M.C. (1983) Proc. Natl. Acad. Sci. USA 80:2642- 
2646.
Sato, C., Nishizawa, K., Nakayama, T. & Kobayashi, T. (1985) J. Cell 
Biol. 100:748-753.
Schachman, H.K. (1959) Ultracentrifugation in Biochemistry, Academic 
Press, Inc., NY, p. 239
Schatzman, R.C., Wise, B.C. & Kuo, J.F. (1981) Biochem. Biophys. Res. 
Commun. 98:669-676.
Schatzman, R.C., Raynor, R.L., Fritz, R.B. & Kuo, J.F. (1983) Biochem J . 
209:435-443.
Schulman, H. (1982) In: Handbook of Experimental Pharmacology 58/1, eds. 
J.A. Nathanson & J.W. Kebabian, Springer, NY, pp. 425-478.
Schulman, H. & Greengard, P. (1978) Nature 271:478-479.
Schwantke, N. 6c LePeuch, C.J. (1984) FEBS Lett. 177:36-40.
Sefton, B.M. 6c Buss, J.E. (1987) J. Cell. Biol. 104:1449-1453.
Shackleford, D.A. 6c Trowbridge, I.S. (1984) J. Biol. Chem. 259:11706- 
11712.
Shackleford, D.A. 6c Trowbridge, I.S. (1986) J. Biol. Chem. 261:8334- 
8341.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
147
Shoji, M., Girard, P.R., Mazzei, G.J., Vogler, W.R. & Kuo, J.F. (1986) 
Biochem. Biophys. Res. Commun. 135:1144-1149.
Shoyab, M., DeLarco, J.E. & Todaro, J.G. (1979) Nature 279:387-391.
Shoyab, M. & Todaro, G.J. (1980) Nature 288:451-455.
Shoyab, M. (1985) Arch. Biochem. Biophys. 236:435-440.
Siegart, W. , Schulman, H. & Greengard, P. (1980) J. Neurochem. 34:548- 
553.
Siegel, L.M. & Monty, K.J. (1966) Biochim. Biophys. Acta 112:346-362. 
Sinnett-Smith, J.W. & Rozengurt, E. (1985) J. Cell Physiol. 124:81-86. 
Skene, J.H.P. (1984) Cell 37:697-700.
Solanki, V., Slaga, T.J., Callahan, M. & Huberman, E. (1981) Proc. Natl. 
Acad. Sci. USA 78:1722-1725.
Streb, H., Irvine, R.F., Berridge, M.J. & Schulz, I. (1983) Nature 
306:67-69.
Su, H.-D., Kemp B.E., Turner, R.S. & Kuo, J.F. (1986) Biochem. Biophys. 
Res. Commun. 134:78-84.
Summers, T.A. & Creutz, C.E. (1985) J. Biol. Chem. 260:2437-2443.
Tachikawa, E., Tank, A.W., Yanazihara, N., Mosimann, W. & Weiner, N.
(1986) Mol. Pharmacol. 30:476-485.
Takai, Y., Kishimoto, A., Inoue, M. & Nishizuka, Y. (1977) J. Biol.
Chem. 252:7603-7609.
Takai, Y., Kishimoto, A., Kikkawa, U., Mori, T., & Nishizuka, Y. (1979a) 
Biophys. Biochem. Res. Commun. 91:1218-1224.
Takai, Y., Kishimoto, A., Iwasa, M., Kawahara, Y., Mori, T. & Nishizuka,
Y. (1979b) J. Biol. Chem. 255:2273-2276.
Takai, Y . , Kishimoto, A., Iwasa, Y., Kawahara, Y., Mori, T., Nishizuka,
Y., Tamura, A. & Fujii, T. (1979c) J. Biochem. (Tokyo) 86:575-578.
Tamaoki, T., Nomoto, H., Takahashi, I., Kato, Y., Morimoto, M. & Tomita, 
F. (1986) Biochem. Biophys. Res. Commun. 135:397-402.
Tamura, T., Friis, R.R. & Bauer, H. (1984) FEBS Lett. 177:151-156.
Tanaka, C. Taniyama, K. & Kusunoki, M. (1984) FEBS Lett. 175:165-169.
Tanaka, C., Fujiwara, H. & Fujii, Y. (1986) FEBS Lett. 195:129-134.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
148
Tanaka, T., Ohmura, T. & Hidaka, H. (1982) Mol. Pharamcol. 22:403-407.
Teo, T.S. & Wang, J.H. (1973) J. Biol. Chem. 248:5950-5955.
Thayer, S.A., Lemon, R.H. & Fairhurst, A.S. (1983) J. Neurochem. 
41:1090-1093.
Towbin, H., Staehelin, T. & Gordon, J. (1979) Proc. Natl. Acad. Sci.
USA 76:4350-4354.
Trevillyan, J.M., Kulkarni, R.K. & Byus, C.V. (1984) J. Biol. Chem. 
259:897-902.
Trevillyan, J.M., Perisic, 0., Traugh, J.A. & Byus, C.V. (1985) J. Biol. 
Chem. 260:3041-3044.
Tsien, R.Y., Pozzan, T. & Rink, T.J. (1982) Nature 295:68-71.
Tsuda, T., Kaibuchi, K., Kawahara, Y., Fukuzaki, H. & Takai, Y. (1985) 
FEBS Lett. 191:205-210.
Tsuyama, S., Bramblett, G.T., Huang, K.-P. & Flavin, M. (1986) J. Biol. 
Chem. 261:4110-4116.
Turgeon, J.L. & Cooper, R.H. (1986) Biochem. J. 237:53-61.
Turner, R.S., Kemp., B.E., Su, H.-D. & Kuo, J.F. (1985) J. Biol. Chem. 
260:11503-11507.
Uchida, T. & Filburn, C.R. (1984) J. Biol. Chem. 259:12311-12314.
Ueda, T. & Greengard, P. (1977) J. Biol. Chem. 252:5155-5163.
Uratsuji, Y., Nakamishi, H., Takegawa, Y., Kishimoto, A. 6c Nishizuka, Y.
(1985) Biochem. Biophys. Res. Commun. 130:654-661.
Vilgrain, I., Cochet, C. 6c Chambaz, E.M. (1984) J. Biol. Chem. 259:3404-
3406.
Van Dongen, C.J., Zwiers, H., De Graan, P.N.E. 6c Gispen, W.H. (1985) 
Biochem. Biophys. Res. Commun. 128:1219-1227.
Vrana, K.E. 6c Roskoski, R., Jr. (1983) J. Neurochem. 40:1692-1700.
Vrana, K.E., Allhiser, C.L. 6c Roskoski, R., Jr. (1981) J. Neurochem. 
36:92-100.
Vulliet, P.R., Langan, T.A. 6c Weiner, N. (1980) Proc. Natl. Acad. Sci. 
USA 77:92-96.
Vulliet, P.R., Woodgett, J.R., Ferrari, S. 6cHardie, D.G. (1985) FEBS 
Lett. 182:335-339
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
149
Walaas, S.I., Naim, A.C. & Greengard, P. (1983a) J. Neurosci. 3:291- 
301.
Walaas, S.I., Naim, A.C. & Greengard, P. (1983b) J. Neurosci. 3:302- 
311.
Walaas, S.I., Naim, A.C. & Greengard, P. (1986) J. Neurosci. 6:954-961.
Walsh, D.A., Perkins, J.P. 6c Krebs, E.G. (1968) J. Biol. Chem. 243:3763- 
3765.
Walsh, M.P., Valentine, K.A., Ngai, P.K., Carruthers, C.A. 6c 
Stollenberg, M.D. (1984) Biochem. J. 224:117-127.
Wang, J. K.-T., Walaas, S.I. & Greengard, P. (1985) Abstr. 15th Ann. 
Meeting Soc. Neurosci. 11:846.
Wang, J. K.-T., Walaas, S.I. 6e Greengard, P. (1988) J. Neurosci. .8:281- 
288.
Weiner, N. (1970) Ann. Rev. Pharmacol. 10:273-290.
Weiner, N., Lee, F.-L., Dreyer, E. 6c Barnes, E. (1970) Life Sci. 
22:1197-1216.
Werth, D.K. & Pastan, I. (1984) J. Biol. Chem. 259:5264-5270.
Werth, D.K., Niedel, J.E. 6c Pastan, I. (1983) J. Biol. Chem. 258:11423- 
11426.
Whittaker, J.R. (1963) Anal. Chem. 35:1950-1953.
Whittaker, V.P. 6e Barker, L.A. (1972) In: Methods of Neurochemistry,
Vol. 2, ed. R. Fried, Dekker, NY, pp. 1-52.
Wightman, P.D. 6c Raetz, R.R.M. (1984) J. Biol. Chem. 259:10048-10052.
Wise, B.C., Raynor, R.L. 6c Kuo J.F. (1982) J. Biol. Chem. 257:8481-8488.
Witters, L.A., Vater, C.A. 6c Lienhard, G.E. (1985) Nature 315:777-778.
Wolf, M., Sahyoun, N., Le Vine, H. Ill 6c Cuatrecasas, P. (1984) Biochem. 
Biophys. Res. Commun. 122:1268-1275.
Wolf, M., Le Vine, H. Ill, May, W.S., Jr., Cuatrecasas, P. 6c Sayhoun, N. 
(1985a) Nature 317:546-549.
Wolf, M., Cuatrecasas, P. 6c Sayhoun, N. (1985b) J. Biol. Chem. 
260:15718-15722.
Wolfman, A. 6c Macara, I.G. (1987) Nature 325:359-361.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
150
Wood, J.G., Girard, P.R., Mazzei, G.J. & Kuo, J.F. (1986) J. Neurosci. 
6:2571-2577.
Woodgett, J.R. 6c Hunter, T. (1987) J. Biol. Chem. 262:4836-4843.
Woodgett, J.R., Hunter, T. & Gould, K.L. (1987) In: Cell Membranes: 
Methods and Reviews, Vol. Ill, eds. E.L. Elson, W.A. Frazier 6c L. 
Glazer, Plenum, NY, in press.
Worley, P.F., Baraban, J.M. 6c Snyder, S.H. (1986) J. Neurosci. 6:199- 
207.
Wu, W.C.-S., Walaas, S.I., Nairn, A.C. & Greengard, P. (1982) Proc. 
Natl. Acad. Sci. USA 79:5249-5253.
Yagi, K., Yazawa, M., Kakiuchi, S., Oshima, M. 6c Uenishi, K. (1978) J. 
Biol Chem. 253:1338-1340.
Yamanishi, J., Takai, Y., Kaibuchi, K., Sano, K., Castagna, M. 6c 
Nishizuka, Y. (1983) Biochem. Biophys. Res. Commun. 112:778-786.
Yamasaki, H., Devron, C. 6c Martel, N. (1982) Carcinogenesis 3:905-910.
Yamauchi, T. 6c Fujisawa, H. (1981) Biochem. Biophys. Res. Commun. 
100:807-813.
Yamauchi, T. 6c Fujisawa, H. (1983) Eur. J. Biochem. 132:15-20.
Zachary, I., Sinnett-Smith, J.W. 6c Rozengurt, E. (1986) J. Cell Biol. 
102:2211-2222.
Zurgil, N. 6c Zisapel, N. (1985) FEBS Lett. 185:257-261.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
151
The results in this dissertation and related work have been presented in 
the following publications:
DeRiemer S. A., Kaczmarek, L. K., Albert, K. A. & Greengard, P. (1983) 
Calcium/phospholipid-dependent protein phosphorylation in Anlvsia 
neurons. Abstracts of the 13th Annual Meeting of the Society for 
Neuroscience 9:77.
Huganir, R. L., Albert, K. A. & Greengard,2^- (1983) Phosphorylation of 
the nicotinic acetylcholine receptor by Ca /phospholipid-dependent 
protein kinase, and comparison with its phophorylation by cAMP-dependent 
protein kinase. Abstracts of the 13th Annual Meeting of the Society for 
Neuroscience 9:578.
Perdahl, E., Adolfsson, R., Alafuzoff, I., Albert, K. A., Nestler, E.
J., Greengard, P. & Winblad, B. (1984) Synapsin I (Protein I) in 
different brain regions in senile dementia of Alzheimer type and 
multiinfarct dementia. J. Neural Transmission 60:133-141.
Albert, K. A., Wu, W. C.-S., Nairn, A. C. & Greengard, P. (1984) 
Inhibition by calmodulin of calcium/phospholipid-dependent protein 
phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 81:3622-3625.
Albert, K. A., Helmer-Matyjek, E., Nairn, A. C., Milller, T. H., Haycock, 
J. W., Greene, L., Goldstein, M. 6c Greengard, P. (1984) 
Calcium/phospholipid-dependent protein kinase (protein kinase C) 
phosphorylates and activates tyrosine hydroxylase. Proc. Natl. Acad. 
Sci. U.S.A. 81:7713-7717.
DeRiemer, S. A., Albert, K. A., Strong, J. A., Greengard, P. &
Kaczmarek, L. K. (1984) Electrophysiological effects of phorbol ester 
and protein kinase C on the bag cell neurons of Anlvsia. Abstracts of 
the 14th Annual Meeting of the Society for Neuroscience 10:867.
DeRiemer, S. A., Strong, J. A., Albert, K. A., Greengard, P. &
Kaczmarek, L. K. (1985) Enhancement of calcium current in Anlvsia 
neurones by phorbol ester and protein kinase C. Nature 313:313-316.
Albert, K. A., Walaas, S. I., Wang, J. K.-T. & Greengard, P. (1986) 
Widespread occurrence of "87kDa", a major specific substrate for protein 
kinase C. Proc. Natl. Acad. Sci. U.S.A. 83:2822-2826.
Hu, G.-Y., Hvalby, 0., Walaas, S. I., Albert, K. A., Skjeflo, P., 
Andersen, P. 6c Greengard, P. (1987) Protein kinase C injection into 
hippocampal pyramidal cells elicits several features of long term 
potentiation. Nature 328:426-429.
Walaas, S. I., Horn, R. S., Adler, A., Albert, K. A., 6c Walaas, 0.
(1987) Insulin increases membrane protein kinase C activity in rat 
diaphragm. FEBS Lett. 220:311-318.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
152
Albert, K. A., Naim, A. C. & Greengard, P. (1987) The 87-kDa protein, a 
major specific substrate for protein kinase C: Purification from bovine
brain and characterization. Proc. Natl. Acad Sci. U.S.A. 84:7046-7050.
Gandy, S., Grebb, J. A., Rosen, N., Albert, K., Anderson, N., Cedarbaum, 
J., Sedvall, G., Posner, J. B., & Greengard, P. (1987) Detection of 60k, 
a putative protein kinase C substrate, in the CSF of patients with 
paraneoplastic cerebellar degeneration. Abstracts of the 17th Annual 
Meeting of the Society for Neuroscience 13:498.
Aderem, A. A., Albert, K. A., Keum, M. M., Wang, J. K. T., Greengard, P. 
& Cohn, Z. A. (1988) Stimulus-dependent myristoylation of a major 
substrate for protein kinase C. Nature 332:362-364.
Walaas, S. I., Wang, J. K. T., Albert, K. A. & Greengard, P. (1988) 
Calcium/diacylglycerol-dependent protein kinase and its major 87 kDa 
substrate are differentially distributed in rat basal ganglia. J. 
Neurochem. Submitted.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
